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This thesis describes the use of compartmentalised microfluidic devices to investigate 
changes in neuronal excitability. All studies carried out in this work were completed in line 
with principles of the NC3Rs (reduction, replacement and refinement). Particular interest was 
given to the study of the excitability of dorsal root ganglion neurons (DRGs) in the context of 
pain-based signalling. This also included the in vitro culture and characterisation of non-
neuronal cells involved in inflammation and nociception.  
Current methods for In vitro modelling of pain pathways often fails to replicate the unique 
morphology of the DRG neurons. These pseudo-unipolar neurons detect nociceptive stimuli 
at the peripheral terminals, and transduce long range action-potentials to higher processing 
centres in the central nervous system. Unlike in vivo modelling of pain behaviours, in vitro 
models of nociception provide the capacity to monitor changes in neuronal function at a 
cellular and molecular level. However, until the development of technology such as 
microfluidics, the standard methods of culture failed to isolate the axons from the soma.  
The primary aim of this project was to develop a model capable of replicating the complex 
microenvironment that terminals of the DRG neurons encounter during the development and 
onset of pain. This involved the optimisation of cell culture methods for inflammatory cells 
used to induce changes in neuronal excitability, both from the context of the peripheral 
terminals, or from the CNS if desired. At a molecular level, the microfluidic model was also 
used to investigate the role of small non-coding RNA (microRNAs) on regulating DRG 
excitability in the context of nociception. This Thesis hypothesises that voltage-gated 
potassium channels form an interesting target for a microRNA of interest. However, it is 
widely acknowledged that microRNAs regulate the expression of multiple mRNAs.  
The use of functional studies using the microfluidic model have shown here that there are 
differences in the way in which a neuron responds to a stimulus, dependent on whether it is 
applied locally to the axon or the soma. Live cell imaging was used to measure evoked changes 
in Ca2+ transients as a proxy for cell excitability. As well as significant differences in the 
response to depolarising agents such as potassium chloride (KCL), the use of biologically 
relevant stimuli to the study of nociception was also developed. The culture of inflammatory 
cells such as bone marrow derived macrophages led to the development of cytokine-rich 
media which was used to evoke changes in neuronal excitability. By exploiting the microfluidic 
 14 
nature of the device, subsequent investigations to the role of microRNA 138-5p in regulating 
neuronal excitability were undertaken. The use of cell permeable microRNA inhibition 
showed a reduction in cell excitability if applied locally to the axons. Bioinformatics led to the 
development of Kv1.2 as a potential target for miR-138-5p in vivo, which could explain the 
effects of miR-138-5p in modulating excitability of the DRGs. 
The findings in this work have demonstrated the potential for development of more 
biologically relevant in vitro models using microfluidic compartmentalised cell culture. For 
example, fluidic isolation has characterised the role of miR-138-5p in regulating DRG 














1 Introduction and literature review 
The formation of precise axonal connections between the peripheral and central nervous 
system is essential for successful function related development. The cells of the nervous 
system form multiple connections in early development, which are systematically pruned to 
form a complex network for effective signal transduction. In this way a sensory stimulus is 
detected by cells of the peripheral nervous system, and action potentials rapidly propagated 
to the central nervous system, whereupon an appropriate motor response is induced. This 
cell signalling is particularly important for complex multi-cellular processes such as pain, 
where transduction of a noxious stimuli into an electrical signal relies on 
compartmentalisation and polarisation of neuronal networks.  
 
1.1 The nervous system: 
 
The central nervous system consists of the brain and the spinal cord, where all neurons are 
encased by up to 30 sheaths of myelin formed by oligodendrocytes. All other neuronal tissue 
forms the peripheral nervous system; these neurons are both sensory and motor in nature 
and propagate action potentials into the central nervous system where it is processed 
accordingly. Dependent on the function of the nerve, the neurons in the peripheral nervous 
system may or may not be myelinated. Dependent on the function of the nerve, the neurons 
in the peripheral nervous system may or may not be myelinated. For example, both small 
diameter unmyelinated C-fibers, and myelinated Aδ fibers are involved in nociceptive 
processing, but remain silent in the absence of a nocifensive stimulus (Yam et al., 2018). The 
obvious advantage of myelination is the capacity for saltatory conduction, where the action 
potential appears to ‘jump’ between the unmyelinated nodes on the axon. However, whether 
a nerve is myelinated by Schwann cells is not dependent on the axon diameter, but rather on 
the expression of neuregulin-1, an epidermal growth factor (Nave and Salzer, 2006). The 
profiling of neurons within the specific areas of the nervous system demonstrates that 
neurons develop in accordance with their function. For example, those neurons that are 
highly involved in movement express high levels of dopaminergic receptors and appear to be 
more prevalent in the frontal lobe of the cortex. In order to understand these pathologies, it 
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is therefore essential to investigate the structure and function of the building block of the 
nervous system, the neuron.  
 
The nervous system is highly complex and first develops within the first 2 to 8 weeks of 
embryo development (Elshazzly and Caban, 2019). Although formation of the neural plate 
begins early in embryogenesis, the nervous system continues to grow, and axonal 
connections continue to form even throughout post-natal development (Discovering the 
Brain, 1992). Once formed, the human brain is estimated to contain 1015 neurons as early as 
aged 3 (Drachman, 2005). At which point, the nervous system undergoes systematic ‘pruning’ 
to ensure that axonal connections are meaningful and propagate action potentials in the most 
effective way possible (Cowan et al., 1984; Meier, Finch and Evan, 2000; Low and Cheng, 
2006). The selective re-structuring of the connections in the human brain is at its core a good 
example of natural selection. The plasticity of the nervous system in early post-natal 
development occurs in multiple ways. More commonly, cells undergo apoptosis due to 
changes in the surrounding environment (Yuan, Lipinski and Degterev, 2003). And this 
programmed cell death reduces unnecessary competition for potential synaptic targets. 
However, it has also been demonstrated that surrounding growth factors and neurotrophins, 
such as NGF, may not solely be involved in maintaining cell viability, but also regulating axon 
development and survival (Singh and Miller, 2005). It is for this reason that such growth 
factors and cytokines are of particular interest in the development of pathologies like pain, 
whereby the activity of sensory neurons appears to become dysfunctional due to changes in 
the surrounding environment.  
It is widely acknowledged that most of the nervous system does not generally acquire new 
neurons post-natally, although there is evidence to suggest that in certain areas adult 
neurogenesis has been detected in rodent modelling (Lei et al., 2019). This doctrine was first 
defined in 1965 (Altman and Das, 1965). Since then it has been demonstrated that the genesis 
of new neurons in adult rodent brains is limited largely to the hippocampal and subventricular 
zones (Ming and Song, 2011). Furthermore, it has been demonstrated that neurogenesis in 
the adult human brain is even further limited than that of the rodent CNS. Most notably, in 
rodents and other mammals neuroblasts appear to migrate from the subventricular zone to 
the olfactory bulb. However, in humans no new neurons were detected here after 
development of the adult CNS (Bergmann et al., 2012). In summary, we should be wary when 
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directly comparing rodent tissue to the CNS of humans.  For example, there is also evidence 
that axons of existing neurons readily regenerate following peripheral nerve injury. Although 
the axonal connections of the central nervous system (CNS) do not readily regenerate, the 
neurons of the peripheral nervous system (PNS) have been shown to (Huebner and 
Strittmatter, 2009).  
 
1.2 The Neuron  
 
The nervous system is comprised of multiple cell types, including neurons (1015) and non-
neuronal cells such as glial cells. It was previously estimated that glial cells outnumbered 
neurons by a factor of 10:1 (HYDEN, 1962) but more recent histological data has suggested 
otherwise. More accurate cell counting techniques have demonstrated that it is more likely 
that the glial cell to neuron ratio is around 1:1, with around 86.1 billion neuronal cells and 
84.6 billion non-neuronal cells (Azevedo et al., 2009; von Bartheld, Bahney and Herculano-
Houzel, 2016). Furthermore, whilst neurons do not continue to divide, and rarely self-
regenerate following injury, the glial cells readily proliferate upon injury. 
 
The signalling and cellular excitability of neuronal cells in the PNS forms the basis of this thesis, 
although we also investigated how the excitability of these cells can be modulated by non-
neuronal cells such as immune cells. Therefore, it must be acknowledged early that the 
neurons cannot function as discrete entities, efficient function of the nervous system relies 
on multiple layers of cell-to-cell communication.  
 
The majority of neurons acquire a highly polarised morphology in development, often 
corresponding to the functional of a neuron in the nervous system. Unlike multipolar neurons 
(figure 1.2.1A) found in the CNS, the neurons of the dorsal root ganglion (DRG) develop an 
unusual pseudo-unipolar structure (see figure 1.2.1B, below.) Classically it is understood that 
the dendrites receive information and transmit it to the soma, whilst the axon carries action 
potentials away from the cell body, towards a receptor cell. The diagram below shows how 
this flow of information is propagated along the cell via action potentials.  
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1.3 The Axon: 
 
The axons, or nerve fibres are long processes along which action potentials are rapidly 
propagated for effective cell communication. For example, in some areas of the human body, 
axons can be up to one metre long, running from the base of the spinal cord to the end of the 
foot. Primarily the axons are connective structures through which complex neuronal 
networks are formed for effective cell-to-cell signalling. Therefore, the transduction and 
transmission of electrical impulses along the axon is essential for rapid neuronal signalling. 
However, due to the highly polarized nature of the neurons, the axons are also critical in the 
bidirectional transport of signalling molecules for successful neuronal signalling. Unlike the 
action potential which is only transported in one direction along the axon, the movement of 
specific axonal components can require either anterograde (e.g. Kinesin) or retrograde (e.g. 
Dynein) transport of molecules. Although similar processes of macromolecular transport can 
be observed in other cells, the scale of protein trafficking observed in the neurons is unique 
due to the elongated axons and polarized phenotype of the cell.  
 
In general, anterograde transport is essential to transport newly synthesised proteins to a 
target of interest, whilst retrograde transport simultaneously clears the cell of misfolded or 
damaged molecules. Microtubule motor proteins drive the movement of molecules along the 
A B 
Figure 1.2.1: Comparison of neuronal phenotypes. 1A) A multipolar neuron phenotype, typically observed by cortical 
neurons in the CNS. 1B) A Pseudounipolar neuron, most commonly recognised as the phenotype of the neurons of the 
dorsal root ganglion. 
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axons, inclusive of organelles, endosomes and RNA vesicles. Where kinesin proteins drive the 
movement of molecules away from the soma, proteins such as dynein are responsible for 
retrograde transport. However, the purification of axonal endosomes have exhibited the 
presence of both motor proteins (Hendricks et al., 2010). Therefore, it is understandable that 
the bi-directional transport of macromolecules is essential not only for the development of 
the nervous system, but also to prevent pathological degeneration.  
 
The “neurotrophic factor hypothesis” was postulated in 1968, following the result that 
removal of chick hindlimbs led to a reduction in motor and sensory neurons (Hamburger and 
Levi-Montalcini, 1949; Levi-Montalcini, 1987). This hypothesis suggested the presence of 
target-derived neurotrophins was required for the survival of neurons, and ultimately led to 
the characterization of nerve growth factor (NGF.) Injection of radio-labelled NGF into the 
axonal terminals led to the discovery that NGF could later be detected in the soma, a result 
which was confirmed both in-vitro and in-vivo (MacInnis and Campenot, 2002). Furthermore, 
the addition of NGF to the axonal compartment of compartmentalised cultures promoted the 
growth of axons over time (Campenot, 1982). However, since then the family of proteins 
referred to as neurotrophins has been further investigated and is also known to incorporate 
BDNF, NT-3 and NT-4/5. These neurotrophins have regulatory roles in both the peripheral and 
central nervous systems, with established roles in both axonal guidance and nerve 
regeneration.   
 
Anterograde transport has been most clearly defined using metabolic labelling techniques in 
the cell (Weiss, 1967). Manipulating the cytoskeleton demonstrated that microtubules are 
essential for rapid movement along the axons, whilst pulse-chase labelling in motor neurons 
led to the discovery of multiple phases involved in anterograde transport along the axons  
(Griffin et al., 1976). Furthermore, the rate of transport appears to be dependent on the 
function and size of the molecule. Organelles have been shown to move at 400mm/day, 
whereas cytoskeletal proteins move away from the soma much more slowly (<8mm/day) 
(Maday et al., 2014). Of particular interest to this project is the anterograde transport of 
mRNA and microRNA along the axons of sensory nerves. Local protein synthesis is essential 
for functional cell-to-cell signalling. Although it is evident that localization of specific mRNA 
within distinct neuronal compartments is important for neuronal function, the mechanisms 
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by which this is regulated have yet to be elucidated (Holt, C. E., and Schuman, 2013). 
Meanwhile microRNAs act as negative regulators of mRNA translation, and the pathway for 
biogenesis of mature miRNA is discussed in detail below. However, precursor microRNA 
molecules have been identified both in the soma and the distal compartments of the axon in 
sensory neurons (Kim, H. H., Kim, P., Phay, M., and Yoo, 2015; Rotem et al., 2017). As such, it 
is understandable that anterograde transport of microRNA and mRNA is important in 
regulation of gene expression in neurons.  
 
1.4 The Action Potential: 
The action potential underlies all electrophysiological neuronal cell-to-cell signalling. The 
action potential is an ‘all-or-nothing’ response, with the resting membrane potential typically 
measuring -60-70mV (as shown in figure 1.4 below.) Therefore, an action potential will only 
be generated if the membrane is sufficiently depolarized. For example, when a stimulus such 
as TRPV1 binds receptor at the terminal of the DRG, a small influx in Na+ ions is triggered and 
the membrane potential is bought closer to the threshold potential of -20mV. This small influx 
of Na+ is known as a generator potential but unlike the action potential, these generator 
potentials have graded responses. There are four main classes of tactile mechanoreceptors 
that relay extracellular stimuli such as touch or pressure, to intracellular signal transduction 
via mechanically gated ion channels. These tactile mechanoreceptors are found in the 
superficial laminae, and deeper layers of the skin. One such example is the Pacinian 
corpuscles (Abraira and Ginty, 2013). Upon mechanical disruption of these receptors, ions 
flow into the cell causing electrical depolarization and generator potentials. When the influx 
of sodium ions associated with stimulation is sufficient to reach threshold potential, the 
membrane rapidly and completely depolarizes to +40mV. This depolarization is rapidly 
followed by repolarization of the membrane by efflux of K+ ions. This transient switch in 
membrane potential is known as the action potential (Hammond, 2015). Figures 1.4.1- 1.4.3 
showshow the depolarisation phase of the action potential is associated with the influx of 
sodium ions (Na+), whilst the repolarisation phase is dependent on the efflux of potassium 
(K+) ions. Following depolarisation, the neuron enters a refractory period, in which an action 
potential cannot be produced because the sodium channels are closed (and do not open) and 
the membrane is undergoing repolarisation via efflux of K+.  
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Rapid cell communication is required between cells of the nervous system for effective signal 
transduction followed by an appropriate response. A good example of this is the reflex 
response; if you hold your hand over an open flame, action potentials are rapidly propagated 
along the nerves of the PNS to the CNS so that your motor neurons are activated, and you 
remove your hand from harm. For this reason, action potentials must be propagated in the 
most efficient way possible, and therefore most of the nerves in the body are myelinated.  
 
 
In the neurons of the PNS, the myelination of fibres is formed by polarised, longitudinal 





Figure 1.4.1: A simplified representation of a myelinated neuron in the PNS, made using BioRender.  
A) The insert demonstrates how the myelination is not continuous, but there are unmyelinated nodes where the ionic 
capacitance is higher, and the action potential can pass through the membrane easily. B) The flow of current through a 
neuron during saltatory conduction of an action potential. Images taken from (Uncini and Kuwabara, 2015) 
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development of the PNS, axons signal to glial precursors, initiating Schwann cell migration 
and survival (Perlin et al., 2011). Both the axons and the surrounding Schwann cells release 
bi-directional trophic signals throughout life to support cell survival (Jessen and Mirsky, 2005; 
Pereira, Lebrun-Julien and Suter, 2012). Critically, the myelination of the axons by the 
Schwann cells helps to regulate the axon cytoskeleton as well as the rate of transport along 
the axon. Myelin provides a high resistance, low capacitance barrier that enables saltatory 
conduction of ions between the unmyelinated nodes of Ranvier (Hillman and Hillman, 1986; 
Salzer, 2003). Effectively, the action potential appears to ‘jump’ between the nodes, where 
the ions cannot pass through the myelin sheath surrounding the axon: 
 
Myelination of the axon is clearly important in propagation of the action potential and 
irreversible de-myelination of nerves is an underlying factor of pathologies such as Multiple 
Sclerosis (Moalem and Tracey, 2006a; Popescu and Lucchinetti, 2012; Huang, Chen and 
Zhang, 2017). The loss of myelin surrounding axons damages the exposed fibre, reducing the 
efficiency of action potential propagation, as well as reducing the capability of the neuron to 
traffic proteins efficiently. The lipidic nature of myelin gives the neuron a low capacitance at 
regions where the Schwann cells surround the axon. Therefore, ions must cross the 
membrane solely at the unmyelinated regions known as the Nodes of Ranvier. The expression 
of voltage-gated channels for sodium and potassium at these regions is therefore also 
instrumental in maintaining successful propagation of the action potential.  
 
In the PNS, it has been demonstrated that there is selective expression of subsets of voltage 





Figure 1.4.2: Distribution of voltage gate channel isoforms at the paranodal and nodal regions. This image has been taken 
from (Rasband and Peles, 2016) as a recreation from (Lakke, 1997). 
Figure 1.4.2 demonstrates that whilst the propagation of action potentials is reliant upon the 
presence of voltage gated channels at the node, the expression of relevant proteins is not 
uniform (Rasband and Peles, 2016).  This differential expression of ion channels is essential in 
the development of functional distinctions in sensory neurons. 
 
The rapid influx of sodium ions in the depolarising phase of the action potential is essential 
for reaching threshold potential. However, evidence has shown that not all subtypes of 
voltage-gated channels open at the same time, see figure 1.4.3. Nociceptive fibres express 
both tetrodotoxin (TTX) sensitive and TTX resistant subtypes of channels. Genes encoding the 
TTX-R channels NaV1.8 and NaV1.9 were initially deemed exclusively expressed in sensory 
neurons (Akopian, Sivilotti and Wood, 1996). Additionally, immunocytochemistry has 
demonstrated higher expression of TTX-R channels in unmyelinated fibres of the DRG, in the 
soma, axon and nerve terminals (Fjell et al., 2000; Fang et al., 2002). Since TTX-R and TTX-S 
channels have very different kinetics with relation with activation and inactivation, it is 
understandable that there is differential activity throughout the action potential (Elliott and 
Elliott, 1993). Higher expression of TTX-R polymodal nociceptors has been deemed to underlie 
activity dependent slowing of conduction in the nociceptors in response to a range of 
nociceptive stimuli (Jonas et al., 2020). 
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Voltage-Gated sodium channels are open during the depolarizing phase, and rapid influx of sodium ions increases the 
membrane potential.  In contrast, the re-polarization of the membrane is largely due to the opening of voltage-gated 
potassium channels, and efflux of potassium from the cell. Evidence for the roles of subsets of voltage gated channels has 
been acquired from relevant literature (Tsantoulas and McMahon, 2014; Dib-Hajj, Geha and Waxman, 2017) 
 
Patch clamping has shown that initial depolarization is resultant from TTX-S sodium currents; 
where these channels (NaV1.3 and NaV1.7 in particular) activate rapidly but are also 
inactivated before the membrane potential has peaked. TTX-R channels are also activated 
and reach maximal amplitude during the rising phase of the action potential. However, these 
channels (especially NaV1.8, as shown by figure 1.4.3) do not completely inactivate during 
the re-polarization of the membrane. It is thought that these TTX-R channels are largely 
responsible for a “shoulder” in the falling phase (Blair and Bean, 2002). Particularly in smaller 
diameter nociceptors it has been shown that TTX-R are responsible for most of the influx of 
Na+ during the depolarizing phase, whilst at low temperatures NaV1.8 are solely responsible 
for the initiation of the action potential (Zimmermann et al., 2007). It has also been 
demonstrated that there is a high composition of NaV at the unmyelinated region of the Node 
Figure 1.4.3: An overview of the action potential.  
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of Ranvier, in particular Nav1.1 and NaV1.6 in the CNS (Rios et al., 2003; Duflocq et al., 2008), 
although the NaV1.6 isoform is also highly clustered at the node in the nerves of the PNS 
(Caldwell et al., 2000; Rasband and Peles, 2016).  
 
Where the movement of sodium ions into the neuron is known to initiate the action potential, 
the movement of potassium channels out of the axon returns the neuron to its resting state. 
In particular the resting membrane potential is known to be regulated by two-pore potassium 
channels, and members of the Kv7 family, as shown in figure 1.4.3. This figure only suggests 
the association of voltage gated potassium channels with regulating the action potential, but 
it is evident that other isoforms of potassium channel are also involved in ionic conductance 
across the neuron membrane. This includes two-pore potassium channels, as well as calcium-
activated potassium channels, and inward rectifiers (Tsantoulas and McMahon, 2014). The 
voltage gated potassium channel is by far the largest family of potassium channels, with over 
40 genes in humans (Gutman et al., 2005). Pharmacological evidence has demonstrated a 
heterogeneous nature of the voltage-gate potassium channel family. Therefore, it is likely that 
a range of Kv channels are expressed in cells, each of which rectifies the action potential with 
unique biophysical properties. Six distinct K+  currents have been observed in the neurons of 
the DRG, 3 of which appear to be unique to small diameter fibres, or nociceptors (Everill, Rizzo 
and Kocsis, 1998; Everill and Kocsis, 1999). Several voltage gated potassium channels cluster 
in the juxta-paranodal regions, in particular those isoforms of the Kv1 family, to regulate 
neuronal excitability (Rasband et al., 2001). Although there is abundant evidence for the role 
of NaV, TRP and even H+ sensitive channels on the surface of the sensory neurons of the DRG, 
there is relatively little in comparison on the diverse range of Kv channels expressed on these 
neurons. The myelinated nerve fibres of the DRG appear to predominantly express isoforms 
of the Kv1 family, with particular interest to Kv1.1 and Kv1.2. These channels form complexes 
to maintain internodal resting potential (Wang et al., 1993; Rasband et al., 1998). Neuropathic 
pain models using spinal nerve ligation (SNL) of L5-L6, has demonstrated the effect of 
potassium channels on sensory nerve excitability. In the ipsilateral fibres of L5-L6 the 
expression of Kv1 channels was significantly reduced, where in comparison little change in 
expression in the uninjured L4 fibres (Rasband et al., 2001). Furthermore, induced axotomy 
demonstrated a significant decrease in the expression of these channels in medium diameter 
fibres of the DRGs. In particular, the downregulation of Kv1.1 has been linked to reduced firing 
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threshold, and consequentially mechanical allodynia (Xian and Nicol, 2007; Hao et al., 2013). 
In contrast, the activity of Kv1.2 has been linked to regulation of the membrane potential by 
augmenting firing rate (Tsantoulas and McMahon, 2014). Additionally, the mechanosensitive 
effects of Kv1.2 have not only been detected in the myelinated fibres of the DRG, but also 
linked to C-fibre activity.  
 
1.5 Disruptions to the action potential: 
Repetitive and controlled regulation of the action potential along the axon is essential for cell-
to-cell communication via synapses, even at a long distance. The movement of ions across 
the membrane is tightly regulated such that resting membrane potential always returns to -
60mV. Therefore, dysregulation of the action potential can induce downstream effects, 
disrupting sensory and motor function. One such family of pathologies in which disruption to 
the action potential is implicated is pain. Pain is defined by IASP as ‘an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage, or described in 
terms of such damage.’ Underlying a painful physical sensation is altered cell signalling of 
sensory neurons, in particular the nociceptive fibres of the DRGs. At a cellular level this is 
often caused by a change in the conductance of the axons, where cell membranes may 
become hyper- or hypoexcitable, and consequentially the action potential is not efficiently 
propagated. Nociception can be defined as the ability to detect noxious stimuli, and in 
humans activation of the nociceptive neurons usually evokes a downstream sensation of 
physical pain.   
 
1.5.1 An overview of pain: 
From a physiological perspective pain is an evolutionary response that provides a protective 
role against noxious stimuli. This physiological response is comprised of both an emotional 
response, and the unpleasant physical sensation associated with pain, known as nociception 
(Basbaum et al., 2009). Generally the pathway involving physical detection of a noxious 
stimuli has been determined to have three main parts.  
1. The first stage involves exposure and subsequent detection of a stimulus via binding 
of receptors (e.g. Capsaicin at TRPV1) on terminals of the DRG neurons. Activation of 
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these receptors bring the membrane closer to threshold potential, in order to 
depolarize the membrane and generate an action potential.   
2. An action potential is propagated along the active nociceptors and integrated into the 
superficial laminae of the dorsal horn, where the sensory neurons of the DRGs 
terminate. (In wound healing, non-neutrophilic CD11b+ cells (most likely 
macrophages) sensitize pseudounipolar DRG neurons via the release of pro-
inflammatory cytokines, NGF and histamine (Ghasemlou et al., 2015) with the ability 
to change the sensitivity of these neurons following nerve injury.) 
3. From here, the action potential is transmitted through pain pathways of the central 
nervous system. These include the ascending pathways to higher processing centres 
(such as the thalamus and the cortex,) and the descending pathways of pain where 
action potentials are transmitted via the spinal cord to the reflex organs (Yam et al., 
2018).  
A good example involves the myotactic (stretch) reflex following tapping the patellar 
tendon with a hammer. It is important to note that from the point at which a stimulus 
is detected by the sensory afferent fibres, to the response from a motor efferent fibre, 
there are several other cell types indirectly involved in signal transduction. Other 
withdrawal reflexes, including the nociceptive withdrawal response (e.g. removing 
your hand from an open flame) are polysynaptic, including one or more synaptic 
connections between the afferent and efferent fibres.)  
 
NB: This is a generalised overview of the typical steps involved in the perception of pain. 
However, it is worth noting that the physical response to detection of a noxious stimuli can 
occur prior to integration in the CNS. It has been demonstrated that decerberation of mice, 
rats and rabbits has not removed the withdrawal reflex in these animals. Removal of the 
forebrain in rats did not appear to impair the ability of these animals to respond relatively 
normally to a noxious stimulus. For example, decerebrate rats still showed normal withdrawal 
responses, vocalization and licking at the site of injury. In this regard the behaviour of the 
decerebrate animals was almost identical to a healthy control.  However, removal of the 
frontal cortex and thalamus induced limitations in the normal behaviour of these rats. Whilst 
they responded appropriately to a noxious stimuli, immediately afterwards these animals 
returned to normal grooming behaviours. Even following contact thermal injury where the 
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ipsilateral paw was extremely sensitive, these animals continued with normal behaviours (e.g 
grooming) and demonstrated no sustained response to protect the site of the injury.  These 
results suggested that the sensory component of the pain pathway was intact and functional, 
but the reactive component was now abnormal where the cortex was removed (Woolf, 1984) 
 
However, it is also evident that there is a pathological component to the development of pain 
often underlying multiple disorders, such as arthritis. In this context, the pain elicited by 
inflammation or even injury to the nervous system evokes a pathophysiological response. The 
sensitisation of firstly the peripheral nociceptors, and subsequently the ascending pathways 
of the pain pathways in the central nervous system induces changes in signalling of the 
nociceptive neurons. The International Association for the Study of Pain (IASP) determined 
that pain can be classified according to the region of the body from which the pain originates. 
As such, there are three classifications of pain, including nociceptive, neuropathic and 
inflammatory (Woolf et al., 1998; Yam et al., 2018). 
 
1.5.2 Peripheral Sensitisation and the DRG neurons:  
In the peripheral nervous system, the cells are comprised of sensory neurons, forming ganglia 
adjacent to, but outside the spinal cord and the CNS. These bundles of fibres are known as 
the Dorsal Root Ganglion cells (DRGs) and in many ways, form the link between the peripheral 
nervous system and the integration of a nociceptive signal to the central nervous system. 
These sensory neurons innervate target tissue in the periphery, but transport neuronal signals 
into the CNS via the dorsal horn of the spinal cord (via the substantia gelatinosa.) Here the 
primary afferent fibres synapse with dorsal horn neurons (known as the second order 
neurons) and form projections to the brain (Todd, 2010; Zeilhofer et al., 2020). 
 It is the relationship between sensory neuron input to the dorsal horn and the downstream 
activation of the second order neurons that determines the excitability of the dorsal horn. 
For this reason, investigating changes in the excitability of these pseudo-unipolar sensory 
fibres form the basis of the model outlined later in this project.   
Peripheral sensitisation refers to the changes in neuronal excitability and sensitivity that occur 
often following peripheral nerve injury and/or inflammation. For example, following injury, 
the threshold for activation of the peripheral nociceptors is reduced, and the sensitivity of 
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these sensory fibres to stimulation is also increased, often manifesting as primary 
hyperalgesia (Gold and Gebhart, 2010).  
There are several ways in which cells can become sensitised, although at a molecular level 
there are often transcriptional dependent changes in protein expression (for example, 
activation of protein kinase A pathway by PGE2.) One of the ways in which peripheral 
sensitisation manifests is via up-regulation of receptors on the terminals of the afferent fibres 
following exposure to inflammatory stimuli such as bradykinin, ATP and prostaglandins (Staud 
and Smitherman, 2002; Campbell and Meyer, 2006). This translational regulation of receptors 
on the DRG terminal increases action potential firing of the nociceptors, and induces a state 
of “pain.”  
 
1.5.3 The switch from acute to chronic pain:  
Neuropathic pain arises from a combination of both peripheral sensitisation in the nociceptor 
terminals, and central sensitisation of nociceptive signalling. The changes in nociceptor 
signalling manifest as mechanical allodynia and hyperalgesia. As such, central sensitisation is 
defined as an increased responsiveness in the neurons of the central nervous system  
(Latremoliere and Woolf, 2009; Louw, Nijs and Puentedura, 2017). The pathophysiology 
arising from a single nociceptive input can lead to either an increase in excitability, and a 
reduction in the threshold for activation of a nociceptor. For example, if the nervous tissue is 
irreversibly damaged a state of mechanical allodynia is induced, and consequently the 
threshold for a pain response is lowered so that even innocuous stimuli are perceived as 
painful (von Hehn, Baron and Woolf, 2012). Unlike other forms of algesia, allodynia serves no 
protective purpose, but is often a co-morbidity underlying conditions such as diabetes, where 
mechanosensitive receptors in the periphery become irreversibly damaged.  
 
However, the inflammatory response arising from exposure to a nociceptive stimulus is 
dynamic and protective. Reversible changes in the sensory nervous system may also induce 
transient hyperactivity of nociceptive neurons known as hyperalgesia. In this condition the 
nociceptors have sensitised so that the detection of a low-level noxious stimulus, induces 
overactivation of nociceptors, and a long-lasting pain response. Whilst primary hyperalgesia 
is said to refer to a state of increased sensitivity at the site of injury, secondary hyperalgesia 
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is referred pain accompanying the damage to tissues surrounding the site of injury 
(Latremoliere and Woolf, 2009; Kuner, 2010).  
 
Rodent studies have previously shown differential responses to inflammatory mediators 
between neonatal and adult DRGs in hyperalgesic priming experiments (Beland and 
Fitzgerald, 2001). For example, peptidergic DRG fibre terminals have been identified in 
rodents before birth, but larger, non-peptidergic fibres are not present until post-natal day 5. 
Furthermore, evidence suggests that the functionality of the sensory circuits is acquired 
postnatally. For example, in the dorsal horn of newborn rodents, neuronal input 
predominantly arises from the low threshold A-fibres, where input from nociceptive C-fibres 
develops later, around post-natal day 10. In vivo it was shown that in adult rodents, the 
exposure of the hindpaw to mustard oil penetrated the skin and produced rapid and long-
lasting flexor responses.  However, these flexor reflexes to chemical irritants such as mustard 
oil did not begin to occur until postnatal day 10-11 (Jennings and Fitzgerald, 1998). In the 
second week of postnatal development it has been demonstrated that there is development 
of glycinergic inhibitory control of the dorsal horn. This coincides with the emergence of C-
fibre maturation, which is most likely responsible for the ability of these neonatal rodents to 
respond appropriately to chemical and inflammatory irritants. Results have shown that in 
tissue at P10-14 the selective block of primary afferent C-fibres with Lidocaine and Capsaicin 
delays the development of glycinergic inhibitory networks, and maintains the dorsal horn in 
a state of newborn excitability (Koch et al., 2012).  
Where newborn animals are particularly sensitive to tactile responses, the maturation and 
refinement of the networks in the spinal cord coincides with a postnatal pruning of A-fibre 
input, and strengthening of nociceptive C-fibre connections.  
When adult tissue was injected with carrageenan at 2% body weight, maturation of the DRGs 
showed development of two sub-populations of cells. This hyperalgesic priming is thought to 
be partially controlled by peptide plasticity in inflammation, especially since many 
neuropeptides are dependent on NGF, which is upregulated in the periphery during the 
inflammatory response (Woolf et al., 1994). In neonatal culture, both the CGRP (peptidergic) 
and IB4 positive (non-peptidergic) cell populations were affected by carrageenan, but only 
after postnatal day 5. Through development the TrkA receptor diversifies the nociceptive 
sublineage and is upregulated on peptidergic fibres but downregulated on the non-
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peptidergic fibres in favour of the glial derived neurotrophic receptor Ret. These non-
peptidergic neurons now bind isolectin B4 (IB4) in two distinct populations of small and 
medium diameter non-peptidergic neurons. Results have shown that following an injection 
with 2% carrageenan in adult tissue, only those cells expressing CGRP increased. These CGRP-
expressing, peptidergic Aδ/C-fibres are affected by inflammation and also express the TrKA 
receptor for NGF in the mature nervous system.  
Of relevance to this work, it was important to consider that tissue was extracted from 
embryonic mice and may not reflect what was previously observed in adult tissue.  
 
In the model described later in this work, we have focused on the role of inflammatory cells 
in inducing a change to the excitability of DRG neurons following exposure to an acute 
stimulus. As such, this model more closely resembles the changes observed in vivo arising 
from primary hyperalgesia. It is important to note that whilst immune cells release 
inflammatory mediators to modulate neuronal response to a stimulus, the nociceptors in turn 
release neuropeptides to modulate the immune cell function at the site of injury. This two-
way signalling between the neurons and the immune system is not only essential for the 
initiation and maintenance of a behavioural response to a nociceptive stimulus, but also for 
the resolution of the inflammatory response to a painful stimulus.   
Figure 1.5.1: The changes in paw withdrawal threshold associated with development of peripheral sensitisation and 
hyperalgesia. 
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1.6 Neurons of the pain pathways: 
There are primarily three types of neurons involved in the transmission and modulation of a 
nociceptive stimulus. This includes the primary afferent fibres, connective interneurons, and 
efferent motor neurons. Although the central nervous system is required for higher 
processing and ‘interpretation’ of a noxious stimulus, the neurons involved in transmission lie 
in the peripheral nervous system.  
 
1.6.1 Dorsal Root Ganglion Neurons (DRGs): 
The pseudo-unipolar neurons that comprise the bundles of fibres known as the dorsal root 
ganglion (DRGs) act as first order sensory neurons of the somatosensory system (Chen et al., 
2019). With the ganglion located in the dorsal root, the DRG neurons themselves form part 
of the peripheral nervous system. However, due to their unique morphology, these neurons 
‘bridge-the-gap’ between detection of a sensory stimulus at receptors in the terminals of 
peripheral nerves, and communicate directly with the neurons of the CNS.  
 
The DRG fibres terminate in the skin, where they form distinct subtypes of low-threshold 
mechanoreceptors based on the diameter and conduction velocity of the fibres. There is 
overwhelming evidence for the role of DRGs in processing both proprioceptive (Koerber, 
Mirnics and Mendell, 2017; Madden et al., 2020) and nociceptive stimuli (Krames, 2015; 
Emery et al., 2018) and therefore the activity of the DRGs have been extensively studied in 
culture. Neuronal fibres of the DRG are varied in diameter, and as such function. For example, 
a cross section of the DRG reveals that small diameter, unmyelinated fibres known as the C-
fibres, are primarily involved in integrating noxious stimuli to the CNS. Whereas, larger 
diameter fibres (such as type II Aβ fibres) can also respond to light-touch. Although the 
existence of Aβ fibres as nociceptors was initially overlooked, evidence has recently suggested 
that in rodent tissue the proportion of Aβ fibre nociceptors ranged from 18-65% (Djouhri and 






Figure 1.6.1 A) simplified diagram of a cross section of the fibres of the DRG showing relative subpopulations of neuronal 
fibres.  
Thicker dotted lines represent additional layers of myelination between the nodes of Ranvier. B) A transverse section of a 
rat lumbar dorsal root ganglion stained with fluorescent markers to distinguish sensory neuron subpopulations involved in 
the pain pathway. (Tsantoulas et al., 2012) 
 
1.6.2 A summary of the activity of fibres within the DRG: 
Some of the sensory fibres within the DRG are myelinated and demonstrate saltatory 
conduction along the axon. These are larger diameter fibres, involved in proprioceptive 
function rather than solely nociceptive function (Djouhri and Lawson, 2004; Koerber, Mirnics 
and Mendell, 2017).   
The large diameter, myelinated Aβ fibres can be further subdivided into type I and type II 
mechanoreceptors dependent on the mechanical and thermal threshold of fibre activation. 
However, the importance of the Aβ (as well as unmyelinated C- and thinly myelinated A𝛅 
fibres) must not be overlooked. As well as being functionally different in adult tissue, the 
neurogenesis of these fibres appears to emerge sequentially throughout development.  
It has been documented that in vivo that A-fibres develop between E15-17 and are later 
followed by C-fibres at E18-20. Therefore, the addition of specific growth factors was 
optimised to help promote differentiation of a nociceptive culture including Aδ and C-fibres. 
Manipulation via transgenic overexpression or deletion of receptors has demonstrated the 
importance of neurotrophin signalling for neuronal survival and differentiation in the DRG 
fibres. The non-peptidergic C-fibres appear to be dependent upon glial derived neurotrophic 
factor (GDNF) in early post-natal life, where the receptor for GDNF (Ret) was shown to be 
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expressed in embryonic rat fibres as early as embryonic day 15.5 (Molliver et al., 1997). The 
addition of GDNF to the in vitro culture of murine DRGs may have helped a sub-population of 
fibres differentiate to represent IB4 positive C-fibres.  
Whereas, the addition of the neurotrophin nerve growth factor (NGF) to the cultures not only 
promoted neuronal growth but may have promoted the expression of the TrkA receptor 
found on C- and Aδ-fibres. In vivo >50% of neurons in the DRG of embryonic mice at E11.5 
have been shown to be TrkA+, with IHC demonstrating the presence of TrkA-mRNA detected 
in 80% of DRG neurons by E13-15. However, in both mice and rats, the proportion of TrkA+ve 
cells was shown to decreased to between 40-60% in post-natal development.  
In adult rodent tissue around 40% of DRG neurons have been shown to express receptors for 
NGF (Barker et al., 2020). Furthermore, many of these NGF-responsive neurons also express 
TRPV1 (Caterina et al., 1997), and treatment with NGF can upregulate TRPV1 expression on 
the plasma membrane  (Xue et al., 2006a). In vivo, following peripheral inflammation anti-
NGF treatment in the hindpaw of rodents appeared to reduce TRPV1 expression, and also 
reduced inflammation-induced hyperalgesia (Cheng and Ji, 2008). As such, there is evidence 
that dysregulation of expression of NGF or it’s corresponding receptor may have a role in 
development of neuropathic pain. There was thought to be potential for anti-NGF treatment 
in humans although this has not yet been verified (Saldanha et al., 1999; Abdiche, Malashock 






Velocity (m/s) Myelin?     
Aβ 6.0-12.0 35.0-75.0 Y 
Touch/ 
Pressure  
Mechanoreceptors (with some 
function in nociceptive signalling)  
A𝛅 1.0-5.0 5.0-35.0 Y 
Fast 
Pain  
Heat Sensitive (Not all Capsaicin 
Sensitive, only subtype II) 
C 0.4-1.2 0.5-2.0 N 
Slow 
Pain  Low pH/ Heat sensitive  
 
Figure 1.6.2: An simplified overview of the fibres of the DRG (Susuki, 2010). There is a wide varibility in the range of stimuli 
that can activate the neurons of the DRG in pain based processing.  Whilst the role of C- and Aδ fibres in nociceptive 
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processing is widely explored, there is also evidence for function of the larger diameter Aβ fibres as both 
mechanoreceptors and nociceptors.  
 
The Aδ nociceptors can be further divided into two subtypes based on their sensitivity to 
heat and Capsaicin, dependent on how highly the TRPV1 (Transient vanilloid receptor 1) 
receptor is expressed on the neuron (Chen and Sehdev, 2019). For example, in a rodent model 
for neuropathic pain, exposure to Resiniferatoxin (RTX) only induced rapid cell death in those 
axons expressing TRPV1 (Tender, Li and Cui, 2008). RTX is a highly potent agonist of the TPRV1 
receptor and induces rapid influx of calcium into the cell via a non-selective cation channel 
and cell death. However, since TRPV1 is selectively expressed on the C-fibres and the type II 
Aδ-fibres, the type I Aδ-fibres remained functional. After this peripheral nerve injury, it was 
demonstrated that there was a significant increase in paw withdrawal threshold (PWT) 
suggesting that although these animals were still allodynic, large diameter fibres are also 
involved in the development of neuropathic pain.  
 
In contrast, the unmyelinated C-type fibres form around 70% of the afferents involved 
in nociceptive signalling. However, as these fibres are unmyelinated action potentials are 
transmitted much more slowly along the axon relative to the larger diameter Aδ fibres. The 
C-fibres are polymodal, activated by heat, pH and even mechanical stimuli (Dubin and 
Patapoutian, 2010). However, they can be categorized into two distinct types; peptidergic 
(expressing CGRP and Substance P) or non-peptidergic fibres, that are highly responsive to 
GDNF. Whilst expression of NGF is essential for function-related developed of the nociceptors 
in embryos, it has been deemed evident that this molecular ‘switch’ from NGF sensitivity in 
the peptidergic fibres, to GDNF sensitivity in the non-peptidergic nociceptors occurs early in 
post-natal development (Molliver et al., 1997).  
 
Non-peptidergic C-fibres have been demonstrated to be involved in the development of 
hypersensitivity to a mechanical stimulus via peripheral sensitization in a mouse model (Pinto 
et al., 2019). These nerves bind Isolectin-B4 (IB4) and may not be involved in low level 
physiological pain processing. However, ablation of these IB4 sensitive nociceptors led to a 
reduction in the expression of TRPV1 as well as P2X3 (an ATP-sensitive purinoceptor) 
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(Burnstock, 2000; Wirkner, Sperlagh and Illes, 2007). Whilst the mechanical threshold for 
activation of these neurons was not altered, there was inhibition of hypersensitivity to GDNF 
(glial derived neurotrophic factor) but not NGF (nerve growth factor). The expression of these 
growth factors, and the corresponding receptors will affect how highly other receptors are 
expressed on the primary afferent fibres via post-transcriptional regulation, for examples TRP 
channels and sodium channels. Therefore, the function acquired in post-natal development 
determines how sensory fibres responds to and overcomes a nociceptive stimulus.  
 
1.7 Receptors expressed on the nociceptors: 
Mechanoreceptors found in the superficial laminae of the skin relay somatosensory stimuli 
via mechanically gated ion channels. Receptors may be either encapsulated or “free” and fall 
into one of four main categories including Merkel’s disks, Meissner’s corpuscles, Ruffini 
endings and Pacinian corpuscles (Abraira and Ginty, 2013). As the somatosensory neurons of 
the DRGs develop in embryonic development, the expression of the A-type fibres emerge first 
(E9-E11) characterised by the expression of Neurogenin 2 (Ngn2) (García-Piqueras et al., 
2019). The cutaneous mechanoreceptors detect a wide range of physiological stimuli, from 
vibration, stretch and noxious pressure depending on which somatosensory fibres are 
activated. Local depolarisation of ion channels located on these mechanoreceptors induces 
receptor potentials which can summate to induce the propagation of an action potential.  
 
The sensory fibres of the DRG are a heterogeneous population of neurons that both respond 
to and detect a diverse range of stimuli. As such, there are a range of proteins expressed on 
these fibres, ranging from neurotransmitter receptors, to ion sensitive channels. The 
molecular composition of the DRG fibres enables the detection of very selective stimulus, 
dependent on the role of the fibre. Of particular interest here are those neurons involved pain 
signalling, often referred to as the ‘high threshold mechanoreceptor’ neurons (HTMRs) in the 
epidermis.  
 
These nociceptive fibres express a variety of receptors involved in pain processing of different 
sensory modalities. In particular, the mechanosensitive responses of the DRG fibres is partly 
due to the cellular organization of ion channels present on the neuronal terminals, and the 
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intrinsic gating properties of each receptor. Furthermore, it has been demonstrated that 
receptors are selectively expressed depending on the function of a fibre. A classic example of 
this is the selective expression of the TRPV1 receptor to the C-fibre terminals, and the 
consequent links with nociception. This localised expression of specific proteins provides a 
molecular profile of which neurons are involved in acute and inflammatory nociceptive 
signalling. Therefore, when developing an in vitro model for changes in cell excitability 
associated with nociception, studying the expression patterns and intrinsic properties of ion 
channels and receptors associated with the nociceptive fibres is a good place to start: 
 
1.7.1 Transient receptor potential channels (TRP): 
One of the most potent families of receptor involved in nociceptive signalling is undoubtedly 
the TRP channels. In mammals, there have been 28 TRP channels identified, which can be 
further subdivided into 6 categories dependent on the shape of the active site of the receptor 
(Montell, 2005). These calcium permeable channels are highly expressed on the neurons of 
the peripheral nervous system, specifically the DRGs, and several have been deemed essential 
in detection of nociceptive stimuli. Real time PCR (polymerase chain reaction) has been used 
to quantify the expression of the TRP channels on somatosensory neurons, with particular 
interest to those fibres of the DRGs (Vandewauw, Owsianik and Voets, 2013). Of those 
channels screened, the data confirmed that 6 TRP channels previously associated with sensing 
noxious stimuli, were all highly detected in the DRGs, including TRPV, TRPM and TRPA 
channels. Of note, there was a variable level of mRNA detected for TRPV1 (vanilloid 1, 
capsaicin sensitive) and TRPM8 (melastatin 8, cold sensitive) dependent on where the ganglia 
were anatomically isolated from in relation to the spinal cord (Vandewauw, Owsianik and 
Voets, 2013).  
 
It is important to note, that whilst useful, quantitative levels of mRNA expressed of any one 
channel do not necessarily correlate to the protein level, or furthermore determine the 
functional relevance of this channel.  
 
With regards to those channels involved in pain, three subtypes of thermally activated TRP 
channel have been determined a largely important in nociceptive signalling (Patapoutian, 
 38 
Tate and Woolf, 2009). These include the TRPA, TRPV and TRPM channels, a summary of 
which is shown below.  
 
1.7.1.1 TRPV1: Vanilloid-1 receptor, A heat sensitive ion channel and key integrator of 
nociceptive signals 
The TRPV1 receptor is a noxious-heat channel, widely regarded for sensitivity to capsaicin, 
and is particularly important in nociceptive pathways involved in hyperalgesic priming (Ferrari 
et al., 2013). Although there are 6 members of the TRPV family, only TRPV1 is sensitive to 
vanilloid compounds, although the other receptors retain a similarity in the amino acid 
sequence forming the channel (Rosenbaum Emir, 2017). Physiologically the TRPV1 receptor 
is best defined as being sensitive to heat greater than 42°C, and is largely expressed on the 
unmyelinated C-fibres of the DRG (Caterina et al., 1997) although it has also been shown to 
be expressed on Aδ fibres too.  
In vivo, the TRPV1 receptor has been identified as early as E12.5 on the terminals of some 
neurons (Hjerling-Leffler et al., 2007), but in P2 neonatal rat cultures it was demonstrated 
that TRPV1 expression was already at a similar level to that of an adult culture (Fitzgerald, 
2005).   
 
In an early knockout study, it was determined that mice lacking the TRPV1 receptor 
demonstrated impaired responses to selective nociceptive stimuli. Whilst the VR1-/- 
genotype mice showed no change when exposed to a noxious stimulus of a mechanical 
nature, if the stimuli was thermal, and targeted the TRPV1 receptor, the response was 
impaired (Caterina et al., 2000).  
Since this study it has been determined that whilst TRPV1 is more selectively expressed on 
the C-fibres of the DRG, it is not expressed on all C-fibres. Evidence has also demonstrated 
that TRPV1 is expressed on the medium diameter Aδ fibres, although the role of TRPV1 here 
may be in response to different threshold temperature or pH. Although it is expressed in 
several regions of the body, such as the respiratory system  (Zhao et al., 2016) and the bladder 
(Liu et al., 2014), TRPV1 is also prominently expressed in laminae I and II of the superficial 
dorsal horn in the CNS (Rosenbaum Emir, 2017). These are the terminals of the pseudo-
unipolar DRG neurons, terminating in the spinal cord.  
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1.7.1.2 Inflammation and TRPV1: 
Although TRPV1 is a heat-noxious receptor, primarily responsive to temperature >42°C, a low 
pH of the surrounding tissue will dramatically alter the activation threshold of the receptor. 
A good example of this is during inflammation, when the exogenous pH drops due to the 
release of inflammatory cells into the periphery (Rajamäki et al., 2013). Immune cells are 
highly metabolically active, working to reduce inflammation and therefore the glycolysis rate 
is high, with lactic acid secretion increasing. During inflammation, many cytokines are 
released by surrounding inflammatory cells, which sensitize nociceptors via peripheral 
sensitization. These include interleukins, ATP, Substance P and neurotrophins such as NGF 
(Pinho-Ribeiro, Verri and Chiu, 2016).  
 
Inflammatory pain is often modelled in vivo via the injection of Complete Freund’s Adjuvant 
(CFA) to induce changes in the threshold of activation of the nociceptors. This is known as 
CFA-induced hyperalgesia, as is characterised by factors such as prolonged activation of the 
nociceptors correlating with an increased amplitude of the pain and the persistence of the 
pain at the site of inflammation . CFA is an emulsion of oil and water, containing inactivated 
mycobacterium tuberculosis. By injecting the antigen into the joint or paw of the animal, the 
corresponding antibodies will be produced and released in the acute immune response. CFA 
has been demonstrated to contain ligands for toll like receptors (e.g. TLR2, TLR4 and TLR9) 
and injection inactivation of the mycobacterium present induces a TH1 dominated immune 
response (Fang et al., 2010). This Th1 response co-ordinates the polarization of immune cells 
like lymphocytes and macrophages (into an M1-like state,) inducing cell-mediated immunity 
(Billiau and Matthys, 2001).  
 
An early study conducted in Wistar rats demonstrated that injection of CFA into a hindpaw 
led to peripheral sensitization and rapid mechanical allodynia of the affected paw (Stein, 
Millan and Herz, 1988). Inflammation was physiologically evident as a result of changes in 
increase in paw volume, core body temperature and reduced water consumption over the 
course of one-month post inoculation with CFA. These results have since been replicated in 
mice to conclude that injection with CFA induced thermal hyperalgesia and mechanical 
allodynia (Pitzer, Kuner and Tappe-Theodor, 2016). The effects of injection on stimulus 
evoked changes in behaviour were investigated using methods such as Von Frey testing, and 
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CatWalk analysis of gait. Results demonstrated a decrease in body weight correlating with 
temporary disruption of gait, potentially as an effect of underlying inflammation in the paw. 
However, it is debated whether the use of gait analysis underlying inflammatory pain is a 
relevant paradigm, since changes may also occur due to neuronal sensitization caused by 
development of neuropathic pain (Piesla et al., 2009). 
 
Although TRPV1 has been identified on both medium diameter A-fibres and smaller diameter 
fibres, it is evident that there is a higher expression of TRPV1 on C-fibres (Michael et al., 2019). 
Using injection of CFA to the paw, the role of the TRPV1 receptor in the development of 
thermal hyperalgesia and mechanical allodynia has been further investigated. Evidence has 
shown that ongoing pain, induced by injection of CFA was likely dependent on input from 
primary afferents expressing high levels of TRPV1 (Okun et al., 2011).  
 
1.7.2 Other TRP channels and pain:  
Temperature is a critical mediator in the activation of many TRP channels involved in 
nociception (Patapoutian et al., 2003). Where the TRPV1 channels are activated at 
temperatures higher than 42°C, there are also those channels that are cold-sensitive. TRPM8, 
also known as the menthol receptor is typically activated at cool temperatures, around 25°C 
although this temperature is not necessarily considered noxious threshold (Bandell et al., 
2004). It was hypothesised that therefore a second population of cold-sensitive TRP receptors 
must be respondent to noxious cold temperatures.  The TRPA1 channel, also known as 
ANKTM1 (Corey, 2003) has been located on selective populations of the DRG fibres, but is 
only activated as temperatures of 17°C or below. Whilst some fibres of the DRG solely express 
TRPV1, or TRPM8 there are some fibres that appear to be polymodal, expressing TRPV1 
alongside TRPA1 (Patapoutian et al., 2003; Story et al., 2003). These sensory neurons are 
therefore activated my noxious heat and noxious cold temperatures, implicating these 
receptors in acute transduction of nociceptive stimuli.  
 
TRPA1 is an ‘itch-sensitive’ transduction channel expressed on the sensory fibres of the DRG 
neurons (Bandell et al., 2004; Schmidt et al., 2009). These TRP channels can be activated by a 
diverse range of noxious stimuli, particularly cold temperature and selective environmental 
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irritants. For this reason, TRPA1 is widely regarded as a mediator of acute and inflammatory 
pain signalling.  
 
TRPA1 expression was quantified using Northern Blot from adult mouse tissue. Receptors 
were localised to only 3.6% of DRG fibres, 97% of which expressed CGRP, and TRPV1. It was 
evident that TRPA1 did not co-localise with NF-150kd expression, used as a marker for the 
large diameter A-fibres. It was determined that TRPA1 was mainly expressed in unmyelinated 
C-fibres, or lightly myelinated Aδ fibres (Story et al., 2003). Although the role of the TRPA1 
channel in nociception was first suggested in 2003, it was not until 2006 that this was 
confirmed using knockout mouse modelling (Kwan et al., 2006). If the Trpa1 gene was deleted 
in mice, the removal of the pore loop domain led to a reduction of sensitivity in response to 
chemical stimuli such as mustard oil. The knockout cohort were normal in viability and 
appearance but demonstrated no calcium response when stimulated with mustard oil 
(Bautista et al., 2006). Meanwhile the prevalence of TRPV1 response was the same in the wild 
type versus the mutant strain, confirming that TRPA1 does not have an impact on heat-
sensitive stimulation by TRPV1. However, the Trpa1-/- population did demonstrate a loss of 
sensitivity to cold temperature relative to wild type littermates (Kwan et al., 2006).  
 
TRPM8 has also been implicated in pain since the receptor is saturated at 8°C, which overlaps 
with the TRPA1 nociceptive range of activation (McKemy, Neuhausser and Julius, 2002). 
However, selective activation of the TRPM8 receptors has also been implicated in inducing a 
state of analgesia. Since the TRP family are calcium-sensitive, activation induces flow of 
calcium (and sodium into the cell) and promotes propagation of the action potential along 
the nociceptor. Of particular importance is the vast range of stimuli that activate those 
receptors involved in nociceptive signalling.  
 
1.7.3 Voltage Gated Sodium Channels:  
Voltage-gated sodium channels (VGSCs) are important in regulating excitability of the primary 
afferent fibres. From integrating the generator potential upon stimulation, to propagation of 
the all-or-nothing action potential along the axon, the voltage-gated nature of the VGSCs 
determines excitability of the neuron. Although there are many subtypes of VGSC, few have 
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been identified with specific roles in acute nociception. This includes NaV1.3, NaV1.7, NaV1.8 
and NaV1.9, all of which are expressed in adult primary afferent fibres. This selective 
expression of VGSCs associated with small fibre neuropathy makes them an attractive target 
for the development of newer, more effective analgesics (He et al., 2010; Chen et al., 2011a).  
 
Hodgkin and Huxley first demonstrated the effect of VGSCs on regulating neuronal 
excitability, through their work on giant squid axons in 1951 (Hodgkin and Huxley, 1952a). 
These experiments formed the basis for understanding neuronal excitability today. Voltage-
clamp experiments were initially used to confirm that the initial depolarising phase of the 
action potential was caused by movement of sodium ions (Hodgkin and Huxley, 1952b). By 
replacing sodium with choline, only the rising phase excitability was affected, whilst the 
resting potential remained unaffected. Under normal physiological conditions, sodium 
conductance rises rapidly, then falls exponentially. However, VGSCs associated with pain have 
shown changes in activity associated with the development of neuropathic pain (Cummins, 
Sheets and Waxman, 2007; Fischer, Mak and McNaughton, 2014). 
 
In mature primary afferent fibres, selective VGSCs are highly expressed, and associated with 
changes in excitability of the neurons. In adult primary sensory neurons five subtypes of 
VGSCs have been shown to be highly expressed, three of which are tetrodotoxin sensitive 
(TTX-S) (Kim et al., 2002). This includes NaV1.1, 1.6 and 1.7, whilst NaV1.8 and 1.9 are known 
to be TTX-resistant (Dib-Hajj et al., 1999; Bao, 2015). NaV1.3 is usually constitutively 
expressed during adulthood, following downregulation associated with functional 
development of the neuron acquired post-natally (Waxman, Kocsis and Black, 1994; Bao, 
2015). However, this subtype of channel can also be re-upregulated following nerve injury 
and is therefore important in the development of neuropathic pain states. The expression 
pattern of the VGSCs of interest have been highlighted the table below, summarised from 
work by Kwong and Carr (Kwong and Carr, 2015). 
 
NaV1.7 has been demonstrated to be abundantly expressed in many regions of the peripheral 
nervous system. Of interest with regards to nociceptive processing is the expression of NaV1.7 
in the primary afferent fibres of the DRG. However, evidence shows higher levels of 
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expression in peptidgeric C-fibres, as well as the free nerve endings, suggesting a role for 
NaV1.7 in pain processing (Levinson, Luo and Henry, 2012). 
 
Aβ-Fibres A𝛅- Fibres C-Fibres (IB4+) C-Fibres (CGRP/ SP+) 
NaV1.1 NaV1.1 NaV1.1 NaV1.1 
NaV1.6 NaV1.6 NaV1.6 NaV1.6 
NaV1.7 NaV1.7 NaV1.7 NaV1.7 
NaV1.8 NaV1.8 NaV1.8 NaV1.8 
    NaV1.9   
 
Immunohistochemical studies has demonstrated that isoforms of NaV1.7, 1.8 and 1.9 are 
localised to excitable cells of the peripheral nervous system, including the DRGs and 
peripheral sensory ganglia (Cregg et al., 2010). Of particular interest as new therapeutic 
targets for pain are NaV1.7, from genetic links to development of pathological pain, and 
NaV1.8 due to selective expression in the axons of the sensory fibres of the DRG (Dib-Hajj et 
al., 2010). 
 
It is understood that prolonged and repetitive firing from peripheral sensory neurons to the 
spinal cord is thought to be one of the ways in which central sensitisation is induced. However, 
the onset of peripheral sensitization also induces up-regulation of nociceptive ion channels 
such as NaV1.7 on the terminals of the DRG (Staud and Smitherman, 2002; Campbell and 
Meyer, 2006). Under physiological conditions, the voltage-gated sodium channels (NaV) 
expressed in the DRG depress this ectopic discharge, and the corresponding pain behaviours 
(Amir, Michaelis and Devor, 1999). This random, increased firing of sensory fibres can be 
inhibited by blocking VGSCs, using selective antagonists such as QX-314. This membrane 
impermeable sodium channel blocker binds to the same target site as Lidocaine, and has been 
shown to dose-dependently inhibit ectopic firing at the DRGs and dorsal horn (Omana-Zapata 
et al., 1997).  
 
There is also evidence to suggest that upregulation of TTX-S channels in the primary afferents 
may contribute to this increased ectopic firing, and ultimately sensitisation of these nerves. 
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For this reason, those NaV channels that are TTX-Sensitive (such as NaV1.7) are of particular 
interest, since low doses of TTX have been demonstrated to reduce ectopic firing of the 
sensory fibres (Lyu et al., 2000). This has been successfully modelled in rats using axotomy of 
the sensory fibres via segmented spinal nerve ligation (C. H. Kim et al., 2001). In a spinal nerve 
ligation model for neuropathic pain the mRNA expression of NaV1.7 was reduced by 40% up 
to 5 days post-operatively (Kim et al., 2002). 
 
1.7.4 Potassium Channels: 
Whilst the role of the voltage gated sodium channels is well-elucidated in the rising phase of 
the action potential, the role of potassium channels, especially voltage-gated channels, is 
known to regulate re-polarisation of the membrane (Hodgkin and Huxley, 1952b). Potassium 
ion current, referred to from here-on as Ik was first assumed to be linearly proportional to  
‘V-EK,’ where V is membrane potential and EK represents the Nernst potential. However, this 
assumption has since been disproven where Ik shows non-linear dependence on (V-EK) under 
physiological conditions. Simply put, the relationship between Ik and Vm can be well 
characterised by the Goldman-Hogkin-Katz (GHK) equation (Goldman, 1943; Hodgkin and 
Katz, 1949). 
 
For this reason, evidence has suggested that changes in the expression, or gating kinetics of 
these potassium channels, may alter the way in which action potentials are propagated. This 
hyperexcitability of sensory neurons is considered essential for the generation of a chronic 
pain state, whereby the nociceptors become sensitised to nociceptive stimuli (Tsantoulas and 
McMahon, 2014). 
 
Aside from being the most diverse family of ion channels expressed in human neurons (Ocaña 
et al., 2004) it is also noticeable that there is a selective expression of multiple potassium 
channels on the DRG neurons. With 78 genes in humans expressing potassium channels, it is 
unsurprising that there are multiple subclasses of ion channel identified (Ocaña et al., 2004). 
Potassium channels can be subdivided into four distinct groups, of which the largest 
superfamily is the voltage-gated potassium channels (Kv) (Johnston, Forsythe and Kopp-
Scheinpflug, 2010). This Kv superfamily is further subdivided dependent on the ability of the 
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capacity of the alpha subunit to form a pore subunit. Only members of the Kv1-Kv4, Kv7 and 
Kv10-Kv12 are pore-forming subunits. However, as figure 8 demonstrates there appears to be 
selective expression of Kv1 subtype receptors at the juxta-paranodal regions in nociceptive 
fibres. Figure 1.7.1 below is a comprehensive overview of where Kv subtypes are found in the 
nociceptors:  
 
However, we cannot disregard the importance of background “leak” channels in maintaining 
resting membrane potential. Although these channels are largely voltage independent, the 
KCNK family of proteins is key in re-setting the membrane potential after action potential 
propagation. Leak channels are driven both by electrical potential and the conductance of 
permeating ions across the neuronal membrane.  The rectification of the membrane potential 
is driven by the concentration gradient of ions moving across these leak channels, a 
phenomenon that can also be attributed to the GHK equation (Goldman, 1943; Huang, Hong 
and De Schutter, 2015). Figure 1.7.1 shows how these channels are also expressed throughout 
the fibres of the DRGs, localised mainly to the C-fibres, but having shown expression patterns 




Figure 1.7.1: A) Subcellular localization of potassium channels in murine DRG neuron (Tsantoulas and McMahon, 2014).  
The pattern shown is not absolute, but reflective of data reported in the literature. Expression patterns may vary between 
organisms or species.  
 
1.8  Role of non-neuronal cells in nociception: 
 
1.8.1 Non-Neuronal Cells: 
With regards to excitability and nociception, the full extent of the role of myelinating cells in 
neuropathic pain still remains poorly understood compared to the neurons. However, sciatic 
nerve injury models (SNI) have shown that Schwann cells have the ability to change 
phenotype following damage to the axon (Scheib and Höke, 2013). Schwann cells adopt a 
‘repair’ cell phenotype and regain capacity for proliferation and release of growth factors such 
as NGF and GDNF (R. R. Ji, Chamessian and Zhang, 2016; Jessen and Arthur-Farraj, 2019). With 
several subtypes of P2X receptors identified on Schwann cells, these cells clearly also have a 
role in ATP signalling (Su et al., 2019). Of course, ATP is well characterised as a key modulator 
of both peripheral and central sensitisation of neurons (Tsuda, Tozaki-Saitoh and Inoue, 2010) 
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and therefore the high expression of P2X-R on Schwann cells led to the conclusion that these 
non-neuronal cells must play a role in the development of neuropathic pain (Burnstock, 2000; 
Su et al., 2019). Although overexpression of P2X4 did not induce increased states of 
hyperalgesia (Su et al., 2019) it was demonstrated that administration of broad-spectrum P2 
receptor antagonist pyridoxal phosphate-6-azophenyl-2ʹ,4ʹ-disulfonic acid (PPADS) following 
nerve injury reduced tactile allodynia and thermal hyperalgesia, and reduced the levels of 
secreted IL-6 and IL-1β (Martucci et al., 2008). Furthermore, it has been demonstrated that 
following CCI, the expression levels of pro-inflammatory cytokines (TNFα, IL-1β and IL-6) are 
upregulated in the DRG fibres and sciatic nerve (Jančálek et al., 2010; Austin et al., 2015). 
These chemokines are not only released from infiltrating macrophages, but also from non-
neuronal cells surrounding the damaged tissue. Activated Schwann cells are hypothesised to 
be an additional source of TNFα production in the early hours following SNI (Wagner and 
Myers, 1996; Campana, 2007). TNFα is detectable 6H post injury in high concentrations, and 
has been shown to induce the release of further pro-inflammatory cytokines such as IL-6 by 
infiltrating macrophages. Further evidence has shown that COX-2 and MCP-1 (both potent 
inflammatory mediators involved in sensitising neurons) are expressed by Schwann cells 
following nerve injury in rats (Toews, Barrett and Morell, 1998; Takahashi et al., 2004). 
 
1.8.2 Macrophages: 
Macrophages are highly motile mononucleolar cells derived from hematopoietic tissue. They 
are widely distributed throughout the body, and due to their phagocytic nature are highly 
involved in mediating innate and adaptive inflammatory processes (Bailey et al., 2020). The 
morphology of macrophages is highly dynamic and dependent on the surrounding 
microenvironment (Mulay et al., 2016). Throughout embryonic development macrophages 
arise from yolk-sac progenitor cells and persist throughout adulthood as self-renewing 
populations of inflammatory cells. However, after birth, macrophages derived from bone-
marrow monocytes are also recruited, to replenish tissue resident macrophages in states of 
inflammation or infection (Gordon and Martinez-Pomares, 2017). Since these blood derived 
monocytes are highly heterogeneous, there is still a wide debate about whether specific 
populations of monocytes migrate to specific tissues in inflammatory processes  (Nahrendorf 
et al., 2007). However, in mice it has been demonstrated that the first bone marrow derived 
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monocytes have an innate inflammatory phenotype (Passlick, Flieger and Loms Ziegler-
Heitbrock, 1989) and rapidly develop into mature tissue macrophages or dendritic cells 
(Randolph et al., 1999).  
 
The plasticity of macrophages refers to the process by which macrophages are polarized to 
differentiate to specific phenotypes, each with a specific biological function. On a simplistic 
level, macrophages are polarized either to an M1 (classically activated, pro-inflammatory) 
phenotype, or an M2 (alternatively activated, anti-inflammatory) phenotypes (Murray, 2017). 
However, the M2 phenotype has rapidly evolved to encompass all those macrophages that 
don’t exhibit a pro-inflammatory phenotype (Martinez et al., 2008). At the centre of this 
M1/M2 axis is arginine metabolism (Thomas and Mattila, 2014) but in line with the way cells 
are polarized, three roles for macrophages have been defined including, wound healing, host 
defence and immune regulation (Edwards et al., 2006). Following the innate response of M1-
like or M2-like macrophages, these polarized cells induce T-helper lymphocytes to further 
amplify the macrophage polarization, and promote continuation of the immune response 
where appropriate (Rath et al., 2014a).  
 
Classically activated macrophages typically refers to pro-inflammatory macrophages induced 
by cell mediated immune responses. This includes the stimulation by cytokines such as IFNγ 
or TNFα inducing a tumoricidal phenotype and increased secretion of pro-inflammatory 
cytokines and nitric oxide synthase (Wager and Wormley, 2014). Nitric oxide is a particularly 
important marker of the innate tumoricidal nature of these pro-inflammatory cells. Nitric 
oxide itself is cytotoxic (Li et al., 2004), but will also induce downstream release of metabolites 
to remove pathogens. Since the adaptive immune response is much slower, the rapid innate 
response of these macrophages is required to remove and reduce inflammation (Mills, 2012). 
Other notable markers for the M1 phenotype include CXCL9, CXCL10, CXCL11, IL-12 and 
suppressor of cytokine signalling 3 (SOCS3) (Mosser and Edwards, 2008). Of particular interest 
here is the present of SOCS3, which restricts cell responsiveness to IL-4, a typical promoter of 
the anti-inflammatory phenotypes (Arnold et al., 2014). On the other hand, alternatively 
activated macrophages are induced by cytokines such as IL-4, IL-10 and IL-13, and 
characteristically resemble the anti-inflammatory phenotype of macrophages. In these cells, 
the expression of arginase metabolises arginine to orthinine and urea (Briken and Mosser, 
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2011; Rath et al., 2014a). However, it is uncommon to see either an M1 or an M2 population, 
but rather a mixed population with a preference for either a pro- or anti-inflammatory 
phenotype dependent on the stimulation and surrounding microenvironment. Studies have 
indicated that these characterizations are more indicative of interlaced signalling pathways, 
and the range of phenotypes that can be induced following stimulation (Atri, Guerfali and 
Laouini, 2018). In line with the classification of cells defined above, it is understandable as to 
why there is potential overlap between phenotypes. Recent evidence has suggested that as 
opposed to discrete populations, macrophages polarize in a spectrum based on their function 
(Mosser and Edwards, 2008).  
 
In fact, it has been suggested that the first cells to infiltrate a lesioned area following 
peripheral nerve injury are macrophages, neutrophils and Schwann cells (Stoll G et al., 1989; 
Lindborg, Mack and Zigmond, 2017). However, the changes in the periphery are also rapidly 
followed by those in the CNS, although these are less involved in the initiation of a pain 
response. For example, microglia (the resident immune cells of the CNS) are also important 
in modulating the neuronal response to nociceptive stimuli (Moalem and Tracey, 2006b).  
Although acute inflammatory and neuropathic pain are deemed as separate clinical 
pathologies, evidence has suggested that pro-inflammatory cytokines released from 
infiltrating inflammatory cells are prominent in the development of peripheral sensitization 
and also chronic pain (Miller et al., 2009). In sciatic nerve transection, murine modelling 
showed that upon injury there was a 3-fold increase in infiltrating macrophages relative to 
resident immune cells (Mueller et al., 2003). In models such as Wallerian degeneration, 
following the distal nerve crush there has been shown to be a rapid influx of cytokine 
production induced by infiltrating macrophages derived from the bone marrow (Mueller et 
al., 2003; Fregnan et al., 2012). In vivo, following axotomy of the DRG neuron, an 
accumulation of infiltrating macrophages has been observed 4-days post injury, and high 
levels of these infiltrating inflammatory cells remained present up to 32-days post injury (Lu 
and Richardson, 1993; Kwon et al., 2015). Immunohistological tissue analysis has shown that 
infiltrating macrophages form ‘rings’ around larger diameter fibres of the DRG neurons, with 
fewer cells migrating towards undamaged tissue or smaller diameter fibres (Vega-Avelaira, 
Géranton and Fitzgerald, 2009). In this study it was shown that reactive macrophages, most 
likely M1-like phenotype, appeared to cluster around larger diameter DRG neuron cell bodies 
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in a model of neuropathic pain. Since these neurons were highly sensitised following spared 
nerve injury, this implicated a strong correlation between the regulation of the peripheral 
nervous system, the peripheral immune system and the development of neuropathic pain. 
 
Whilst in vitro culture of bone derived monocytes is useful in the context of flexibility and 
tissue availability, the response seen in these cells may not be translatable to other forms of 
cultures. The L-conditioned media from L929 cells contains high concentrations of mCSF 
(colony stimulating factor) and as such is used to sustain a population of healthy monocytes. 
However, evidence has shown that the presence of mCSF in the culture may cause cells to 
favour an M2 like phenotype, prior to stimulation. 
 
1.8.3 Microglial cells: 
Microglial cells are the resident macrophages of the CNS, accounting for up to 15% of the glial 
cells expressed in the brain and spinal cord. First described by Rio-Hortega in the early 20th 
century (Del Rio-Hortega, 1919), the origin of microglial cells has been widely debated, where 
they were first described as “non-neuronal elements deriving from oligodendrocytes and 
astrocytes”. However, unlike bone marrow derived macrophages, it has since been 
demonstrated that microglial cells originate from the yolk sac early in gestation (Ginhoux et 
al., 2010). Rodent studies have shown that progenitor cells colonize the cerebrum as early as 
the 4th week of development, maturing into microglial cells throughout the CNS (Menassa and 
Gomez-Nicola, 2018; Wang et al., 2019).  Two key functions are thought to define the function 
of microglial cells in the CNS including homeostasis of the CNS and immune regulation and 
defence (Ginhoux and Prinz, 2015).  
Microglial cells develop from the mesodermal layer in development and have many common 
features with other myeloid cells such as macrophages. Although each cell develops 
differently, both macrophages and microglial cells are essential in the innate immune 
response, by maintaining homeostasis and actively scanning the surrounding environment for 
invading pathogens. As such, both cells types have the ability to adapt to changes in the 
surrounding environment and polarize accordingly. Upon detection of invading pathogens or 
chemokines released from damaged surrounding tissue, microglial cells undergo physiological 
changes to help resolve injury, promote repair of damaged tissue and resolve inflammation 
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(Goldmann and Prinz, 2013). In a similar way to that observed in peripheral macrophages, the 
microglial cells of the CNS can also be stimulated to exhibit a pro-inflammatory M1-like or a 
more regenerative M2-like phenotype (Michelucci et al., 2009). However, in spinal cord tissue 
extracted from disease models, where inflammation is increased (such as murine modelling 
in vivo for ALS) the microenvironment of the microglia is far more complex. Characteristically, 
upon detection of invading pathogens, the CNS microglia undergo a switch from a ramified 
resting state, to an ameboid morphology (Davalos et al., 2005).  
Phenotypic similarities were first reported in immunohistochemical studies where it was 
demonstrated that microglial cells also expressed several markers that are highly expressed 
on macrophage cells (Perry, Hume and Gordon, 1985). In mice and humans this first included 
the presence of the surface glycoprotein F4/80, CSF-1 receptor, as well as integrin CD11b 
(Akiyama and McGeer, 1990). Additional markers that have since been identified include the 
presence of the fractalkine receptor (CX3CR1) and the calcium binding protein Iba-1 (Prinz 
and Mildner, 2011; Amici, Dong and Guerau-de-Arellano, 2017). Whilst there are many 
similarities between macrophages and microglial cells, it has also been shown that microglia 
have a unique transcriptomic ‘signature’ that distinguishes them from other inflammatory 
cells (Butovsky et al., 2012). Using flow cytometry and RNA sequencing of microglia isolated 
from the spinal cord tissue of mice, in a single study 29 genes were identified that 
distinguished peripheral monocytes from CNS microglial cells (Chiu et al., 2013). 
 
In early post-natal rodent tissue (P10) the dorsal horn response to nerve injury was 
demonstrated to be weak where there was low activation of the neuroimmune response in 
these animals (Moss et al., 2007). Although in early life the dorsal horn was shown to be 
insensitive to pro-inflammatory cytokines, it has been demonstrated that neuropathic injury 
in neonates primes microglia to become reactive in later life (Vega-Avelaira, Géranton and 
Fitzgerald, 2009). Using neonatal microglia it was recently demonstrated that the phenotype 
of the cells changed dependent on how long they were kept in culture (Caldeira et al., 2014). 
In a ‘quiescent’ state, microglia appear to exhibit a more ramified phenotype, with shorter 
processes extending from the cell body. However, it is important to note that even when 
quiescent, microglia are still actively sensing changes in the surrounding cellular environment. 
Upon inflammation, it has been demonstrated that the cell structure changes to a more 
ameboid morphology, where cells are more phagocytic (Leong and Ling, 1992; Kozlowski and 
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Weimer, 2012). It was demonstrated that the longer cells were left in an in vitro culture, the 
more they favoured a ramified morphology closer to that of an M0-M2 like cell (DiV16.) The 
cells isolated from murine spinal cord here were cultured for a minimum for 14-days prior to 
use in any downstream experiments, and this time period may have affected the morphology 
of the cells.  
 
Scattered throughout the CNS, microglia come into close contact with neurons, mediating 
synaptic pruning and neuronal cell signalling (Kim and De Vellis, 2005). In particular there is 
evidence for the role of chemokines such as fractalkine (CX3CL1) in mediating release of 
trophic factors from microglial cells in neurodevelopment. Binding of fractalkine to receptors 
on the surface of spinal cord derived microglia induces activation of the MAPK pathway and 
promotes the release of pro-inflammatory cytokines from the cell, as well as the transcription 
and upregulation of membrane bound receptors such as P2X4 for ATP  (Ji and Strichartz, 2004; 
Kazuhide and Makoto, 2009). The P2X4 receptor for ATP is solely expressed on microglia in 
the spinal cord, and evidence has shown that knockdown of P2X4 can partially reverse 
mechanical and thermal hyperalgesia evoked by spinal nerve transection (Tsuda et al., 2003, 
2009). In a separate murine model deficient in CX3CR1, neurons in cortical layer V showed 
decreased post-natal survival. This correlated with reduced secretion of insulin-like growth 
factor secretion from microglial cells surrounding the neurons, demonstrating the role for 
microglial cells in mediating neuronal survival as well as modulating the inflammatory 
response to changes in DRG excitability (Ueno et al., 2013).  
 
1.9 Protein turnover and local translation in the nervous system: 
 
In the mature nervous system, it is estimated that each excitatory neuron synapses with up 
to 100,000 other neurons. To regulate and maintain function and plasticity of the nervous 
system, protein turnover is essential. Although action potentials are only propagated in one 
direction along the axon, the cytoskeleton of the neuron also acts as scaffolding for 
bidirectional transport of protein or mRNA (Sotelo-Silveira et al., 2006). The specialised 
function of each part of the neuron means that proteins must be selectively regulated. Recent 
works have provided evidence that translation of mRNA is not only temporally regulated but 
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also spatially regulated. This dynamic turnover of protein in the cell is resultant from a process 
known as local translation (Di Liegro, Schiera and Di Liegro, 2014). Local translation of proteins 
refers to post-transcriptional regulation of mRNA in subcellular compartments. Undoubtedly 
in highly polarized cells like neurons this is essential for dynamic regulation of efficient cell-
to-cell signalling, where regular turnover of proteins is necessary to adapt to changes in the 
microenvironment of the cell (Jung, Yoon and Holt, 2012). Classic examples of local translation 
in the neuron include turnover of proteins the growth cone, and synaptic plasticity. The 
fastest rate of protein transport in human axons has been recorded at 1µM/second. However, 
since the longest axons of the body can be up to 1 metre long, without local translation it 
could take up to 11.6 days to transport proteins from the soma to the distal part of an axon 
(Maday et al., 2014). Therefore, on-site synthesis of proteins in neurons has evolved as an 
essential component in effective cell signalling and synaptic plasticity.  
 
Local protein synthesis was first observed by the detection of amino acids being incorporated 
into the axon of the neuron, although at the time a lack of evidence meant that the theory of 
local protein translation in neurons was not widely acknowledged (Giuditta, Dettbarn and 
Brzin, 1968; Sotelo-Silveira et al., 2006). It was first hypothesised that local protein translation 
did not occur in mature axons, and ribosomal RNA observed in the axoplasm was most likely 
RNA transfer from the mitochondria of the neuron. However, this study used polyacrylamide 
gel electrophoresis to visualise the RNA and as such, the low sensitivity of the technique 
meant that only low levels of ribosomal RNA were detected in the axoplasm of the squid giant 
axon (Lasek, Dabrowski and Nordlander, 1973).  Initial evidence subsequently suggested that 
although present, local protein synthesis in the axon only occurred during development of 
the cell since electron dense polysomes were only detected in the proximal axonal segments, 
but not in the distal compartment (Steward and Ribak, 1986). However, as biochemical 
detection methods have become more sensitive (e.g. the development of microarrays, qPCR 
and electron microscopy) ribosomal RNA has been observed from both cortical and sensory 
neuron axons (Bassell et al., 1998). Compelling evidence came in 2009 when axons of cultured 
peripheral sensory neurons showed metabolically labelled, newly synthesized proteins being 
trafficked to the cell membrane (Merianda et al., 2009). Synaptic plasticity is one of the 
earliest acknowledged examples of local translation, where connections are formed based on 
neuronal firing and metabolic requirements of the cell. This process of protein turnover at 
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the synapse requires new RNA, and protein synthesis (Davis and Squire, 1984; Sutton and 
Schuman, 2006). It has been demonstrated that neuronal proteins quantified in vitro had a 
short half-life of up to 6 days (Dörrbaum et al., 2018) whilst in vivo protein turnover appears 
occur every 10 days (Fornasiero et al., 2018). In particular those proteins that demonstrated 
highest levels of turnover included proteins found in the growth cone, like MAP2 (Garner, 
Tucker and Matus, 1988) and proteins involved in synaptic transmission such as Camk2A 
(Burgin et al., 1990). Several techniques have been used to identify proteins (or polysomal 
RNA) in the distal portion of the axon. In-situ hybridization was one of the first methods that 
made it possible to identify proteins in the distal compartment of the cell, although initially 
low-sensitivity of the detection meant that few transcripts were identified, two of which were 
Camk2A and Map2. However, more recent developments including qPCR of rodent sensory 
neurons have led to the identification of hundreds of transcripts located in the distal 
compartment of the axon, not having been translocated from the soma (Zheng et al., 2001). 
Furthermore, the purification of excitatory synaptosomes led to the identification of more 
than 400 transcripts selectively expressed in the active zone of the synaptic terminal (Hafner 
et al., 2019). 
 
Nowadays it is widely accepted that mRNAs are 1. locally translated within the cell. 2. Are 
transported via the microtubules of the axon, and 3. That the 3’ and 5’ untranslated regions 
of an mRNA are key in the regulation and localization of a protein (Eom et al., 2003; Tushev 
et al., 2018). RNA interference (or RNAi) refers to the cellular mechanisms of post-
transcriptional regulation of protein expression, whereby protein synthesis may be inhibited. 
Small changes in the sequence of the UTRs affect downstream binding and subsequent 
translation of a protein. Furthermore, it is clear that there is a large scale of diversity in the 
3’UTR of neuronal mRNAs especially, since these cells must constantly react and adapt to 
incoming cell signals and adjust protein expression accordingly. Genes transcribing proteins 
in the nucleus are usually transcribed by RNA polymerase II. The primary transcript is 
processed by splicing to form mRNA and is exported into the cytoplasm where ribosomes 
catalyze translation of mRNA to mature polypeptide chains. However, this translation can be 
regulated by small sequences of double stranded RNA molecules involved in translational 
repression. Both siRNA (short interfering) and miRNA (micro) are short double-stranded RNA 
molecules involved in RNAi. The key difference is that siRNA binds with full complementation 
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to one mRNA of interest, which is then degraded. Whereas, miRNAs only bind to mRNA at the 
seed sequence in the 3’UTR; meaning that one microRNA sequence can potentially bind to 
and inhibit the translation of multiple mRNA sequences. Therefore, alternative regulation of 
neuronal mRNAs via the UTRs most likely arises as a consequence of the presence, or absence 
of several microRNA sequences (Lin and Holt, 2008; Tushev et al., 2018). 
 
1.10  MicroRNA: 
MicroRNAs are an endogenous family of small, non-coding RNA roughly 21-25 nucleotides in 
length. First discovered in C.Elegans in 1993, Lin-4 was initially thought to be an isolated 
regulatory sequence (Lee, Feinbaum and Ambros, 1993). However by 2000, the conserved 
and temporal expression of the Let-7 family of microRNA had been first reported (Pasquinelli 
et al., 2000). To date around 2000 microRNA have been identified in the human genome, 
although sequencing shows that many are conserved between species such as rat and mouse 
(De Rie et al., 2017; Alles et al., 2019).  
 
1.10.1 MicroRNAs as regulators of translation in the nervous system: 
It is well established that these short non-coding sequences are involved in regulating protein 
turnover, by targeting mRNA degradation and facilitating translational repression. In 
particular, the role of microRNA in local protein translation has been investigated with  
relevance here to the subcellular expression in polarised cells such as neurons (Siegel et al., 
2009). For example, it has been elucidated that the expression of specific microRNA in the 
axonal “compartment” of a neuron can repress translation of proteins, thereby acting as 
regulators of translation (Wang et al., 2015; Zhang et al., 2015). Of course, given the dynamic 
metabolic requirements of neurons, it is unsurprising that these cells can rapidly regulate 
protein turnover at a subcellular level, where the soma and the axon often have different 
metabolic requirements with respect to the surrounding microenvironment. Given the 
distinct subcellular expression of select mRNAs in the axons of neurons, recent works have 
also identified roles for microRNA in axonal outgrowth as well as maintaining neuronal 
viability (Baudet et al., 2012). In a screen of several microRNAs, it was demonstrated here 
that the specific loss of miR-124 induced a synchronised “loss of function” in growth cone 
pathway-finding. This finding was most likely induced by the delayed onset of Semaphorin-3 
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sensitivity in these neurons by inhibition of miR-124 expression in the axon (Baudet et al., 
2012).  
 
Work has been ongoing in the Dajas-Bailador lab for many years to characterise the function 
of specific microRNAs in neuronal development and connectivity. In an earlier study it was 
shown that miR-9 had roles in regulating axonal extension of cortical neurons, by regulating 
expression of Map1b and subsequent microtubule stability (Dajas-Bailador et al., 2012). 
Results showed that microRNA-9 was detected as early as embryonic day 17 (E17) in culture, 
but the addition of a locked nucleic acid inhibitor (LNAi) for miR-9 showed reduced axonal 
extensions in cortical outgrowths. Furthermore, the role of miR-9 as a target for signalling 
pathways controlling neuronal extension was elucidated. The expression of miR-9 was 
identified as being linked to expression of the chemoattractant brain derived neurotrophic 
factor (BDNF) in a biphasic manner, thus linking the microRNA of interest to a protein target 
in a signalling pathway of interest. Short stimulation of the axons with BDNF induced an 
increase in axonal length, although this response was reversed is miR-9 was overexpressed. 
Critically, in this study neurons were cultured using compartmentalised microfluidic devices, 
where the change in miR-9 expression correlating with increase in axonal length, was only 
observed when BDNF was locally applied to the axons. Consequently, this work has helped to 
pave the way for further studies in compartmentalised devices, investigating the role of 
microRNA in local translation of mRNA in neurons.  
Following this, the role of miR-26a was elucidated in early stage development of mouse 
cortical neurons using microfluidic devices (Lucci et al., 2020). MiR-26a was shown to 
modulate neuronal growth and polarity in primary neuron cultures via the activity of GSK-3β. 
Functionally GSK-3β was detected in both the somal and axonal compartments of the 
microfluidic devices, and a molecular mechanism was demonstrated whereby the local 
translation of GSK-3β is quiescently repressed by miR-26a, and allows elongation of cortical 
axons.  However, upon targeted inhibition of the expression of miR-26a in the axon, 
translational repression of GSK-3β is removed, and protein turnover is increased. This 
increase in GSK-3β has been further implicated in neurodegeneration, with implications in the 
development of Alzheimer’s and Parkinson’s disease models (Jacobs et al., 2012; Golpich et 
al., 2015).  
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There is increasing evidence for the role of microRNA and translational repression in disease 
pathology. For example, the extracellular expression of specific microRNAs have been 
facilitated as potential biomarkers for the onset of disease (Reid, Kirschner and van Zandwijk, 
2011). It is evident that the aberrant expression of microRNA often underlies the pathologies 
of diseases; such as cancer where the dysregulation of microRNA expression is key to the 
disease pathology (Tüfekci et al., 2014). There is compelling evidence for microRNAs acting 
as either tumour suppressors or oncogenes, depending on the endogenous expression of the 
microRNA. One of the most well-known examples of this, is the role of miR15a and miR16-1 
in leukemia. In a mouse model it was demonstrated that mice that developed chronic 
lymphocytic leukemia (CLL) had a much lower expression of these miRs endogenously. 
Physiologically these miRs act as tumour suppressors by inducing apoptosis, but ablation of 
the mature miR sequence led to development of a cancer phenotype (Esquela-Kerscher and 
Slack, 2006).   
 
MicroRNAs have also been demonstrated to affect pathologies of the nervous system, 
including nociception (Andersen, Duroux and Gazerani, 2014; Sakai and Suzuki, 2014). Pain is 
highly dependent on the sensory nerves, but dysregulation of protein expression, specifically 
receptors or ion channels may induce hypersensitivity of these neurons. 
 
There are multiple stages at which the regulation of microRNA could be endogenously 
affected. In order to understand how microRNA expression affects disease pathologies, the 
process of miRNA biogenesis must be further examined.  
 
1.10.2 Biogenesis of microRNA: 
 
There are still new microRNAs being discovered, although the majority of miRNA biogenesis 
follows a similar pathway. MicroRNA is transcribed from the DNA sequence into a primary 
miRNA sequence (pri-miRNA). From here, pri-miRNA is processed into a precursor sequence 
and eventually a mature microRNA (O’Brien et al., 2018). It is widely reported that these 
mature microRNA sequences interact with the 3’ untranslated region (UTR) of mRNA to 
regulate translational repression of protein (Ha and Kim, 2014). However, there have been 
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examples where the miR target is the 5’UTR or even the gene promoter sequence (Lytle, Yario 
and Steitz, 2007).  
 
The majority of microRNAs are generated via the canonical biogenesis pathway (O’Brien et 
al., 2018) as shown below in figure 1.10.1: 
 
 
Figure 1.10.1: An overview of the canonical pathway of microRNA biogenesis, made using Biorender 
 
The canonical pathway begins by transcription of DNA by Polymerase II, into the pri-miRNA 
stem-loop sequence. From here, flanking sequences on the pri-miRNA are cleaved by 
ribonuclease III enzyme Drosha and the associated RNA binding protein DGCR8 (Denli et al., 
2004). The pri-miRNA is processed into a smaller pre-miRNA molecule with a 2 nucleotide 
overhang at the 3’ end of the stem loop (Han et al., 2004).  
 
The pre-miRNA is then exported to the cytoplasm where it is processed by the double 
stranded RNA-specific RNAse III endonuclease, Dicer (Lee et al., 2003; Bartel, 2004). Dicer 
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cleaves phosphodiester bonds in the RNA sequence to form small dsRNAs, including (but not 
limited to) microRNAs. Pre-miRNA is cut by removing the loop and terminal base pairs, whilst 
leaving a short sequence, including the 5’ phosphate and 2 nucleotide overhang at the 3’ end 
that is characteristic of RNAse III digestion.  
There is some evidence to suggest that different at different stages of the canonical pathway, 
microRNAs are selectively expressed at different regions of the neuron. Where neurons are 
polarized cells, the metabolic requirements of the axon versus the soma are different but also 
dynamic. For example, it has been shown that pri-miRNAs are localised only to post-synaptic 
densities (Lugli et al., 2012). However, PCR reactions from the distal portion of DRG neurons 
detected amplicons for precursor microRNAs such as pre-miR-138-1 in the somal RNA only, 
but not in the dendritic RNA fragments (Natera-Naranjo et al., 2010; Kim et al., 2015). In 
contrast, mature miR-138 has been localised to the soma, axons and dendrites of cultured 
DRG neurons using fluorescence in situ hybridization (Siegel et al., 2009; Kim, H. H., Kim, P., 
Phay, M., and Yoo, 2015). As such, the evidence provided here demonstrates that the 
expression of microRNA may change dependent on the microenvironment of the cell, and 
consequently the translational repression activity of the microRNA is dependent on the 
biogenesis of mature microRNA.  
 
1.10.3 Association with the RNA Induced Silencing Complex: 
 
The RNA induced silencing complex (RISC) is a protein complex that can actively promote 
mRNA degeneration or inhibit translation of RNA. In the canonical pathway for miRNA 
biogenesis this RISC is comprised of Argonaute (AGO) and the guide strand of the pre-miRNA 
molecule. The miRISC binds to a complementary sequence on target mRNA known as a 
microRNA response element (MRE.) The degree of complement binding between the miRNA 
duplex and miRISC determines the mechanism of post-transcriptional regulation of mRNA. If 
the target sequence of the MRE is fully complementary to the miRISC, then mRNA is 




However, the majority of MREs do not show complete complementation to the miRISC (Jonas 
and Izaurralde, 2015). If cleavage by AGO alone is not possible, the RISC is also comprised of 
additional elements. In humans, this RISC is comprised of an AGO2 component, as well as 
glycine-tryptophan (GW182) and other proteins like helicases (Krol, Loedige and Filipowicz, 
2010). Interestingly it has been demonstrated that whilst important, the miRNA:mRNA 
binding is not essential for translational repression. Artificial tethering of either the Ago (Pillai, 
Artus and Filipowicz, 2004) or GW182 (Eulalio et al., 2009) components of miRISC at the 3’UTR 
of target mRNA demonstrated a positive effect on gene silencing in a luciferase reporter 
format (Bos et al., 2016). 
 
Although either strand of the miRNA duplex can associate with the miRISC, it is widely 
acknowledged that most microRNAs have a dominant guide strand. For example, miR-138-5p 
recognises the 5’ dominant strand in the precursor (Ambros et al., 2003). When the dominant 
strand of the miR duplex associates with miRISC, the other strand of miRNA is degraded. From 
here, microRNA associated with AGO2 and GW182 induces downstream translational 
repression of target mRNA (Kim, Han and Siomi, 2009; Galagali and Kim, 2018).  
 
There also appears to be a developmental effect of miRISC association and the effect on gene 
silencing. For example, it has been demonstrated that in early development, miRISC activity 
induces translational repression by shortening the poly-A tail of the transcript, but critically 
does not reduce transcript stability (Bazzini, Lee and Giraldez, 2012; Subtelny et al., 2014).  
 
1.10.4 Other pathways for microRNA Biogenesis: 
 
Multiple non-canonical methods of microRNA biogenesis have been hypothesised to date, 
proposing alternate combinations of proteins involved in canonical biogenesis. Of particular 
interest are Drosha, Dicer, Exportin activity and Ago in the RISC. For this reason, non-canonical 
biogenesis can be categorised into Drosha-independent and Dicer-independent pathways 
(O’Brien et al., 2018). For example, pre-miRNA generated with a 7-methylguanosine cap in 
the Drosha-independent pathway, resembles a Dicer substrate (Xie et al., 2013). The m7G cap 
 61 
at the 5’UTR are directly exported from the nucleus, without the need for Dicer cleavage 
(Yang and Lai, 2011; Xie and Steitz, 2014)  
 
The resultant effect of miRNA association with the RISC is variable with respect to expression 
of target mRNA. There is evidence for both translational repression and RNA degradation 
inducing gene silencing (Bartel, 2009) but the environmental factors governing how this is 
determined have not yet been fully elucidated.  
 
1.10.5 Utilising the miRNA seed sequence for target recognition in a signalling 
pathway: 
 
A prominent method of target interaction with microRNA is the utilisation and cross-
referencing of bioinformatic databases. As previously stated, microRNA duplexes bind to the 
miRISC. It has become evident that since microRNA conforms to Watson-Crick base pairing, 
the MRE sequence of the mRNA is complementary to the ‘seed sequence’ of the microRNA. 
This seed sequence, usually 6 nucleotides long near the 5’UTR, is the only section of the 
microRNA that must be entirely complementary to the target mRNA (Lewis et al., 2003), in 
order for a microRNA to potentially target a protein of interest. Other factors, such as low GC 
composition or length of the 3’UTR (Grimson et al., 2007) have been demonstrated as 
additional factors that may affect seed binding to a target. However, the basis of most binding 
prediction algorithms first investigates the complementation of the seed sequence to the 
mRNA of interest (Paraskevopoulou et al., 2013a; Kozomara and Griffiths-Jones, 2014; 
Peterson et al., 2014; Agarwal et al., 2015). 
 
Although it is evident that seed sequence complementation to the MRE is important, the 
inaccuracy  of prediction algorithms often leads to false predictions (Liu and Wang, 2019). 
This is most likely due to the effect of interactions between the miRNA and mRNA that are 
independent of complementary seed sequence binding. As such, there is often a need for 
experimental validation of microRNA, following bioinformatic identification of a protein 
target of interest. Chapter 2.4 describes the use of the dual luciferase reporter system for 
target validation, a technique that is later used and discussed in Chapter 5.  
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1.11 Summary and aims of this thesis: 
 
Of particular interest to this project was the use of microfluidic culture for modelling complex 
multi-cellular signalling pathways, such as those involved in nociception. Until recently the 
study of nociception in vitro has often been limited by the method of culture, and failure to 
replicate the complex cell signalling pathways and cell morphologies involved in pain-based 
signalling. However, the development of microfluidic culture has been previously been 
demonstrated to provide a useful tool for modelling the complexity of neuronal signalling in 
vitro (Taylor et al., 2005).  
The primary objective of this project was to develop a microfluidic model that could be used 
to investigate induced changes in neuronal excitability, in the context of pain-based signalling. 
This included healthy and reproducible culture of DRG neurons in vitro that replicated the 
unique pseudounipolar morphology of these cells observed in vivo.  
 
The following aims were outlined during the initial stages of this project: 
• To replicate the complex microenvironment of the pseudounipolar DRG neurons by 
using microfluidically isolated cultures. This included, but was not limited to the 
additional culture and characterisation of non-neuronal cells that interact with and 
induce changes in DRG neurons at the neuronal terminals. 
• To use the microfluidic model developed in this project to investigate changes in 
neuronal excitability as a proxy for pain. 
• Neurons are highly polarised cells, and it was hypothesised that protein expression is 
locally regulated in the cell. By exploiting the microfluidic nature of the model, we also 
aimed to investigate the effect of local protein translation on DRG excitability. This 
work also included the investigation into a microRNA of interest and the potential role 
in regulating excitability in pain-based signalling. 





2 Materials and Methods 
Standard protocols are not repeated (i.e DRG dissection and microfluidic seeding). Suppliers 
for all reagents have been named in the first citing. 
 
2.1.1 Animals  
Mice (C57/BL6) were housed, bred and treated in compliance with the ethics and animal 
welfare in place in the University, in accordance with the Animal (Scientific Procedures) Act 
1986. Animals were sacrificed and tissue collected in accordance with UK home office 
regulations and procedures under Schedule 1 of ASPA 1986. 
 
2.1.2 Cell culture: 
As an NC3Rs project, this thesis describes the use of multiple cell types. Per dissection, up to 
3 cell subtypes were potentially extracted from one pregnant female adult mouse, and the 
additional embryonic tissue in the case of DRG neuron culture. 
 
2.2 Cell Culture based protocols:  
All tissue dissections used sterile instruments and cell culture was undertaken in a sterile 
environment using a class II cabinet. All reagents used in the sterile culture environment were 
sprayed with 70% ethanol before use.   
 
2.2.1 Coating of plates, dishes and coverslips 
Dishes or coverslips (if non-sterile) were soaked thoroughly in 70% ethanol and air-dried in a 
class II cabinet. 
Poly-L-Lysine (PLL, Sigma) was diluted in sterile water to a final concentration of 0.02mg/ml 
and added so that the coating covered the base of the dishes. The coating was left soaking on 
the dishes for one hour in a class II cabinet. PLL was removed from coated Nuncs/ coverslips, 
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at which point they were washed twice with sterile water and left to dry completely 
overnight.  
On the day of dissection, laminin (Sigma) was diluted in DMEM (D6546) to a final 
concentration of 20µg/ml. In microfluidic devices a minimum of 100µl per channel was added. 
Or if using coverslips for dissociated plate culture, a 50µl drop was added to the centre of a 
culture dish. Plates were incubated for one hour at 37°C in an incubator whilst neurons were 
dissected. Laminin was removed and plates were washed with DMEM prior to seeding of cells. 
2.2.2 In vitro culture of bone marrow derived macrophages: 
In order that the cell culture medium is consistent throughout the model, this protocol 
describes the culture of macrophages with Dulbecco’s modified eagle medium (high glucose 
DMEM, D6546 Sigma) from an adapted form of the culture method by (Massier et al., 2015).   
 
2.2.2.1 Preparation of L-conditioned media (LCM) 
L929 cells (Sigma) were kindly provided by the Martinez laboratory and thawed in a water 
bath at 37ᵒC. LCM media stock was made by combining DMEM with 10% (v/v) HI FBS, 1% (v/v) 
PS, 1% (v/v) GM in a 500ml bottle.  
1ml of defrosted cells was added to a sterile falcon tube, with 17.5ml LCM media stock added 
drop-by-drop. Media was not added vigorously to avoid damaging the cells.  Cells were 
centrifuged at 250xg for 5-minutes at +4ᵒC to form a dense pellet and remove DMSO from 
suspension. The supernatant was removed, and the pellet resuspended in the small volume 
remaining by tapping the falcon tube gently. From here the cell pellet was completely re-
suspended in 3ml of the LCM media stock and added to a T-75cm2 with 15ml additional LCM 
media to cover the base of the flask. After 2-days in culture, the flask was passaged into 4-T-
75cm2 flasks, and after a further 2 days the T-75cm2 were sub-cultured into 10 x 225cm2 petri 
dishes. When the cells began to touch each other in culture on day 8, the time elapsed was 
counted for a further 10-days. On the 10th day the supernatant was filtrated and frozen at -
20ᵒC in 15ml aliquots until required.  
 
2.2.2.2 Preparation of media for culture of macrophages in vitro:  
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The initial stock was made by combining DMEM with 10% (v/v) HI FBS, 1% (v/v) PS, 1% (v/v) 
GM in a 50ml tube. At which point, 7.5ml of the “stock” was removed, and replaced with 7.5 
ml of the defrosted LCM.  
In order that the macrophage media could be tested in live imaging protocols, a protocol for 
making a stock without phenol red present was also prepared. In this case, all reagents were 
the same but high glucose DMEM without phenol red (Gibco, 31053028) 
 
2.2.2.3 Culturing cells in macrophage media:  
Bone marrow was usually isolated from fresh tissue since the viability of cells appeared 
increased: the long bones from a pregnant adult female were cut, and excess muscle 
surrounding the bones was removed. Using a 25G needle and 20ml PBS (without calcium and 
magnesium, Sigma) the bone marrow was flushed from within the bones, into a sterile 50ml 
falcon.  
Cells were centrifuged at 250xg for 5 minutes at 4ᵒC. By quickly discarding the supernatant 
into the waste pot, this process forms a dense pellet of cells at the bottom of the falcon. Cells 
were partially re-suspended by gently flicking the end of the falcon, before 5-10ml pre-
prepared DMEM macrophage media was added drop-by-drop to completely re-suspend the 
cells. 
25ml of ‘macrophage media’ was added onto a 140mm non-tissue culture treated petri dish 
(Fisher, 501V) prior to the addition of the cell-suspension. Cells were incubated at 37ᵒC, 5% 
CO2 for 3-5 days before changing the media. Although undifferentiated, a healthy 
macrophage culture appeared between 70-90% confluent, where cells were morphologically 
rounded or elongated with a ‘halo.’  
At day 7 in vitro (DiV7) cells were washed twice with PBS (without calcium and magnesium) 
each time incubating on ice for between 2 to 10 minutes. By adding PBS-EDTA at 10mM (pH 
8.0) for up to 20 minutes on ice, cells were detached easily from the cell plate.  
If cells were re-plated into a 6-well plate, 2ml/well of cells was pipetted and the plate re-
incubated at 37ᵒC, 5% CO2 until ready to be used. If used for immunofluorescence, cells were 
re-plated into a 6-well plate onto a glass coverslip and cultured until used. Cells could also be 
cryopreserved in resuspension 10% (v/v) DMSO with 90% (v/v) FBS.  
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2.2.2.4 Polarizing cells in vitro:  
Culture of mature macrophages in media supplemented with cytokines of interest has been 
shown to demonstrate changes in the phenotype of cells. In this protocol, from DiV7 onwards, 
macrophage cells were re-plated and grown in macrophage media supplemented with 
inflammatory stimuli to promote cell polarisation.  
Exposure to cytokines was required for a minimum of 24 hours, with literature suggesting 
that this period was optimized between 24-48 hours. Phenotypic changes were observed 
between cells cultured in the presence of lipopolysaccharide (LPS) with interferon-γ (IFN-γ, 
Miltyni Biotech) as compared to those cultured with interleukin-4 (IL-4, Miltinyi Biotech) only.  
As a control, following re-plating, murine macrophage colony stimulating factor (m-CSF, 
Fisher) was used to maintain a population of cells in the MØ condition.  
 
Cells from one confluent 140mm petri dish were divided and plated onto three 90mm 
bacterial-grade petri dishes (Sarstedt.) At this point, once cells had adhered to the plastic, the 
following protocol for cell polarization was used, based on the literature on classical activation 
of macrophages (Murray et al., 2014; Massier et al., 2015.)  
 
The concentrations of the cytokines used to promote differentiation of each culture were as 
follows:  
 
M1-like culture: 100ng/ml IFN-γ + 100ng/ml LPS 
M2-like culture: 20ng/ml IL-4 
MØ- like control culture: 100ng/ml mCSF 
 
Media from polarized cells was collected and frozen in aliquots at -20°C to be used in 
downstream co-culture or live cell imaging techniques. The protocol was optimised for use so 
that cells were exposed to polarizing stimuli for 24-hours, then the media replaced for 2-hours 
prior to collection. In this way the frozen stocks of ‘polarized media’ contained cytokines 
released from polarized cells, but low levels of polarizing stimuli.  
 
Based on the stimuli used, the polarized macrophages produced most closely resembled an 
M1a-like and M2a-like phenotype, as described by (Melton et al., 2015). For use in imaging 
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protocols, all polarized media generated was phenol red free to avoid cross-reaction at 
470nM excitation wavelength. 
 
2.2.2.5 Cytokine array: 
The cytokine array was purchased from Abcam (ab133999) for use with media extracted from 
polarized macrophage cells (see 2.2.2.4.) The cytokine array permitted semi-quantitative 
analysis of 40 targets in one experiment rather than the quantification of selected targets of 
interest. Rather than being a plate-based assay, media was added to a membrane, followed 
by a biotinylated detector antibody, as well as horseradish peroxidase (HRP.)  
 
Using ImageJ the results of the array were analysed using dot-blot densitometry. The 
background was removed from each image, using a rolling ball radius set to 25 pixels as 
standard. Only after correcting to the background does the integrated density for the empty 
wells equal 0 (or close to.)  The scan of the membrane shown has been converted to an 8-bit 
binary image and inverted. Only those cytokines detected at levels higher than the negative 
control are now quantified. Densitometry was used for a semi-quantitiative analysis of the 
fold change in the most highly expressed cytokines present in different media subtypes. N=2, 
error bars representing the standard deviation of the fold change. The results provided a 
‘snapshot’ of inflammatory cell profiles, although the results observed in mice may not 
directly reflect that observed in human tissue. 
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Figure 2.2.1 shows an example of a membrane exposed to M1-like media after a 10-minute 
exposure. A circle was drawn around D6 for both media subtypes, since this point was 
considered to be the largest spot recorded on the membrane. The integrated density was 
calculated using Fiji. The area analysed was left the same for every point on the membrane, 
and the result for wells 1C-2D were subtracted, since these points are “blank” controls. In this 
way, the background on the membrane was removed from the result, and the data was then 
normalised to the endogenous positive control.  
 




Figure 2.2.1: Example scan of cytokine array membrane exposed to M1-like 
media for 10-minutes. 
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2.2.3 Microglial Culture in vitro: 
Using the spinal cords isolated from E16.5 tissue, a mixed glial population was cultured from 
which the microglia were isolated as required.  
 
Microglial seeding media= High glucose DMEM, no Ca2+ (Gibco 21068028) supplemented 
with 10% (v/v) HI FBS, 1% (v/v) PS and 1% (v/v) GM 
Microglial replating media= High glucose DMEM, no Ca2+ (Gibco 21068028) supplemented 
with 10% (v/v) HI Horse serum (Gibco), 1% (v/v) PS and 1% (v/v) GM 
 
Spinal cords were removed during embryonic dissection and placed in 5ml Leibovitz's L-15 
media (Gibco) on ice. The tissue was then transferred to a sterile 50ml tube, and the volume 
of media was topped up to a minimum of 10ml before the spinal cords were homogenized by 
pipetting. The suspension was then centrifuged at 2500xg for 5 minutes at 4°C, and the 
supernatant aspirated from the pellet. Cells were gently re-suspended in 10ml L-15 using a 
10ml serological pipette, and the suspension passed through a 100µM cell strainer (Corning) 
to remove cell debris. 
The cell suspension was re-spun at 2500xg for 5 minutes at 4°C, and the pellet re-suspended 
in 6ml microglial seeding media. Cells were transferred to T-25cm2 flasks, were incubated at 
37°C, 5% CO2 and the media changed on day 5, then every 48-72 hours until cells were 
confluent. 
Upon reaching confluency (usually between DiV10-14) cells were placed on an orbital shaker 
at 150rpm for between 2-4 hours (maximum) at 37°C, 5% CO2 to lift the microglial layer from 
the astrocytes. The flask was checked every hour to ensure only the microglial cells were 
removed. These cells were resuspended in microglial re-plating media, on pre-coated PLL 
dishes or coverslips (see Chapter 2.2.1,) using 100µl droplet per coverslip, and topping up 
media after 24 hours.  
 
2.2.3.1 Microglial polarization: 
Culture of mature microglia in media supplemented with cytokines of interest also 
demonstrated changes in the phenotype of cells. For continuity, the same protocol was used 
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for the microglial polarization as the macrophage culture (section 2.2.2.4), although IFNγ was 
not used to prime the development of the M1-like cells.  
 
2.2.3.2 Microglial Phagocytosis assay:  
(see Bioprotocols (Lian, Roy and Zheng, 2016)) 
After microglia were attached to pre-coated PLL coverslips (0.1mg/ml, see section 2.2.1) 
polarization was promoted for between 24-48H using the protocol described in section 
2.2.2.4. 
Latex fluorescent beads (diameter 1µM, Sigma L1030) were pre-opsonized in HI FBS for 1 hour 
at 37°C, then diluted into high glucose DMEM (D6546) for a final concentration of beads to 
FBS in DMEM at 0.01% (v/v) and 0.05% (v/v) respectively.  
 
Cell media was replaced with microglial media containing the latex beads and cells re-
incubated for a minimum of 1 hour at 37°C. Cells were washed thoroughly with PBS and then 
fixed with 4% PFA. Downstream immunofluorescence protocols (section 2.5) were used to 
quantify microglial phagocytosis with relevance to cell phenotype.  
 
2.2.4 In vitro culture of dorsal root ganglion:  
Embryonic DRG (E16.5) were extracted from pregnant adult C57-BL6 mice and placed in 
Leibowitz-15 (L15, Fisher) medium on ice. From here DRGs were treated for 10 minutes with 
0.025% (w/v) trypsin (Sigma) in calcium and magnesium free PBS followed by 15-20 minutes 
digestion with 0.2% (w/v) collagenase-II (Gibco) at 37ᵒC. The cell pellet was removed from the 
collagenase and transferred to 1ml high glucose DMEM (D6546 Sigma) supplemented with 
10% FBS (Fisher) and gently dissociated.  
Cell suspension was centrifuged for 5 minutes at 100xg (4000rpm) in a tabletop 
minicentrifuge and the resulting cell pellet suspended in the appropriate volume of DRG 
growth media (DMEM, 2% (v/v) B27 (Invitrogen), 1% (v/v) PS (Sigma,) 2mM GM (Fisher), 
50ng/ml Glial-Derived Neurotrophic factor (GDNF, Sigma), 50ng/ml Nerve Growth Factor 
(NGF 2.5S, Invitrogen) and 4µM Aphidocolin (Aph, Sigma). The anti-mitotic Aphidicolin was 
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included within the DRG growth media in order to restrict excessive growth of non-neuronal 
cells.  
 
2.2.4.1 Microfluidic seeding: 
 
Preparation of the microfluidic devices SND150 (Xona) was completed as described by Garcez 
et al., (2016.) Dissociated cultures were seeded in microfluidic chambers on plates pre-coated 
with PLL and Laminin as described in 2.2.1. A maximum 10µl cell suspension was slowly added 
drop-by-drop to each well in the somal compartment, with each of the axonal compartments 
being filled with 150µl DRG growth media.  
After 4 to 6 hours the culture was supplemented with 200µl additional growth media for 
culture on the somal side. Cultures were maintained at 37°C, 5% CO2 in a high humidity 
incubator with an average of 8-12 DRGs dissociated to a cell concentration of 5x106 cells/ml 
in each 2-channel microfluidic chamber (Xona, SND150.)  
Hydrostatic pressure was used to ensure that media entered but did not pass through the 
microgrooves. This was achieved by ensuring that the volume of media was higher in the 
somal compartment than the axonal compartment of the chamber at all times (see figure 
Figure 2.2.2: Schematic showing the design of a two channel microfluidic device with microgroove length 150μM 
separating the microfluidically isolated compartments, image taken from Xona microfluidics. 
 
 72 
2.2.2.) Wells on the axonal side of the chamber were filled with 150µl each of DRG growth 
media compared to 200µl per well on the somal side. 
 
2.2.4.2 Dissociated plate-based culture of DRGs: 
Laminin (Sigma) in DMEM was applied to the centre of a PLL-coated Nunclon (35x10mm) cell 
culture dish at least one hour prior to cell seeding. Laminin solution was removed, and 30μl 
of DRG cell suspension containing 3-5 dissociated ganglia was applied to the centre of the 
dish in a droplet. Cells were left to adhere overnight, and 1-2ml of DRG growth media was 
added to the cells the following morning. Media was gently replaced every 3-4 days of culture, 
ensuring not to lift the cell suspension from the plate when re-adding new media.  
 
2.2.4.3 Culture of DRG on porous membranes: 
Cell culture inserts (Corning) with a porous PET membrane (1.0µM diameter pores) were 
placed into a tissue culture grade 6-well plate. The culture method was derived from works 
described by Unsain et al., (2014) regarding the culture of sensory neurons using porous 
filters. When the insert was placed into the 6-well plate, two compartments were formed as 
shown by chapter 5, figure 5.3.1.  
 
All cultures using these inserts were pre-coated with 1mg/ml PLL for 1 hour (on both sides of 
the insert) before exposure to laminin (20µg/ml) for 1 hour at 37°C on the day of culture. The 
“axonal compartment” of these inserts sits in a minimum of 2ml DRG growth media, which 
contains growth factors, whilst the cell pellet is seeded in 100µl of DRG growth media without 
NGF and GDNF onto the membrane, and topped up to 1ml after 24 hours, after the cells have 
attached to the membrane. Media was exchanged every 3 days of culture. 
 
2.3 Functional studies with DRG in microfluidic chambers:  
 
2.3.1 Calcium Imaging: 
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Standard imaging buffer was prepared fresh every two to four weeks in autoclaved sterile 
water containing 135mM NaCl, 3mM KCl, 10mM HEPES, 15mM glucose (all Sigma), pH 7.4. To 
each 10ml of complete buffer used 1mM MgSO4 and 2mM CaCl2 was added on the day of use.  
 
Changes in fluorescence were recorded by quantifying the increase in Fluo-5F (AM) signal 
following stimulation of a cell. Fluo-5F AM (ThermoFisher) is a single wavelength, labelled 
calcium indicator, with similar properties to other indicators such as Fluo-3 (Thomas et al., 
2000). However, unlike other analogs of calcium indicators used in epifluorescent signalling 
experiments, Fluo-5F has a lower binding affinity for calcium within the cell, making small 
changes in intracellular calcium (1µM-1mM) more easily detectable without saturation of the 
response of the fluorescent ligand (Paredes et al., 2008, 2009). A lower affinity calcium 
indicator dye was selected as most suitable for this assay, where the concentration of calcium 
in the endoplasmic reticulum ranges between 0.1 and 1mM (Raffaello et al., 2016).  
 
Cell permeable Fluo-5 AM (ThermoFisher, 11544786) was diluted into 454µl Pluronic F127 
20% solution in DMSO (Sigma, 10767854) in order to create a 10mM stock of Fluo-5, aliquoted 
to 10µl aliquots and stored at -20°C until use. The aliquots were protected from white light at 
all times (foil wrapped vessels etc.) 
 
This protocol has been optimised for live cell imaging of DRG cultures seeded into two-
channel microfluidic chambers, although can also be carried out for dissociated cell cultures 
seeded onto coverslips.  
 
2.3.1.1 Cell loading and de-esterification: 
The media was removed gently from the somal compartment of the chamber, and the cells 
gently washed twice with complete imaging buffer. From this point onward, the entire 
protocol was completed in the dark, to avoid bleaching of the Fluo-5 signal.  
Fluo5 (in pluronic) stock was diluted in complete imaging buffer to a final concentration of 
100nM, and 100µl applied to the somal compartment of each microfluidic device.  
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Fluo-5 was then removed from the somal compartment of the chamber after a loading period 
of 30 minutes, and replaced with 100µl imaging buffer, at which point the cells were left to 
completely de-esterify for a minimum of 30 minutes.  
 
2.3.1.2 Technical notes on dye loading and extrusion: 
Loading of the calcium indicator dye was highly efficient, but there was potential for extrusion 
of the molecule from the cell body during longer imaging protocols, especially if the cell was 
continuously exposed to light. When exposed to light at a specific wavelength, 470nM the 
increase in “free” calcium in the cell was recorded as an increase in fluorescence where 
calcium binds to fluo-5 and light is emitted. However, if exposed for long periods of time, or 
to high intensities of light (such as ambient light) the fluorophore becomes unstable and the 
signal will photobleach, rendering the fluorophore unable to fluoresce and inducing high 
levels of background fluorescence. Whilst the acetoxymethyl ester group attached to fluo-5 
was essential for making the dye cell permeable, once inside the cell, the de-esterification 
period was required to completely hydrolyse this AM ester bond before recording (Lock, 
Parker and Smith, 2015).  Since Fluo-5 is a fluorescent molecule, complete removal of the 
attached ester was required to reduce background fluorescence when quantifying changes in 
fluorescence to a stimulus.  
 
The phenomenon referred to as “bleaching” of the signal, is one of the disadvantages of using 
non-ratiometric calcium indicators, such as Fluo-5. Calcium indicator dyes have been 
engineered in several forms, including salts, dextrans and hydrophobic acetoxymethyl (AM) 
ester forms. With a lower binding affinity, and a cell permeable nature, the most appealing 
form for this experimental design was the AM ester form (Paredes et al., 2009; Lock et al., 
2015). However, without complete de-esterification of the indicator loaded into the cell, the 
background signal would fluctuate where there was a mixture of free and calcium-bound 
indicator dye trapped within the cell whilst imaging. For this reason, it was important to time 




An Olympus IX70 Inverted tissue culture microscope could to a CCD camera (photometrics 
CoolSnap MYO, global shutter) was used and data acquired in micromanager (Tsuchida et al., 
2014). Using multi-acquisition in Fiji an image stack was recorded in line with cell stimulation. 
An exemplar recording measured 480 frames, one every 250ms, with a total run time of 2 
minutes. Appropriate imaging settings were selected on micromanager (Tsuchida et al., 
2014). Usually this was set for 50ms exposure in the 470nM wavelength filter and 2x2 image 
binning. However, if doing longer read times reducing the binning to 4x4 reduced the size of 
the file. For analysis purposes, the images were saved as a stack file to allow multiple analyses 
of the same cell.  
 
Once the cells were completely loaded imaging buffer was removed from the chamber and 
placed on the platform. Using 10X magnification the cells were brought into focus (using 
eyepieces and green light illumination, 470nM). Once the cells were in focus the eye piece 
was switched to camera and the image re-focused before stopping live imaging.  
 
All cultures were recorded for up to 20 seconds prior to stimulation, in order to determine an 
initial level of excitability. Since pseudounipolar sensory neurons do not fire spontaneously 
(unlike cortical neurons) this provided a stable baseline Fluo-5 signal, for which the post-
stimulation response would be normalised to.  
By starting the acquisition sequence, the shutter opened and closed every 250mS until the 
sequence was complete. Watching the timer on the screen, after a maximum of 10 seconds, 
the first stimulus was added (e.g., 30µl KCl 25mM) to the axonal compartment of the 
chamber, then if required the second stimuli was added at 2 minutes and 20 seconds. 
Different stimuli were selected according to which fibres of the DRG were being targeted. 
 
Although cell viability was not an issue during this time period, the background signal from 
Fluo-5 would begin to saturate the image if the cells were continuously exposed at 470nM for 
prolonged periods of time. All time-course analyses have been adapted to show a total time-
course of 60 seconds, including 10 seconds baseline prior to stimulation. 
 
2.3.1.4 Image Analysis for Ca2+ signalling experiments:  
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All image analysis was completed using the ImageJ software from Fiji (Schindelin et al., 2012). 
Using ImageJ, the stack file was opened and navigated to find excitation of the cells in 
response to a stimulus. Cells were manually selected, and added to the ROI manager tab. 
Once a minimum of 10 cells were selected, the multi-measure feature calculated the area 
(μM) as well as the mean fluorescence intensity (ΔF) of each cell per image taken. Data was 
exported to an excel template and manually analysed to plot a time-course analysis. All data 
was normalised to the baseline fluorescence intensity. 
 
Each chamber was only imaged once, starting with stimulation of the axonal compartment, 
at which point it was removed from the stage, washed with imaging buffer and the stimuli 
usually then added directly to the somal compartment.  
In order to normalise the intensity of the Fluo-5 signal, an average value for the baseline 
fluorescence (F0) was calculated before stimulation. The stimulus-response was calibrated by 
removing this background from the maximum fluorescence at every time point (Ft) on the 
image stack.  
The change in fluorescence over time was plotted using the equation ((∆F=Ft-F0)/F0). In this 
equation Ft represents fluorescence at a given time point, where F0 is equal to the ‘resting 
fluorescence’ of a cell. 
Values were primarily plotted as a time-course analysis (XY curve) to visualise the change in 
fluorescence as a measure of excitability in response to a specific stimulus. The percentage 
increase in fluorescence following stimulation could be extracted from the data, by 
calculating the difference between maximum and minimum ∆F/F.  
 
2.3.1.5 Statistical analysis of Ca2+ imaging:  
For the purposes of the data shown in this thesis the following definitions are important:  
Biological replicates (N): Each chamber was only imaged once, with different conditions 
tested across multiple preparations. Given that each biological replicate was taken from a 
separate embryonic litter, each microfluidic device (or dissociated plate) was assumed to be 
a biological replicate.  
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Technical replicates: it is important to acknowledge that the tissue used here was taken from 
dissociated embryonic tissue, with tissue from multiple embryos used when seeding multiple 
plates. In the case of the microfluidics we refer to the individual cells within each channel as 
the technical replicates of each condition.  
 
Data represents the mean ± SEM of 3 (or more) independent biological replicates/repeats of 
an experimental condition. The N number chosen was dependent on the type of test 
condition, in line with necessary power calculations and the principles of the 3Rs. Where 
possible, conditions were tested using tissue from more than one animal to allow for tissue 
variability, but without wasting tissue. The significance level for statistical analysis was 
assumed to be 5%.  
In line with the principles of the 3Rs a power calculation was performed to ask; 
a) What was the smallest effect that could have biological relevance? 
b) What was the largest effect of a treatment compared to a control? 
For example, when comparing stimulation of dissociated plates versus microfluidics, a post-
hoc power calculation estimated that a minimum N=6 would determine statistical 
significance, and the P values have been highlighted on the figures. The power calculation 
was estimated using the peak excitability (ΔF) for three biological repeats, where no 
appropriate published data was available to perform the calculation before starting the 
experiment. Estimates were calculated using a low and high estimate of the signal to noise 
ratio: 
  Mean 1  Mean 2 Std Dev.  S/N Ratio  N number at 80% confidence  
N=3 2.5 1.8 0.2 3.5 3 
      0.4 1.8 6 
This estimation assumes P=0.05 is significant and used a two-sided format.   
 
In each repeat (N) a minimum of 10 cells (replicate values) were analysed, although this was 
dependent on the field of view and normally approximately 20 cells were selected. Using 
GraphPad Prism 9.0 peak fluorescence data was analysed to show a Gaussian population for 
downstream statistical analysis purposes.  
With three or more groups for comparison, a one-way ANOVA (analysis of variance) was used 
to determine significant differences between data sets. For multiple comparisons of data sets, 
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an additional Dunnett’s comparison. Tests was used. Degrees of freedom (F) was calculated 
within groups and between groups and was reported as F(Df1, Df2). 
 
If comparing significance between two groups, a parametric (usually unpaired) t-test was 
used.  Where descriptive statistics deemed the standard deviations of data sets were different 
then a post-hoc Welch’s analysis was also applied (as stated in the figure legends.) A Grubbs’ 
analysis was performed and a maximum of one outlier was removed where α=0.05. 
 
 Values of P<0.05 were considered to be statistically significant.  
 
2.4 MicroRNA functional analysis tools: 
2.4.1 MicroRNA ‘power’ inhibitors; 
A cell permeable miRNA power inhibitor control (Negative Control A, 
TAACACGTCTATACGCCCA, ID Y100199006-DDA) and the miRCURY LNA miR-138-5p Power 
inhibitor (MIMAT0000150: 5'AGCUGGUGUUGUGAAUCAGGCCG, ID YI04102106) were 
obtained from Qiagen. 
 
At DiV5 the media was changed in the microfluidic device, and the miR-138-5p inhibitor (or 
non-targeting control probe) was added at a concentration of 100nM for 24-hours. The 
schematic in each figure indicates where the inhibitor was added.  
 
2.4.2 Small interfering RNA (siRNA):  
Accell smartpool siRNA for Mouse Kcna2 (Horizon, E-058746-00-0010, 10nmol) and a non-
targeting siRNA control (Horizon, D-001910-10-20, 20nmol) were purchased from Horizon 
discoveries. Pellets were resuspended to a working concentration of 100μM in 1X siRNA 
buffer and stored at -20°C until required.  
 
At DiV5 the media was changed in the microfluidic device, and the smartpool siRNA for Kv1.2 
(smartpool negative control siRNA) was added to the axonal compartment at a final 
concentration of 100nM for 24-hours. 
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2.4.3 Target prediction using Bioinformatics: 
 
Target searching for interactions with the 3’UTR of miR-138-5p is described in-depth in 
Chapter 5, part B. It is important to be aware that prior to use of siRNA, targets of interest 
were identified and validated. When identifying potential candidate targets a range of 
bioinformatic searching tools were used. This included, Diana Tools microT-CDS 
(Paraskevopoulou et al., 2013a) Tarbase (Karagkouni et al., 2018) TargetScan v7.2 (Agarwal 
et al., 2015) and miRTarBase (Hsu et al., 2011).  
 
  
2.4.4 Target validation using Luciferase assay: 
 
The dual-luciferase reporter assay is relatively low throughput, but can be easily manipulated 
to provide a semi-quantitative output regarding changes in protein expression dependent on 
a microRNA of interest (Jin et al., 2013). First the protein of interest is expressed in a vector 
such as pmiRGlo (Guo et al., 2013). Once the insert has been successfully sequenced to 
contain the seed sequence of the microRNA of interest, an immortalised cell line is 
transfected with the protein. A microRNA mimic is co-transfected alongside the luciferase 
reporter construct and the microRNA mimic binds to the target site identified in the construct, 
protein translation is subsequently repressed.  
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By inserting miRNA target sites downstream of the primary reporter gene (FLuc) a reduced 
FLuc expression is observed. This indicates binding of miRNA mimic to cloned miRNA 
sequence inserted into the pmiR vector. Where reduction in FLuc expression is used to 
monitor miRNA regulation, the RLuc site acts as a control reporter sequence. In this way, by 
remaining stable, the RLuc site normalizes the signal of the dual luciferase assay between 
samples in transfected cell lines.  
 
2.4.4.1 Luciferase cloning: 
Forward and reverse oligonucleotides were designed for 4 protein targets of interest, 
encompassing a total of 9 potential target sites to be tested where proteins such as KCNA2 
(also known as Kv1.2) contained 5 potential target sites for miR-138-5p. The oligonucleotides 
were all 51 bp in length and were designed so that when annealed they contained the 
potential 3’UTR target sequence in 3’ – 5’ direction. 
 
Only the desired miRNA target region was inserted into the pmirGLO Dual-Luciferase miRNA 
Target Expression Vector (Promega), as opposed to the entire 3’UTR. Restriction sites were 
included on either end (NheI and SalI) so that overhangs created by oligonucleotide annealing 
Figure 2.4.1 The dual luciferase reporter system using pmiRGlo and expression of firefly luciferase (FLuc) to quantify miR-
mimic binding to a protein sequence of interest in vector 
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were complementary to those generated by restriction enzyme digestion of the pmirGLO 
Vector’s multiple cloning site. Primers were also phosphorylated at the 5’ end of the 
oligonucleotides for ease of insertion into the pmirGLO vector. An internal NotI restriction 
site was also added to oligonucleotides for downstream clone confirmation. This addition 
creates a ~125bp insert when digested with NotI because of a NotI site at position 93 in the 
vector. 
 
miR138-5p complement: 3’ cggccugauucacaacACCAGCu 5’ 
Seed sequence 3’ to 5’ uggucg (search complement accagc). Seed sequence in bold. 
 
 Forward Sequence (NheI/NotI/ SalI) BP %GC Tm 
KCNA2 
Site 1 
CTAGCATGCGGCCGCGAATGTATCTTTGGGGAGGGGGCACCAGCTTACACG 51 61 87 
KCNA2 
Site 2 
CTAGCATGCGGCCGCGAATGTACACATGCAAAATGCACACCAGCCTACACG 51 55 85 
KCNA2 
Site 3 
CTAGCATGCGGCCGCGAATGTATCATCCTGCTAGTATTACCAGCTTACACG 51 51 81 
KCNA2 
Site 4 
CTAGCATGCGGCCGCGAATGTACTTGGCCCTTATTGAGACCAGCATACACG 51 55 83 
KCNA2 
Site 5 
CTAGCATGCGGCCGCGAATGTATCATGAAAATTTAGACACCAGCTTACACG 51 47 79 
KCNB1 
Site 1 
CTAGCATGCGGCCGCGAATGTAGTGCCGGGTCACGTGCACCAGCGTACACG 51 65 89 
KCNB1 
Site 2 
CTAGCATGCGGCCGCGAATGTAGGCCATCCCAGAAGGCACCAGCGTACACG 51 63 88 
KCNG1 
Site 1 
CTAGCATGCGGCCGCGAATGTACCTGTTCAGACCTCCCACCAGCCTACACG 51 61 86 
KCNG1 
Site 2 
CTAGCATGCGGCCGCGAATGTAGCTCTGTCCCTGCAGGACCAGCCTACACG 51 63 88 
KCNK10 
Site 1 
CTAGCATGCGGCCGCGAATGTAGGCAGCTTTCCCTTAGACCAGCCTACACG 51 59 85 
KCNK10 
Site 2 
CTAGCATGCGGCCGCGAATGTAGAGTCTCCTTTCCCCAACCAGCCTACACG 51 59 85 
KCNK10 
Site 3 
CTAGCATGCGGCCGCGAATGTAGTATGTCTGGCAAAGAACCAGCCTACACG 51 55 83 
KCNK10 
Site 4 
CTAGCATGCGGCCGCGAATGTATGGTAGATCACATGACACCAGCTTACACG 51 53 82 
 Reverse Sequence BP %GC Tm 
KCNA2 
Site 1 
TCGACGTGTAAGCTGGTGCCCCCTCCCCAAAGATACATTCGCGGCCGCATG 51 61 87 
KCNA2 
Site 2 
TCGACGTGTAGGCTGGTGTGCATTTTGCATGTGTACATTCGCGGCCGCATG 51 55 85 
KCNA2 
Site 3 




TCGACGTGTATGCTGGTCTCAATAAGGGCCAAGTACATTCGCGGCCGCATG 51 55 84 
KCNA2 
Site 5 
TCGACGTGTAAGCTGGTGTCTAAATTTTCATGATACATTCGCGGCCGCATG 51 47 80 
KCNB1 
Site 1 
TCGACGTGTACGCTGGTGCACGTGACCCGGCACTACATTCGCGGCCGCATG 51 65 89 
KCNB1 
Site 2 
TCGACGTGTACGCTGGTGCCTTCTGGGATGGCCTACATTCGCGGCCGCATG 51 63 88 
KCNG1 
Site 1 
TCGACGTGTAGGCTGGTGGGAGGTCTGAACAGGTACATTCGCGGCCGCATG 51 61 86 
KCNG1 
Site 2 
TCGACGTGTAGGCTGGTCCTGCAGGGACAGAGCTACATTCGCGGCCGCATG 51 63 88 
KCNK10 
Site 1 
TCGACGTGTAGGCTGGTCTAAGGGAAAGCTGCCTACATTCGCGGCCGCATG 51 59 86 
KCNK10 
Site 2 





51 55 84 
KCNK10 
Site 4 
TCGACGTGTAAGCTGGTGTCATGTGATCTACCATACATTCGCGGCCGCATG 51 53 83 
Table 2.1 Oligonucleotides designed for protein target sites for use in the luciferase assay. Complementary 
oligonucleotides were designed for the potential targets of KCNA2, KCNB1, KCNG1 and KCNK10, they contained 
NheI and SalI ends to incorporate into the pmirGLO vector and an internal NotI site (sites indicated in different 
colours). The site of the seed sequence for miR138-5p is also highlighted in yellow. 
 
The pmirGLO vector (500ng/μl) was digested with 20u of both NheI-HF (NEB) and SalI-HF 
(NEB) for 15 minutes at 37°C as per the manufacturers instructions, before being treated with 
1u alkaline phosphatase (NEB) for 60-minutes at 37°C, to dephosphorylate the 
oligonucleotides and prevent re-ligation of the linearized plasmid DNA. Samples were purified 
by running the digested vector on a 1% (w/v) agarose gel using Tris-Acetate-EDTA buffer (40 
mM Tris, 20 mM acetic acid, 1mM EDTA), excising the DNA band and then gel extracting the 
DNA using the QIAquick Gel extraction kit as per manufacturer’s instructions (Qiagen).  
 
Oligonucleotides were delivered in a lyophilised state (Integrated DNA technologies) and 
suspended in hyclone water to a concentration of 1μg/μl prior to annealing.   
Forward and reverse primer were combined with oligonucleotide annealing buffer (10mM 
Tris pH7.5, 50mM NaCl and 1mM EDTA), and heated to 90°C for 3 minutes, then to 37°C for 
15 minutes to anneal the complementary pairs.  
 
 83 
4ng of annealed oligos were ligated into 50ug of the linearized pmirGLO dual luciferase vector 
overnight at 16°C using T4 DNA ligase (NEB) as per manufacturer’s instructions. The resulting 
plasmid was transformed into XL10 gold high-efficiency competent cells. In brief, 5ul of the 
ligation reaction was incubated with 100ul of XL10 competent bacterial cells for 30 minutes 
on ice, then heat shocked at 42°C in a pre-heated waterbath for 40 seconds, before being 
incubated immediately on ice and re-suspended in 900µl LB broth. After 1-hour shaking at 
200rpm and 37°C the ligation mixture was cultured on an LB agar plate with selectivity for 
Ampicillin (Sigma) overnight at 37°C. 
Colonies were picked and cultured for miniprep (Qiagen) extraction of the plasmid using 
distilled water following manufacturer’s instructions. Efficient cloning was confirmed through 
NotI (NEB) digestion of plasmid followed by agarose gel visualisation of resulting fragment 
bands.  
Successful insertion of the annealed oligonucleotides was then confirmed through Sanger 
sequencing (DeepSeq Lab, University of Nottingham). Upon optimisation of this protocol, it 
was evident that insert would only be detected at concentrations higher than 500ng/µl. 
 
2.4.4.2 Site directed Mutagenesis: 
Primers were re-designed for those sequences successfully cloned into the pmiRGlo vector. 
This time a mutant version of the inserted sequence was generated via PCR, where four 
nucleotides in the target seed sequence were mutated. In each mutation, the site 
represented the 2nd to the 6th nucleotides of the microRNA seed sequence.  
The primers for site-directed mutagenesis were designed in-house and are shown in Table 2.2 
below: 






















44 59 81.2 


















49 43 77.2 
KCNK10 
Site 1 
CCTGCAGGTCGACGTGTAGGTGTTTCTAAGGGAAAGCTGCCTAC 44 59 81.2 
Table 2.2 Primer sequences used for SDM 
The PCR reaction for mutant strand synthesis is shown here: 
1 cycle           95°C         30 seconds 
18 cycles       95°C         30 seconds 
                       55°C         1 minute 
                       68°C         9 minutes 
hold at 4°C. 
The product was digested using 20u DpnI (NEB) at 37°C for 1-hour as per the manufacturer’s 
instructions, to remove the parental dsDNA strand prior to transformation into XL10 cells as 
described above. Confirmation of mutagenesis was achieved using Sanger sequencing.  
 
 
2.4.4.2.1 Treatment of pmirGLO with miRNA mimic and transfection into HEK cells: 
 
HEK-293T cells were seeded into a 24-well plate at a seeding density of 0.8x 105 cells/ml in 
high glucose DMEM with 10% (v/v) FBS and 1% (v/v) PS. After 24-hours incubation at 37°C 
and 5% CO2 cells were transfected with the pmirGLO vector containing the DNA insert.  
The DNA was diluted to 200ng/μl, with each condition to be tested run in triplicate for both 
the miRNA mimic and the LNA control sequence.  
Transfection mixture was assembled as follows (per well): 
• 0.5µl Lipofectamine2000 mixed with 100µl Opti-Mem and incubated for 20 minutes 
at room temperature. 
• 50µl Opti-mem + 1µl DNA (insert in pmirGLO at 200ng) + 2.5µl 20µM mimic/ LNA 
mimic control. Mix was incubated for 5 minutes at room temperature.  
• Solutions were combined and incubated at room temperature for 30 minutes, then 
added dropwise to cells without removing the media. Cells were then incubated at 
37°C and 5% CO2 for 48 hours with the transfection mix. 
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Following transfection, media was removed from cells and they were washed with ice-cold 
PBS prior to lysis in 100µl passive lysis buffer (per well.) Cells were rocked for 30-minutes at 
room temperature, making sure to cover the plate to protect the light sensitive reagents. 
When lysis was complete, the contents of each well were collected in separate lo-bind DNA 
tubes before use in the dual luciferase assay. The protocol could also be stopped here, with 
DNA frozen at -80ºC until required.  
2.4.4.2.2 Dual Luciferase assay: 
This assay required the use of a GloMax® Navigator microplate luminometer (Promega), as 
well as the Promega Dual-Luciferase® reporter assay kit.   
The reagents luciferase assay reagent II (LARII) and Stop and Glo® were prepared as per 
manufacturer’s instructions.   
In triplicate 10µl of each sample was pipetted into a well of a white 96 well plate. A slightly 
modified method from that of the manufacturer was used; 25µl of each of the luciferase assay 
reagent II (LAR II) and Stop & Glo® was used per well.  
An additional 700µl of each reagent was also required to prime the lines of the Glomax plate 
reader.  
2.4.4.2.3 Analysis of Luminescence: 
Luminescence emission was recorded in relative light units (RLU) in counts per second (CPS) 
by the GloMax Luminometer plate reader. Results were exported to excel, and the relative 
result for FLuc was divided by the control response for the RLuc response of the same sample. 
The changes in the FLuc/RLuc ratio are indicative of direct inhibition of the FLuc reporter gene. 
Therefore, this FLuc/RLuc ratio was used as a reflective change in target modulation, arising 
as a result of miR target binding to the introduced mimic and results were expressed as 
percentage change from the control samples. Whilst this dual-luciferase assay is ratiometric 
by design, there were some limitations to the assay.  
 
2.5 TRIzol extraction of RNA: 
This is a standard protocol used in the Dajas-Bailador lab for RNA extraction from neuronal 
cultures (Garcez, Guillemot and Dajas-Bailador, 2017). However, when extraction RNA was 
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extracted from microfluidic chambers RNA is pooled to increase the concentration, 
particularly from the axonal compartments.  
 
Samples were lysed using 1ml TRIzol reagent (Invitrogen) per condition and incubated at 
room temperature for 5 minutes to allow dissociation of ribonucleoprotein complexes. One 
fifth volume of chloroform (ThermoFisher) was added to each of the samples and vortexed, 
before being incubated for up to five minutes at room temperature. Each sample was then 
centrifuged at 12,000x g for 15 minutes, in a centrifuge pre-cooled to 4°C. 
 
Following centrifugation, three layers become visible; the clear aqueous phase, the 
interphase, and the organic layer (phenol-red chloroform phase.) The upper, known as the 
aqueous layer, contains the RNA required. Without disturbing the layers below, as much of 
the aqueous phase as possible was collected and transferred to a new Lo-bind tube 
(Eppendorf.)  
 
One half volume of isopropanol (i.e. 500µl for every 1ml TRIzol used for lysis, ThermoFisher) 
was added to the aqueous phase and the samples incubated at room temperature for 10 
minutes. If extracting RNA from only the axonal compartment, the concentration is often very 
low. To make the downstream pellet more visible, 0.66µl Glycoblue (ThermoFisher) was 
added into the aqueous phase per 0.5ml isopropanol. Each sample was centrifuged again at 
12000x g, this time for 10 minutes at 4°C. 
The supernatant was gently removed from each of the RNA pellets and the RNA was washed 
in one volume of 75% ethanol in Hyclone RNAse and DNAse free water (GE healthcare.) Each 
sample was briefly vortexed before one final centrifugation for 5 minutes at 7500xg, at 4°C. 
The RNA pellet was allowed to air dry before resuspension in maximum 30µl Hyclone, and to 
aid RNA resuspension, each sample was incubated for up to 10 minutes at 55-60°C.  
 
RNA concentration and purity was then determined using a 2000c UV/IV Spectrophotometer 
(Nanodrop, ThermoFisher Scientific) before storage at -80°C. Partially dissolved RNA showed 
a 260/280 ratio of less than 1.6, although a good yield from the axonal compartment was 
considered anything between 30-50ng/ml.  
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2.5.1 Extraction of RNA fractions from porous trans-well inserts: 
After culturing DRGs in Twiss-chambers (Corning) for a minimum of 5 days in vitro, and once 
the axons have crossed through the channel to the axonal side, the chamber was washed with 
PBS, whilst the cells remained attached to the insert.  
Media was aspirated gently from the cultures, usually following exposure of the “axonal 
compartment” to polarised media (or control media) for 8 hours, and the cells were washed 
gently twice with sterile PBS.  To increase the yield of RNA collected, when washing the inserts 
with TRIzol, the cells were also gently scraped to promote cell lifting. The procedure for RNA 
extraction was followed as described in 2.5 above.  
 
2.5.2 Quantitative polymerase chain reaction (qPCR):  
qPCR was carried out to determine the levels of select miRNAs within extracted RNA samples 
and uses SYBR green that binds to double stranded DNA and subsequently fluoresces. The 
emitted fluorescence during the PCR is directly proportional to the amount of DNA amplified 
product detected in every cycle. 
 
2.5.3 cDNA Synthesis: 
cDNA was synthesised from mature miRNAs using the miRCURY LNA™ Universal cDNA 
synthesis kit (Qiagen, UK), which uses a poly-T primer. This method uses ExiLENT SYBR Green 
master mix dye (Qiagen) that binds to double stranded DNA and subsequently fluoresces. The 
emitted fluorescence during the PCR is directly proportional to the amount of DNA amplified 
product detected in every cycle.  
 
2.5.4 qPCR using SYBR green: 
qPCR was undertaken using the ExiLENT SYBR® Green master mix kit (Qiagen, UK), and the 
Applied Biosystems Step One Plus thermocycler was used in standard mode using cycling 
parameters recommended by Qiagen: 
 
Polymerase Activation/Denaturation; 95°C for 10 min 
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Amplification cycles; 40 cycles at 95°C for 10s, then 60°C, for 1 min. The ramp-rate was set to 
1.6°C/s, with an optional melt-curve analysis.  
 
Data was acquired using Applied Biosystems SDS2.3 programme and Ct values were analysed 
for relative miRNA quantification using the comparative ΔΔCt method (Livak and Schmittgen, 
2001; Nolan, Hands and Bustin, 2006; Rao et al., 2013). Biological repeat samples were run 
across multiple mouse dissections, using miRCURY LNA™ primers (Qiagen, UK). Per plate each 
biological repeat was run with two technical replicate wells. See section 2.5.4.3 below for a 
technical note on the exclusion of CT values for housekeeper miR133b, which was only 
consistently detected in 3 out of 5 biological repeat samples.  
 
microRNA of interest: miR-138-5p primers used were the hsa-miR-138-5p LNA PCR primer set 
(Qiagen) which have been reported to be compatible with samples from mice (as well as rat.) 
 
2.5.4.1 Internal Controls for normalization of fold change expression in qPCR: 
ROX™ (Fisher Scientific - UK Ltd) was used as a passive reference for normalising for non-PCR 
related fluorescence variations, and was incorporated by SDS2.3 to calculate Ct values. A non-
template control (NTC) of water was also included for each primer to confirm absence of 
background signal and lack of contamination. Spike in samples containing Sp6 were used as 
inter-plate calibrators (IPCs) to confirm PCR efficiency and added at the cDNA synthesis stage. 
If possible, an IPC was run for one sample and one control sample per plate (in minimum 
duplicate.) In most cases, the DRG media control (or the MØ control) were used as the IPC 
samples between plates.  Average IPC Ct values between plates that were within ≤5% of each 
other were deemed acceptable to use. 
 
2.5.4.2 Housekeeper genes for reference fold change expression in qPCR: 
A range of housekeepers were used, having first been identified in a hyperalgesic priming 
study by J. Spalton, in collaboration with Dr Alex Rathbone and Professor Victoria Chapman. 
Since this study involved the effect of inflammation on RNA, it was anticipated that most 
housekeepers would change dependent on the inflammatory condition that they were 
exposed to. A housekeeper was deemed suitable if the change in Ct value was less than 2-
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fold overtime and between pooled control and treated samples and when the same trend of 
the Ct value was seen between housekeepers and miRNAs of interest in control samples when 
serial diluted (Livak and Schmittgen, 2001). 
 
Housekeepers used were miR-133b, miR-134-5p and SNORD33 
Primers for SNORD33 were designed in-house for rat using Primer3 software by Clare Martin, 
but have been demonstrated to be compatible with mice:  
SNORD33_F: 5’AGCTTGTGATGAGGATGTCTCC  
SNORD33_R: 5’TGGTAGTGCATGTAGAGTCGTC  
 
miR-133b and miR-134-5p primers were LNA PCR primer set (Qiagen), details in Table 2.3 
  Sequence  ID Conserved 
in Mouse 
 mmu-miR-133b 5’UUUGGUCCCCUUCAACCAGCUA MIMAT0000770 Y 
hsa-miR-134 5’UGUGACUGGUUGACCAGAGGGG MIMAT0000447 Y 
hsa-miR-138-5p 5’AGCUGGUGUUGUGAAUCAGGCCG MIMAT0000430 
 
Y 
Table 2.3 Details of LNA Primers (Qiagen, UK) 
 
2.5.4.3 Analysis of qPCR: 
Using the SDS2.3 software thresholds were standardised for each miRNA and remained 
consistent between plates. The Ct values were analysed using relative quantification and the 
comparative Ct method (2-ΔΔCt); the geometric mean of the housekeepers miR-134-5p, miR-
133b, and SNO33 was used as the endogenous control and the 24-hour time point exposure 
to DRG media as the calibrator. Results were expressed as fold change in expression. 
GraphPad Prism was then used to plot the fold change data with error bars showing SEM. 
Individual housekeeper values for miR133b of 34.8 and 39.9 were excluded prior to 
calculaction of the geomean, where the average dCT value was 24-29.  
 
2.6 Immunofluorescent staining of primary cells:  
Cells were washed in PBS before being fixed with 4% (w/v) Paraformaldehyde (PFA) in PBS 
containing 2.7% (w/v) sucrose at room temperature for 30 minutes. Following which samples 
were washed twice in PBS with 10mM glycine (PBS/glycine), before being permeabilised by 
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incubation for half an hour in PBS/glycine with 0.2% (v/v) triton. After washing cell samples 
twice for 2 minutes in PBS with 0.1% (v/v) Triton (PBS/Triton), cells were blocked in 3% (w/v) 
BSA in PBS for 30 minutes. The primary antibody was diluted in 3% (w/v) BSA, 50µl was added 
per coverslip and samples left overnight at 4°C in a humidified chamber.  
Cells were washed three times in PBS/Triton. At this point the secondary antibody was added 
after dilution in 3% (w/v) BSA (e.g. 1µl alexa fluor 488 for βIII-tubulin in 300µl 3% BSA was a 
typical stain for the axons of the neuronal cultures). Coverslips were left at room temperature 
for up to two hours, and then washed again once with PBS/Triton before being mounted on 
slides with up to 20µl hard set VectaShield (Vector Laboratories). If required, DAPI was also 
added to the stain in the presence of the secondary antibody, at final concentration of 300nM. 
 
Antibodies  Working dilution  Manufacturer details 
Anti-Acetylated tubulin  1:300  Cat no. T7451; Sigma-Aldrich 
Anti-βIII tubulin  1:100 Cat no. ab18207; Abcam 
Rabbit polyclonal to liver Arginase 1:300-1:500 ab91279, Abcam 
Mouse monoclonal [NOS-IN] to 
iNOS 1:300-1:500 
ab49999, Abcam  
Kv1.2 trial size antibody 1:300 Alamone labs, APC-010 
Table 2.6.1: List of antibodies, dilutions and suppliers used in this Thesis 
 
 
2.6.1 Quantifying relative expression of protein markers using 
immunofluorescence: 
2.6.1.1 Acquisition:  
Unless stated otherwise phase contrast/brightfield images were acquired using a 20X 
objective of a widefield fluorescence microscope (Zeiss 200M, Axiovert) couple to a CCD 
camera (CoolSnap MYO). All images were acquired using Micro-manager software v2.0 
(Edelstein et al., 2014) and analysed using ImageJ (FIJI). All images in this assay were acquired 
at 20X magnification, 100-milliSecond exposure and using a triple channel stain (including 
DAPI for nuclear localisation) where appropriate. 
 
2.6.1.2 Plot profile analysis: 
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Upon analysis the image stack was opened in ImageJ and converted to an 8-bit colour image, 
in this way all images were comparable where the pixel intensity always ranged from 0-255. 
(In a binary image format, zero represents an area of black, whilst 255 is white, although over 
exposure can lead to a value of 256, indicating greyscale.) By splitting the channels (FITC, 
Arginase-1 in green /TRITC, iNOS in red) it was possible to view the relative intensity of each 
stain. The image was converted to binary, and the whole area selected. Using ImageJ built in 
analysis, the Plot profile plugin tool was used to a 2-dimensional representation of the relative 
pixel intensity along a line within the image. Of course, this selection also included 
background regions, where little to no stain was present within a cell. For this reason, 5 areas 
of background were selected from each image and an average intensity was calculated. This 
background value was subtracted from every value in the plot-profile range, and 






























3 In Vitro modelling of nociceptive cellular 
connectivity using compartmentalised 
microfluidic culture systems 
 
3.1 Introduction 
International guidelines for the study of nociception in vivo require that all animal studies are 
carried out under strict ethical guidelines. The framework of these guidelines are based on 
the principles of the 3Rs incorporating the Reduction, Replacement and Refinement of 
animals in research (McGrath et al., 2010). Complete replacement of animals in pain-based 
research is difficult due to the nature of behavioural testing, where pain can be inferred in 
vivo from the development of pain-like behaviours. For example, rats and mice can be 
assessed or their willingness to move and behaviour such as paw withdrawal can be 
quantified following exposure to inflammatory mediators such as carrageenan in the hindpaw 
(Larson, Wilcox and Fairbanks, 2019). Especially with regards to drug development (e.g. 
analgesics) it is important to monitor changes in pain in a living animal for reasons such as 
efficacy and safety.  Although useful for studying behavioural changes, there are also clear 
limitations to in vivo modelling. For example, monitoring changes in cellular excitability at a 
molecular level enables the study of subtle changes in protein regulation and neuronal 
signalling, which cannot be detected from an in vivo behavioural model (Sandkühler, 2009). 
Furthermore, models involving scoring such as the use of the facial grimace scale analyses 
have the potential for human bias, where it is down to the investigator to determine the level 
of ‘pain’ that the animal is feeling (Hirst et al., 2014; Deuis, Dvorakova and Vetter, 2017). 
Therefore, there is a clear need for the development of biologically relevant in vitro models 
of nociception that reduce the use of animal tissue, and enable the study of the molecular 
changes underlying development of pain pathologies.    
 
At a cellular level, the formation of precise axonal connections between the peripheral and 
central nervous system is particularly important for complex multi-cellular processes such as 
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pain. Until recently, it has not been possible to model the cellular interactions in nociceptive 
circuits in vitro, with cell culture experiments often failing to replicate the complex pseudo-
unipolar nature of the dorsal root ganglia (DRG) neurons (Djouhri and Lawson, 2004; Krames, 
2014; Fenstermacher, Pazyra-Murphy and Segal, 2015; Emery et al., 2018). In vitro modelling 
using microfluidic compartmentalised cell cultures has previously been used  to demonstrate 
the capability of DRG neurons to locally respond to a nociceptive signals (Tsantoulas et al., 
2013). However, despite the response of the peripheral and central nervous systems being 
critical in promoting a painful response to an inflammatory mediator, non-neuronal cells are 
also essential in the resolution (R.-R. Ji, Chamessian and Zhang, 2016). In vivo this includes 
cells such as the keratinocytes in the skin, microglial (see chapter 1.8.3) and astrocytic cells of 
the CNS, as well as peripheral macrophages; the resident cells of the innate immune system 
(Katz and Rosenbloom, 2015). With respect to understanding the inflammatory response to a 
nociceptive stimulus, the response of peripheral inflammatory cells like macrophages is key 
(see chapter 1.8.)  
This chapter describes the development and optimisation of an in vitro microfluidic model, 
(including the culture of DRG neurons) that permits the replication of some of the diverse 
environments these cells encounter in vivo in the context of inflammatory responses and 
nociception.  
 
3.1.1 Peripheral Sensitization of DRG neurons 
In states of inflammation, primary afferents of the DRG become sensitized (Gold and Gebhart, 
2010). This sensitisation refers to the change in the threshold for activation of these sensory 
neurons, which is potentially accompanied by a change in the magnitude of response of the 
peripheral terminals to stimulation, and consequently a downstream change in the 
physiological response (see Chapters 1.5.2 regarding peripheral sensitisation and 1.7 for 
receptors on the nociceptors). For example, one of the key components of sensitization is 
that the painful sensation outlasts the presence of the noxious stimulus at the nociceptor 
terminals (Sandkühler, 2009). This phenomenon occurs in response to the prolonged 
activation of sensory afferents and the chemical mediators released by surrounding non-
neuronal cells (e.g. macrophages etc.). 
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There are a wide range of receptors present on the surface of the peripheral terminals of 
these neurons, although intra-cellular secondary messenger systems are also important (R. R. 
Ji, Chamessian and Zhang, 2016). The diagram in figure 3.1.1 shows an example of the range 
of signalling molecules that have been studied as key modulators of the DRGs and pain, 
although there are undoubtedly more.   
 
There are also a wide range of signalling molecules involved in the development and 
mediation of peripheral sensitization, including ATP, prostaglandins (PGE2) and neurotrophins 
such as NGF. The role of NGF in peripheral sensitization is well documented, with long 
standing evidence to support the role of NGF as a peripherally produced mediator of 
inflammatory pain states (Aloe and Levi-Montalcini, 1977).  NGF has been demonstrated to 
have a complex role in inflammatory pain as well as chronic pain states, where endogenous 
levels of NGF can be elevated (Sarchielli et al., 2007). NGF is synthesised and released from 
inflammatory cells such as mast cells, macrophages and Schwann cells upon tissue injury or 
inflammation, and binds to high affinity tropomyosin kinase A receptors (TrkA) selectively 
expressed on the terminals of subpopulations of DRG neurons. NGF is also known to bind p75 
receptors although the role of p75 is not discussed here.  Upon trkA receptor binding, the 
NGF/TrkA complex is retrogradely transported to the DRG where the cell bodies of the 
primary afferent fibres are located. This leads to transcription and upregulation of 
neuropeptides (e.g. substance P), ion channels, and receptors as well as anterograde 
transport of neurotransmitters (Mantyh et al., 2011). The modulation of these proteins (such 
as ion channels) sensitizes the primary afferent fibres by changing the excitability of the 
neuron. Where NGF signalling occurs via retrograde transport, there is a delay (hours to days) 
before the onset of hypersensitivity of the neurons is observed. One particularly important 
mechanism of NGF-TrkA binding is the sensitisation of the heat-sensitive TRPV1 channel 
expressed on smaller diameter peptidergic fibres via phosphorylation. The mechanisms by 
which TRPV1 is phosphorylated have been debated, including evidence to support the role of 
mitogen activated pathway kinase (MAPK) signalling and phosphatidylinositol-3-kinase 
(PI3K.) (Bonnington and McNaughton, 2003). However, it is evident that even the direct 
binding of NGF to the TrkA receptor induces phosphorylation of TRPV1. This sensitisation of 
the TRPV1 channel lowers the threshold for thermal activation of these channels, and 
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consequently lowers the temperature of the sensory neurons for detection of noxious heat 
(Galoyan, Petruska and Mendell, 2003). 
 
Underlying the onset of peripheral sensitisation, it is likely that receptors other than TRPV1 
present on the terminals of the DRG neurons are also upregulated and sensitized. For 
example, an influx of neutrophils migrate to an area of damaged tissue and the release of pro-
inflammatory cytokines induces changes in neuronal excitability (Cunha et al., 2008).  For 
example, in studies of neuropathic pain, the release of chemokines such as CCL2 from 
nociceptors has been shown to regulate the production of inflammatory cytokines from 
polarized macrophages via TLR signalling pathways (Zhang et al., 2013; Liu et al., 2016). 
 
3.1.2 Hyperalgesic priming and the transition from acute to chronic pain 
It is essential for survival that animals are able to sense and avoid hazardous situations that 
may cause physical harm. Although acute pain is defined as a protective and evolutionary 
response, the onset of chronic pain is not deemed to have any physiological benefits.  
 
Figure 3.1.1: Interactions between distinct parts of a nociceptor with different types of non-neuronal cells, (R. R. Ji, 
Chamessian and Zhang, 2016) 
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First developed by Levine in 2003 (Parada et al., 2003; Reichling and Levine, 2009; Ferrari et 
al., 2013) the in vivo models of hyperalgesic priming have become very useful for investigating 
the cellular and molecular processes involved in the transition from acute to chronic pain (see 
chapter 1.5.3, hyperalgesic priming and central sensitiation.). Levine (Reichling and Levine, 
2009) showed that a short-lived exposure of a rat hind paw to an inflammagen such as 
carrageenan led to an acute inflammatory response (see figure 1.5.1.) The initial exposure to 
this inflammatory mediator (e.g. carrageenan) was then followed a reduction in mechanical 
pain threshold, as measured by the change in paw withdrawal threshold using Von Frey 
filament recording. This model provides an insight into the mechanism by which the 
development of acute and chronic pain can be investigated. The nervous system was said to 
have been “primed” for a hyperalgesic response. For example, a second exposure to 
prostaglandin-E2 (PGE2) now evoked a prolonged decrease in paw withdrawal threshold 
lasting at least 24 hours (Reichling and Levine, 2009).  
 
3.1.3 Modelling Nociceptive networks in vitro: 
 
In order to model the complexity of the nociceptive circuit in vitro, we used microfluidic 
culture devices to attempt to closely replicate the complex and dynamic cell signalling 
pathways between the peripheral nervous system and the central nervous system. The 
pseudounipolar DRG neurons are characterised as the neurons that “bridge the gap” between 
detection of an inflammatory stimulus at the periphery, and integration to the higher 






















Spinal cord microglial cells 
Figure 3.1.2: Modelling the reflex arc in vitro using compartmentalised microfluidic models 
  
Axonal side A (rhodopsin-2)  
Axonal side B (calcein) 
 
Figure 3.1.3: The pseudounipolar nature of the DRG neurons was highlighted using triple channel microfluidic devices. The 
uptake of fluorescent dyes into the soma was used to determine if the axon had developed through the microgrooves 
using changes in Calcium signalling.   
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The image shown in figure 3.1.3 is taken from Clara Patricio of the Dajas-Bailador lab using 
E18 rat tissue cultures in a triple channel microfluidic device. This preliminary data helped to 
show functional characterization of the DRGs in microfluidic chambers, where the soma and 
the axons were fluidically isolated.  The pseudounipolar nature of these cells has also been 
highlighted here using dual-staining immunofluorescence.  
A red dye (Rhodopsin-2) and a green dye (Calcein) were applied to opposite lateral 
compartments of a triple channel microfluidic device, as shown in the schematic in figure 
3.1.3 above. Only some of the cells in the device have taken up both rhodopsin-2 and calcein 
resulting in these cells being labelled yellow. This indicated that they had axons crossing into 
both lateral compartments of the microfluidic device. Figure 3.1.3 demonstrates that where 
a significant number of neurons developed axons that extended into both lateral 
compartments, the pseudounipolar nature of the DRG neurons was replicated in vitro using 
the compartmentalised microfluidic devices. Since the DRG neurons develop this unique 
pseudounipolar morphology, it was hypothesised that the axonal terminals would polarize 
based on what the axon was exposed to in the microfluidic device.  
A recent work published after our original findings, confirmed our original findings, showing 
that in triple channel microfluidic devices from rat cultures, on average 18±7% of DRG soma 
extended bilaterally, with both axons responding to stimulation. In this model, the DRG 
neurons from embryonic rats were co-cultured with mixed populations of dorsal horn 
neurons from the ascending pain pathway in an attempt to model the cell-to-cell signalling 
between the peripheral and central nervous systems (Vysokov, McMahon and Raouf, 2019). 
The regulation of excitability of the second order interneurons in the dorsal horn is directly 
related to input from the DRG neurons, and affects the modulation of pain (section 1.5.2.)  
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In contrast, we developed a step-by-step approach, beginning the investigation studying cell 
signalling at the peripheral terminals of the DRG neurons rather than the level of the spinal 
cord (or the CNS.) Two-channel microfluidic devices were used to reduce materials and time 
course of in vitro culture of primary cells in line with the 3Rs. In our model, the dual-channel 
microfluidic devices (Xona, SND150) were used to demonstrate changes in the excitability of 
the DRG neurons.  
 
In vivo, the exposure of the peripheral terminals of the nociceptor to inflammatory mediators 
reduces the threshold of activation (see chapter 1.5-1.7.) The molecular processes underlying 
hyperalgesic priming also include translational regulation of ion channels on the neuron 
terminals. In our model, investigating the bi-directional signalling between peripheral 
macrophages and DRG neurons has been deemed to most closely resemble the development 
of hyperalgesia following peripheral sensitisation. 
 
One of the advantages of these microfluidic cultures was the flexibility of the model for 
culture and analysis. The hydrostratic pressure in the device created two microfluidically 
isolated chambers as described in 2.2.4.1.  As shown in this work, immunofluorescence and 
brightfield imaging provided a useful tool for visualising and quantifying changes in cellular 







Figure 3.1.4: A schematic showing the development of a simplified version of the NC3Rs model. This model focused on the 
investigation of cell signalling between the peripheral inflammatory cells and the dorsal root ganglion   
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devices led to the development of stimuli that were more biologically relevant in the study of 
nociception. 
 
In this model, there were several further techniques that could be applied downstream of the 
cell culture to quantify changes in protein expression or neuronal signalling. This included the 
capacity to functionally investigate changes in the excitability of the DRG cultures via calcium 
signalling assays, such as those described by Tsantoulas et al., (2013.). This microfluidic model 
also provided the ability to selectively record information being relayed from the axon to the 
soma. This included both retrograde transport of proteins, and the propagation of the action 
potential along the axon of the DRG.  
We also included direct comparison to standard plated-based culture (colloquially referred to 
as ‘dissociated plates’). In these cultures, a stimulus was applied to the whole culture, and 
therefore could not be solely ascribed to an axonal receptor or channel response. 
Additionally, it was possible to isolate axonal versus ‘somal’ RNA from the microfluidic 
devices. This technique is commonly used in the Dajas-Bailador laboratory to investigate 
changes in local protein translation following treatment of the axonal compartment (Garcez, 
Guillemot and Dajas-Bailador, 2017; Lucci et al., 2020).  
 
In some experiments the direct culture of inflammatory cells that could potentially migrate 
through the microgrooves was excluded. Instead, media extracted from polarized cells, such 
as bone marrow derived macrophages, was used to induce a change in neuronal signalling. 
As shown in the schematic in figure 3.1.4, the culture of spinal cord microglia was removed, 
with this simplified microfluidic model focusing on how peripheral inflammatory cells induced 
changes in neuronal excitability. (See chapter 1.8.3 for discussion on the role of microglial 
cells as inflammatory mediators in the CNS.)  
The use of smaller two-channel microfluidics provided the flexibility to characterise functional 
changes in each cell type more quickly, and as such the development of the model of 
hyperalgesic priming was accelerated. Whilst the microglial cells were removed from cell-to-
cell signalling experiments involving microfluidic culture, a protocol was devised for 
maintaining an embryonic culture and characterising polarised cells.  
 
 101 
3.1.3.1 Objectives of the NC3Rs:  
This work was funded by the national centre for reduction, replacement and refinement of 
the use of animal tissue in scientific research (NC3Rs.) This project was categorised as a 
reduction project, and as such when developing the model, it was imperative that while we 
gained knowledge on nociceptive mechanisms, we did so by meeting the NC3Rs objectives.  
 
3.1.3.2 Reducing the number of animals required:  
In order to maximise the tissue taken per animal, as well as the viability of the cultures 
seeded, cell culture protocols were adapted accordingly in line with the principles of the 3Rs. 
Theoretically, microfluidic modelling has the potential to reduce the number of mice required 
by 90%.  
Based on previous studies from the Hathway and Chapman laboratories, it was estimated that 
an in vivo model for hyperalgesic priming would require around 300 animals to screen 15 
compounds of interest (at a minimum N=3.) In comparison, only 30 mice embryos would be 
required to seed up to 75 dual channel microfluidic chambers for in vitro testing of DRG 
neuronal excitability. Furthermore, in contrast to standard in vitro models that have limited 
capacity to model the complexity of neuronal cell signalling in nociception, the microfluidic 
model replicates the pseudounipolar nature of the cells observed in vivo.  Therefore, this 
model provides flexibility to investigate both how localised axonal exposure to specific 
compounds can affect DRG neuron excitability in live cell signalling, and also quantify changes 
in local protein expression using standard molecular biology techniques such as qPCR.  
One litter from a pregnant C57/BL6 at E16.5 served up to 6 people per preparation, with the 
additional potential for culture of multiple cell types extracted from animal. Theoretically this 
could include astrocytes, cortical neurons, bone marrow derived macrophages, DRG neurons, 
with the possibility for development of other cell preparations if desired. The methods used 
in this chapter have been described in full detail in chapter 2.   
 
3.1.4 Experimental aims of the chapter: 
• In line with the proposed NC3Rs model, develop experimental models for 3 cell 
types involved in primary afferent function.  
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• Compare the use of microfluidic culture of DRG neurons to the traditional culture of 
dissociated DRG neurons in normal culture plates 
• Investigate phenotypic changes of those cells involved in inflammatory responses, 
to model what would typically be observed in vivo when these cells responded to 
an inflammatory stimulus 
 
3.2 Results and Discussion: 
3.2.1 Culture of DRG neurons in compartmentalised microfluidic chambers:  
As a first attempt to model hyperalgesic priming in vitro, work focused on the use of neonatal 
cultures from rats, which have been previously used in an in vivo study in the Hathway lab 
(James Spalton PhD thesis). Rodent models of nociception commonly involve the use of both 
rats and mice, where both species can be inexpensively housed, are easily to handle and 
mature quickly (Larson, Wilcox and Fairbanks, 2019). Over time, several stimulus-evoked 
methods have been developed to model nociceptive behaviours in vivo, including Von Frey 
stimulation (Görlitz and Frey, 1972; Deuis, Dvorakova and Vetter, 2017) and the Randall-
Selitto test as a measure of mechanical hyperalgesia (Randall and Selitto, 1957). Although the 
genomes of mice and rats are largely similar, evidence has suggested that some fragments in 
the genome of the rat are closer to that of humans (Zhao et al., 2004). However, 99% of the 
human genome is conserved in mice, making either species a suitable candidate for modelling 
nociception in vitro (Commission, 2010). 
 
To reduce the use of tissue in line with the 3Rs, this study was developed to incorporate the 
use of a pre-existing colony of rats, isolating cells from neonatal tissue at P2. Neonates were 
chosen as they more closely reflect the functional phenotype of nociceptive neurons 
observed in adult rodents, than the partial development of nociceptive function observed in 
embryonic tissue. Furthermore, neonates have been shown to display pain-like behaviours 
such as hyperalgesia in vivo (Vega-Avelaira, Ballesteros and López-García, 2013). The use of 
multiple pups versus one adult yielded increased capacity for microfluidic device cell culture 
per prep.  
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However, preliminary results demonstrated that non-neuronal cells extracted in the 
dissection of DRGs from P2 rats were capable of active migration through the microgrooves 
despite the narrow width (1-2µM (Taylor et al., 2005)). The localisation of a DAPI nuclear stain 
was present in both the somal and the axonal compartment, where the NeuN neuronal cell 
marker was only shown in the soma (see figures 3.2.1 below.) This migration of non-neuronal 
cells between compartments removed the properties of compartmentalisation from the 
device and rendered these cultures of P2 rat neurons impractical for modelling localised 
changes in central and peripheral connectivity. In particular the presence of a high number of 
non-neuronal cells present in the P2 culture was deemed responsible for the migration of 
cells through the microgrooves.   
Image was taken from a P2 neonatal rat culture around DiV5 using Zeiss 200M. (Red=acetylated tubulin staining for axons, 
Blue= DAPI nuclear stain, Green= NeuN staining for neuronal cells only. Composite image on the far right shows all 
channels combined at 20X magnification.) 
 
3.2.1.1 Troubleshooting cell migration in P2 rat DRG cultures: 
 
Initially the concentration of GDNF was halved from 50ng/ml to 25ng/ml to attempt to reduce 




Figure 3.2.1: Separating channels to demonstrate migration of those cells stained with DAPI nuclear stain through the microgrooves of a 
two-channel microfluidic device.Where DAPI nuclear staining was localised to both the axonal and the somal compartment of these 
devices, the microfluidic isolation was lost ,rendering them useless. 
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were fixed and stained. Figure 7.1.1 (appendix 1) showed that the reduction of GDNF 
concentration did not stop the movement of cells through the microgrooves. 
Following the observation that halving the concentration of GDNF in the media did not 
prevent cell migration, anti-mitotics were introduced to the culture (see figure 3.2.2.) When 
using P2-derived cells this included testing increased concentrations of Aphidicolin, as well as 
the introduction of 5’-fluorodeoxyuridine (FDU). FDU has been shown to reduce the dividing 
of non-neuronal cells in culture of primary cells (Rieske and Kreutzberg, 1977). By co-staining 
with DAPI and NeuN it was possible to distinguish between neurons and non-neuronal cells, 
such as satellite glia. Since non-neuronal cells will only express DAPI, an estimated number of 
cells in each section of the chamber was calculated, and used to quantify cell migration. 
 
Figure 3.2.2 shows that even higher concentrations (40μM FDU, fig. 3.2.2C) anti-mitotics did 
not completely prevent migration of non-neuronal cells, as was demonstrated by the 
presence of the DAPI stain in the axonal compartment (see figure 3.2.2D). Furthermore, as 
the concentration of anti-mitotics was increased the number of neurons stained with NeuN 
that appeared viable at DiV5 was reduced from 54.8±9.2 cells per chamber to 23±5.6 cells 
with 40μM FDU. FDU has previously been shown to be preferable for use in culture compared 
to anti-mitotics such as Ara’C (cytosine arabinoside) where Ara’C was shown to reduce 
neuronal viability overtime where 99% of proliferating cells were removed in a cortical culture 
(Hui, Zhang and Herrup, 2016). 
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A) Rat P2 cells (Control) in DRG media. B) P2 Rat cells in DRG media supplemented with 20µM FDU only. C) P2 rat cells in 
DRG media supplemented with 40µM FDU with Aph. D) Counting the number of cells stained with DAPI in the axonal 
compartment. Results of a one-way ANOVA with multiple comparisons to the P2-control, Degrees of freedom (F)= 6.431 (2, 
12), P=0.012.  N=5 biological replicate chambers. Bars showing Mean ± SEM, P<0.05 significance threshold.Post-hoc  
Dunnett’s multiple comparisons (dF=12) showing P-values of 0.17 (NS) and 0.16 (NS) respectively.  E) Counting the number 
of cells marked with NeuN in the somal compartment. Results of a one-way ANOVA with multiple comparison to the P2-
control. F(2, 11)= 18.27 where P=0.0003. Mean ± SEM, P<0.05 significance threshold, N=5 vs N=4 biological replicates with 
one statistical outlier removed using Grubbs’ analysis for P2 +40µM FDU. Post-hoc Dunnett’s multiple comparison test 
(df=11) showing P values 0.0121 and 0.0002 respectively.   
D E 
Figure 3.2.2: Attempting to optimise neonatal rat culture in microfluidic devices. Addition of DAPI nuclear stain showed migration of 
non-neuronal cells through the microgrooves, meaning microfluidic isolation of these cultures was lost. Anti-mitotics were added to 
attempt to reduce the ratio of non-neuronal cells in culture;  
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3.2.1.2 Culturing embryonic murine DRG cultures in vitro: 
 
As an alternative approach, from here-on we used E16.5 mouse cultures, where the ratio of 
non-neuronal cells surrounding DRG neurons is intrinsically lower due to the age-related 
development of nociceptive neurons (Herculano-Houzel, Mota and Lent, 2006; Bandeira, Lent 
and Herculano-Houzel, 2009). Effectively, embryonic cultures had fewer non-neuronal cells 
to migrate to the somal compartment, and the chamber showed retained microfluidic 
isolation and functional compartmentalisation when sealed to the plate. No migration of cells 
through the microgrooves was observed in these cultures (figure 3.2.3.) 
By maintaining a fluid gradient between the compartments and retaining fluidic isolation (as 
described in chapter 2.2.4.1,) it was possible to spatially isolate the axon from the cell body 
(Taylor et al., 2005). The development of a microfluidic model for the culture of DRG neurons 
often required comparison to standard ‘dissociated’ plate cultures. The immunofluorescent 
Figure 3.2.3: Dual-staining of DRG neurons cultured from E16.5 murine tissue in a two-channel 
microfluidic device. No migration of cells through the microgrooves was observed, the DAPI nuclear stain 





staining depicted in figure 3.2.4 shows DAPI (blue) with βIII-Tubulin marking the axons of the 
neurons (green in the microfluidic device, and red in the dissociated plate culture.) 
 
 
It is important to note that in the microfluidic devices used for testing, the DAPI (nuclear) stain 
was only localised to the somal compartment, into which the dissociated cells were seeded. 
However, not all cells that were stained with DAPI were also labelled with β-Tubulin, which 
most likely identifies them as non-neuronal cells. The addition of an anti-mitotic (Aphidicolin, 
see Chapter 2.2.4) to the cultures helped to reduce the population of non-neuronal cells, but 
crucially did not eliminate them.  
Dissociated culture Microfluidic culture 
 Figure 3.2.4: Immunofluorescent staining of E16.5 mouse DRG neurons at DiV5 in culture to compare methods 
of culture.  
 Images taken at 20X magnification using Zeiss 200M axiovert microscope. (DAPI nuclear stain= blue, β-tubulin 
axonal marker=green in microfluidic culture, red in dissociated plate culture) 
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In the peripheral nervous system, the Schwann cells are the most abundant form of glial cells, 
and can be myelinating or non-myelinating- although both phenotypes originate from neural 
crest tissue. Where satellite cells surround the somata of the DRGs, the myelinating Schwann 
cells ensheath the larger diameter axons of the DRG fibres in a one-to-one ratio for trophic 
support (R. R. Ji, Chamessian and Zhang, 2016; Chen et al., 2018). Therefore, for viability of 
the neurons in vitro it was important that they were surrounded by non-neuronal cells such 
as these perineuronal Schwann cells.  
 
3.2.1.3 Discussion and conclusions from the development of in vitro culture of DRG 
neurons: 
Initial extraction of DRG neurons from postnatal rat tissue was not deemed successful, but 
healthy cultures of neurons were isolated from E16.5 murine tissue and retained microfluidic 
isolation.  
The switch from P2 to E16.5 tissue was necessary to reduce the migration of non-neuronal 
cells through the microgrooves of the microfluidic devices. However, these myelinating non-
neuronal cells are essential for viability of the culture, and were not completely removed. 
Whilst non-neuronal cells provide essential trophic support to neurons, there is compelling 
evidence to support a role in modulating excitability in pathologies such as neuropathic pain. 
In vivo, the production of cytokines from non-neuronal cells has been linked to nerve damage 
and the infiltration of inflammatory cells such as macrophages. For example, the infiltration 
of pro-inflammatory macrophages was observed after only 2 hours following CCI in a model 
of peripheral nerve injury, and was shown to exacerbate muscle atrophy in the model of pain 
described (Shimada et al., 2020).  
 
In vivo models of nociception generally focus on the responses of Aδ and C fibres (see chapter 
1.6 regarding the structure of the DRG fibres) the morphological diversity of neurons in the 
DRG does not fully arise until postnatal development (de Moraes, Kushmerick and Naves, 
2017). In adults, the neurons of the DRGs have distinct action potentials based on the 
amplitude of response and duration of cell signalling. This reflects the development of mature 
DRG neurons in adult cells, and the downstream effect of this on protein expression and 
subsequent threshold activation of nociceptors (Lawson, 2002; Koerber, Druzinsky and 
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Mendell, 2017). When developing an embryonic model in vitro it was important to 
acknowledge that the results may not directly replicate the results observed from adult tissue, 
since there are many differences between the transcriptomes of adult and embryonic tissue 
(Gumy et al., 2011). 
 
It has been demonstrated that the subtypes of fibres involved in nociceptive signalling 
develop in waves (E12.5, E15.5) during embryonic development, and often only acquire full 
functionality post-natally. Evidence has shown that by E15.5 in vivo, only 80% of the neurons 
in the DRG have acquired sensory diversity (Lechner et al., 2009).  However, the remaining 
20% do not reach maturity until P0-P1 post-natally (where often this response requires 
mechanosensitive priming, for example by NGF.) A good example of this phased development 
includes the TRP (transient receptor potential) receptors involved in a range of nociceptive 
signalling. Although the TRPV1 channel (heat sensitive,) is present by E15.5 in vivo, the TRPM8 
receptor (cold-sensitive) does not appear until postnatal development (Hjerling-Leffler et al., 
2007). Despite this meaning that the suitability for these embryonic in vitro cultures in a pain-
based study must be approached with caution, the layered development of the nociceptive 
pathways also gives rise to the ability to stimulate selective neuronal subtypes.  
 
The following sections describe the development and optimisation of culture methods for 
non-neuronal subtypes which are involved in bi-directional signalling with the DRG neurons. 
Cell signalling between the primary afferents and inflammatory cells at the peripheral 
terminals induce changes in DRG signalling, and as a consequence inflammatory cells such as 










3.3 Culture of inflammatory macrophage cells: 
 
The inherent sensitivity of bone marrow derived cells to inflammatory cytokines and 
chemokines make them highly useful as tools for in vitro modelling of inflammation and 
macrophage biology, although there are still clear limitations to this (Bailey et al., 2020). Cell 
heterogeneity is a common limitation of in vitro culture of macrophage tissue (Murray et al., 
2014a), where inflammatory mediators and culture conditions affect the endogenous 
morphology and motility of the cells. Not only are macrophages highly motile, of particular 
interest is the ability of these cells to adapt to their surrounding environment, and become 
transiently ‘polarized.’ The role of macrophages as inflammatory mediators has been 
discussed in Chapter 1.8.2.  
 
One full set of adult female long bones were flushed per prep to culture bone marrow derived 
macrophages as inflammatory mediators of the peripheral immune system. By 7 days in vitro, 
cells formed a mature population of monocytes. Cells were re-plated and polarized in 
accordance with protocols described for classical versus alternative “activation,” (Classen, 
Lloberas and Celada, 2009; Rath et al., 2014a).  Chapter 2.2.3 describes in detail the protocol 
used for isolation and in vitro culture of BMDMs. A healthy culture of macrophages showed 
adherence and elongation of cell processes at DiV7 as shown in figure 3.3.1.  
Figure 3.3.1: Bright-field imaging at 20X of a healthy culture of 
monocytes isolated from bone marrow of adult mouse femur tissue. 
Imaged at DiV7. Cells have attached to the plastic and showed an 
elongated phenotype 
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3.3.1 Culture of Macrophages in microfluidics:  
One of the main objectives of this model was to attempt co-culture of 2 types of primary cell 
types in a 2-channel microfluidic device, in order to accurately reproduce the bi-directional 
signalling between peripheral inflammatory cells and the axonal terminals of the sensory 
primary afferents.  
 
Having previously demonstrated the ability to culture E16.5 neurons in the 2-channel 
microfluidic device (see section 3.2.1.3) the direct co-culture with bone marrow derived 
macrophages in one compartment of the microfluidic device was attempted.  
A) No coating; whilst few cells adhered and elongated, most cells died and developed a rounded morphology once they 
detached from the chamber. B) PLL+ Laminin; few cells made it past the well, those that did, did not adhere and died 
within the channel. C) PLL only; A greater yield of cells passed from the reservoir into the channel and adhered within 24H 
hours. There was also evidence of cellular elongation that would be typically observed in a mature population of BMDMs. 
 
Upon lifting the monocyte layer from bacterial grade plastic at DiV7, cells were re-plated into 
two-channel microfluidic devices. A range of coating was used to demonstrate what, if any 
preparation would be required to seed macrophage cells into microfluidic upon downstream 
co-culture with DRG neurons. The results demonstrated that unsurprisingly cells did not 
adhere to laminin, a class of protein extracted from the basement membrane of viable cells 
that forms an extracellular scaffold for cellular support, adhesion and migration of cells 
(Yurchenco, 2011).  
No coating PLL + Laminin PLL only A B C 
Figure 3.3.2: Multiple methods of coating for culturing bone derived monocytes in the lateral compartment of microfluidic 
devices were investigated  to ensure cell adhesion without migration through the microgrooves:  
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Whilst some cells adhered to cell-culture grade plastic (without coating, figure 3.3.2A) there 
was still some evidence of low cell viability, or cells self-polarizing towards the M1_like 
phenotype, with a “fried egg” like morphology (see Chapter 1.8.2.)  
To achieve co-culture of macrophages with DRG neurons, macrophages must adhere to PLL 
(20 μg/ml) and Laminin (20 μg/ml), as this coating was required to support DRG culture in 
microfluidics (see Chapter 2.2.1), and therefore this combination was also tested. When 
macrophage-like cells did not adhere to the coating, they died within the chamber, exhibiting 
a rounded morphology (figure 3.3.2B.)  
It was evident that most cells adhered to PLL only. Cells that survived seeding into the 
microfluidics quickly elongated (figure 3.3.2C.) All cultures were seeded at 1x 106 cells/ml. 
However, the representative images in figure 3.3.2 show that not all the cells made it past the 
reservoir in the chambers.  
For this reason, the model was altered to fulfil the original requirements for “co-culture” of 
primary cells in one microfluidic device. It was decided to instead utilise the unique nature of 
the microfluidic devices, and expose only the axonal compartment to media extracted from 
polarized macrophages. Following polarization, the media collected from polarized 
macrophages should contain high and changing levels of inflammatory cytokines.  
 
3.3.2 Polarization of macrophages in vitro: 
In vivo there are two types of macrophages, resident cells and infiltrating cells (Griffin, George 
and Ho, 1993).. For example, it has been well characterised that following nerve injury, high 
levels of chemo-attractive peptide C-C motif ligand 2 (CCL2 formerly called MCP-1) induce 
migration of monocytes to the inflamed area (Zigmond and Echevarria, 2019).  
 
Macrophages have been shown to continuously adapt to cues in the surrounding 
microenvironment, and can even express both M1 and M2 markers in response to 
surrounding pathological conditions (Bazzan et al., 2017; Lee et al., 2018). It has also been 
demonstrated that in vitro macrophages demonstrate cellular plasticity and switch 
phenotype in response to surrounding stimulus, making BMDMs a suitable candidate for this 
project (Khallou-Laschet et al., 2010). Following axotomy, it has been shown that 
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accumulation of polarized macrophages can be detected as early as 4-days after injury, and 
continues to be detectable up to 32-days post-injury. These infiltrating polarised cells have 
been shown to form rings around larger diameter neurons, with macrophages contributing 
to the innate inflammatory response (Vega-Avelaira, Géranton and Fitzgerald, 2009). 
 
There are varying models of macrophage biology in vitro, where peritoneal cells mature in 
vivo prior to culture (see Chapter 1.8.2.) Furthermore, it has been suggested that the ex vivo 
nature of differentiating the BMDMs may induce functional differences to those acquired by 
cells in vivo. Of particular interest to this study was the capacity of BMDMs to polarize towards 
different phenotypes. It has been demonstrated that exposure to polarizing stimuli induces 
BMDMS to upregulate chemokine and cytokine expression, as well as releasing more 
cytokines, therefore making them a useful tool for this model (Zajd et al., 2020).  
 
Cells were polarized using appropriate stimuli for classical (Celada et al., 1984) and alternative 
(Stein et al., 1992) activation of cells (Zhang, Goncalves and Mosser, 2008) as discussed in 
Chapters 1.8.2. Based on the literature (Mosser and Zhang, 2008) it was hypothesised that a 
minimum period of 24-hours was required to induce a change in the phenotype of 
inflammatory cells. To promote development of a classically activated cell (M1a,) 
macrophages were exposed to LPS and IFNγ or to IL-4 to promote development of a 
population of alternatively activated (M2a) cells (see Chapter 2.2.2.4.) Following stimulation 
and incubation for 24-hours, most cells had  polarized either towards an M1a or M2a 
phenotype (Huang et al., 2018). Since macrophages are inflammatory cells, they respond 
dynamically to the cues in the surrounding microenvironment, which in many ways makes a 
perfect candidate for use in a microfluidic culture system of hyperalgesic priming. 
 
However, since inflammatory cells continually respond to these changes, it would be 
inappropriate to refer to these cells as solely “pro” or “anti” inflammatory, while a better 
reflection of the cellular process should consider that polarization always generates a mixed 
population of cells depending on how much a cell was exposed to a cytokine in culture. 
Therefore, from now on, inflammatory cell populations are referred to as M1-like or M2-like, 





The route of macrophage polarization can at least partly be classified by the route of arginine 
metabolism induced by an inflammatory stimulus (Thomas and Mattila, 2014). The diagram 
in Figure 3.3.3, based on that by Yang and Ming, (2014) demonstrates how specific proteins 
surrounding the conversion from L-Arginine to L-Ornithine can be used as cell markers of 
polarization. Using immunofluorescence for markers of inflammation, there was a 
quantifiable shift between arginase-1 (Arg-1) and inducible nitric oxide synthase (iNOS) as 
shown in figure 3.3.4A.  
 
Arginase-1 was higher in cells exposed to IL-4 for 24H, where these cells were stimulated to 
polarize more towards an M2_like, anti-inflammatory phenotype. Whereas, those cells 
exposed to IFNγ and LPS for 24 hours, polarized towards an M1_like (pro-inflammatory) cell 
type, shown by the higher levels of the classical M1 marker iNOS. It was unsurprising that the 
results of polarizing cells did not show a complete shift towards only one phenotype. Figure 
3.3.4B demonstrates how it was possible to quantify the shift towards an inflammatory 
phenotype, based on the changes in expression of cellular markers iNOS and Arg1. Exposure 
Arginase  
L-Arginine  L-Ornithine  
IL-4, IL-13 
Tissue Repair   
Cell  
Cytotoxicity  
IFNγ, IL-1β, TNFα 
iNOS  
Figure 3.3.3: Overview for the role of the metabolism of L-arginine in characterising the phenotype of macrophages. In 
vivo, this switch between arginine and orthinine metabolism can be used to characterise the phenotype of inflammatory 
cells (See Mosser and Zhang., 2008) 
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with pro-inflammatory mediators demonstrated a 62.4±3.3% expression of iNOS in M1_like 
macrophages (N=3, Mean±SD), relative to a 20.4±7.2% expression of iNOS in an M2_like 
population (N=3, Mean±SD). 
An important step in understanding the process mediating the potential changes in neuronal 
excitability after macrophage polarisation is the investigation of the cytokine composition 
present in the media. This was important to determine since the polarized inflammatory cells 
would be required for the model of hyperalgesic priming, to induce changes in neuronal 
excitability. To determine the presence of multiple populations of cells, the chosen subtype 
of conditioned media was tested using a semi-quantitative cytokine array, to ascertain the 
concentration of 40 selected inflammatory targets (as described in Chapter 2.2.2.5). The 
results of this array are shown and discussed in further detail in appendix 1, figure 7.2.1.  
As shown in figure 7.2.1 the array was used to primarily to determine if there were obvious 
differences in the cytokine profiles of the M1-like media and M2-like media. The array 
provided some interesting insight in the composition of the media, but the semi-quantitative 
nature of the assay meant that it did not have the capacity to provide absolute quantification 
of the concentration of selected cytokines present. In order to confirm the results of the 
assay, future work would include the use of media extracted fresh from cells, as well as lysis 
of the polarized cells in the plate to also calculate the total concentration of protein within 
each population of cells.  
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Figure 3.3.4: Exposure to inflammatory stimuli for 24H induced a quantifiable change in macrophage phenotype: 
 A) Triple channel immunofluorescence to directly compare the expression of markers of activation. (FITC= iNOS, 
TRITC= ARG-1, +DAPI nuclear marker. Both channels were  exposed at 100mS for direct comparison. Background 
fluorescence has been removed during statistical analysis. 















































B) Quantifying marker expression in a region of interest using densitometry of the split channel 
immunofluorescence images. Data represents N=3 stainings from different dates, with 5 replicate images taken 
from each coverslip. All images were taken at 20X magnification using the Zeiss 200M. Results of a one-way 
ANOVA with statistical threshold at P<0.05. F (3, 8) =65.18 where P<0.0001. Post-hoc Sidak’s test for multiple 
pairwise comparisons showed P<0.0001 and P<0.0001 as shown. 
 
3.3.3 Discussion and conclusions from the culture and polarization of 
macrophages in vitro: 
Bone marrow was isolated from adult murine tissue and cultured on bacterial grade plastic 
to produce healthy populations of BMDMs. When optimising the culture of macrophages in 
microfluidic devices it was shown that coating was particularly important in the development 
of a healthy culture.  
 
In vitro it has previously been demonstrated that macrophages will not adhere solely to 
laminin (20µg/ml) without the addition of phorbol myristate acetate (PMA, 50ng/ml) which 
resulted in rapid adhesion (Mercurio and Shaw, 1988). Although the basement membrane is 
formed from multiple protein subtypes such as laminins, fibronectins and collagens, the 
composition varies dependent on the tissue (Guldager Kring Rasmussen and Karsdal, 2016). 
Critically, it has been demonstrated that adherence of immune cells (such as monocytes and 
macrophages) to the basement membrane can induce specific immune functions of these 
cells. For example, the expression of laminins-111, 411 and 511 in vivo, induce the adherence 
on monocytes, followed by production of pro-inflammatory cytokines such as TNFα, IL-6 and 
IL1β, and increased phagocytic cellular activity (Simon and Bromberg, 2017). For this reason, 
although cells did not adhere to culture plates in the presence of laminin alone, the use of 
this protein to coat the lateral compartment of the chamber was not appropriate, as it would 
potentially induce pro-inflammatory phagocytosis. 
 
The unique requirements for optimal culture of macrophages did not meet the culture 
conditions previously optimised for the culture of E16.5 murine DRGs in two-channel 
microfluidic devices. It was hypothesised that the cytokines in the media collected from 
polarized macrophages could induce sensitisation of axonal terminals without the need for 
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direct cell co-culture.  In addition, only changing media in the device would help to maintain 
optimal conditions for neuronal growth and give flexibility to the model. 
 
By quantifying the expression of Arg1 or iNOS as markers for polarized cells, it was shown to 
be possible to induce populations of macrophages similar to either an M1-like or an M2-like 
phenotype in vitro. Upon extracting media from polarized cells, it was also determined that 
each cell population had a unique cytokine profile. Although the use of iNOS and Arginase-1 
as markers for polarized cells is highly documented, it may have been more conclusive to use 
4 cell markers.  This would have helped reduced the cross talk between cell types, since both 
proteins are expressed in both cellular phenotypes. Other useful markers may include 
mannose receptor (CD206, normally downregulated by exposure to IFNy) or changes in the 
IL-12 axis. Of course, there is little evidence reported in embryonic tissue, and therefore this 
novel model cannot necessarily be directly compared to neonatal or adult studies.  
 
It is important to note that the media tested here was extracted from polarized cells relatively 
early in relation to the development of an anti-inflammatory phenotype. M2 macrophages 
are often hallmarked by the presence of IL-10 and other key anti-inflammatory cytokines. 
However, it is also true that M2-like cells may secrete cytokines associated with M1-cell 
activation (Roszer, 2015). Of particular interest from this array (figure 7.1.2) was the presence 
of high levels of IL-12, CCL5 and CCL2. Although the inactive form (p40 subunit) of IL-12 was 
detected at a high concentration in the M2-cell population, it was noticeable that the IL-12 
p70 (active subunit) was only detected from M1-like cells. This data supported the evidence 
for IL12 as a pro-inflammatory cytokine, but also demonstrated the plasticity of macrophages, 
whereby the stimulation with IL-4 induced release of IL-12 from an M2-cell culture. However, 
it is essential to acknowledge that the signatures of macrophages observed in vivo and those 
cultured in vitro will not be identical since they are dynamic inflammatory cells, highly 
respondent to the surrounding environment.  
The classical versus alternative activation axis was first established as a binary dichotomy by 
(Mills et al., 2000), but this simplified explanation of the M1/M2 paradigm has since become 
outdated. It has been established that M1/M2 polarization is largely dependent on the stimuli 
used, where polarized cells form a spectrum, and the M1 and M2 phenotype sit at either end 
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(Mantovani et al., 2004). Physiologically, a “cocktail” of inflammatory mediators regulates 
macrophage polarization, although here a fixed concentration of only one cytokine was used 
to induce a specific phenotype. Therefore, it was difficult to anticipate how downstream 
inflammatory targets would respond. Although the upregulation of Arginase-1 was more 
prominent in the M2-like macrophage populations, it has been demonstrated that M1-like 
macrophages stimulated by TLRs also express this marker (El Kasmi et al., 2008). The 
endogenous phenotype of macrophages is most likely regulated by multiple cell signalling 
pathways, for example the SOCS (suppressor of cytokine signalling) proteins (Briken and 
Mosser, 2011; Davis et al., 2013). It has been observed, specifically in M2-like macrophages, 
that SOCS1 (but not SOCS3) can lead to rapid downstream induction of the M2-like phenotype 
after treatment of IL-4 in vitro (Dickensheets et al., 2007). Therefore, although Arginase-1 is 
a well characterised marker for M2-like macrophages, caution should be exercised when 
considering the change in phenotype of the cells, since there are likely other cellular 
processes involved in the regulation of these markers.  
Although cells were stimulated with cytokines aimed to evoke M1a and M2a cells, our results 
support the now overwhelming evidence suggesting that this “switch” between pro and anti-
inflammatory cells is not as binary as once thought. In fact, in in vitro studies it is possible to 
distinguish between phenotypes based on the stimulus used to induce the molecular change. 
In this case the cells would therefore be referred to as M[LPS+IFNy] or M[IL-4]. This is because 
multiple stimuli can be used to polarize cells towards an M2-like phenotype, but not all M2-
like cells show the same molecular profile (Murray et al., 2014b). The regulation of 
macrophage phenotype is a dynamic process, where concentrations of surrounding cytokines 
can rapidly induce changes to the cellular activity and morphology. Whilst M1-like cells 
release cytokines to inhibit proliferation of surrounding cells, the M2-like phenotype is more 
involved in the resolution phase of inflammation. For this reason, M2-like cells release 
cytokines more involved in tissue regeneration and repair. Polarizing these cells in vivo is 
tightly regulated by surrounding signalling pathways and post-transcriptional regulation. 
However, it is not as simple as to suggest that the molecular switch between phenotypes is 
an “all or nothing” response. Crucially there is also evidence to support the hypothesis that 
some cytokines may mediate the regulation of both pro-inflammatory and anti-inflammatory 
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phenotypes (Martinez and Gordon, 2014). The role of a select cytokine appears to be 
dependent on 3 distinct parameters (Shachar and Karin, 2013):  
 
1. Local concentration of the cytokine surrounding an area of inflammation 
2. The stage of injury in disease pathology  
3. The combination with other cytokines  
 
Bone marrow derived macrophages have a unique cytokine profile compared to other 
inflammatory cells such as peritoneal macrophages. If this study were continued or optimised 
further, the use of additional antibodies such as CD68 or CD11b would have been useful to 
create a panel of markers for cell specific antigen detection to distinguish macrophages from 
other hematopoetic cells. It would theoretically have also been possible to use techniques 
such as flow cytometry to identify the inflammatory ‘profile’ of the different phenotypes of 
bone marrow derived macrophages grown in our cultures.  
3.4 In vitro culture of spinal cord microglia as a model for inflammatory cells 
in the CNS:  
 
In addition to modelling the inflammatory cells that can affect the peripheral nervous system, 
a protocol was developed to culture spinal cord derived microglial cells. In vivo the microglia 
modulate the inflammation in the CNS to further promote inflammation and hyperexcitability 
of neurons, or to resolve injury and hyperalgesia (see Chapter 1.8.3.)  In a similar way to 
peripheral macrophages, CNS microglia respond dynamically to cytokines in the 
microenvironment, which is critical in resolution of sensitisation. It was hypothesised that the 
media extracted from polarized microglia would either potentiate the hyperexcitability 
induced by pro-inflammatory macrophages, or reduce nociceptor sensitisation. Other 
potential cellular candidates included second-order dorsal horn neurons isolated from the 
spinal cord, to which the DRG neurons might synapse in vivo.  
 
To determine the purity of the microglial culture we used a dual-staining IF model with Iba-1 
(microglial cell marker) and GFAP (astrocytic cell marker), as shown in figure 3.4.1 below. 
Since the cells were isolated from embryonic spinal cord, the GFAP signal represents 
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progenitor cells for CNS astrocytes. A higher level of expression of Iba-1 versus GFAP in culture 
(see Chapter 1.8) suggested that the culture method of the cells favoured the development 
of microglial like cells. Shown here is the quantification of Iba-1 relative to GFAP in a culture 
of quiescent microglial cells extracted from the spinal cord. In a mixed population of cells Iba-
1 was detected at 80.58±8.1% (mean±standard deviation) relative to 19.42±8.1% GFAP. These 
results suggested the presence of a microglial-rich population of non-neuronal cells isolated 
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 A) An exemplar image of M0 microglial cells at 20X magnification, showing dual-staining with iba1 (microglial marker) 
versus GFAP (astrocytic cell marker.) Shown on the left is the triple-channel image including DAPI nuclear stai, iba-1 (TRITC) 
and GFAP (FITC). The FITC and TRITC channels have been separated to show a lower expression of the GFAP marker 
respectively.  
B) Quantification of the purity of a mixed glial cell population, using %-expression IBA-1 vs. GFAP in M0 population of cells.  
Data represents an N=3 coverslips from 3 separate cell preparations, with n=5 ROI analysed per coverslip. (Error bars ± 





3.4.1 Polarizing microglial cells in vitro 
It has been demonstrated that microglial cells polarize to favour different phenotypes in a 
very similar way to peripheral macrophages (Michelucci et al., 2009). Although the 
transcriptional profiles of monocytes and microglial cells are similar, they are not identical (as 
discussed in Chapter 1.8.3.) One of the defining factors of microglial cells is the innate cellular 
response to inflammation. Unlike macrophages which are stimulated to polarize, the 
microglial cells become activated and differentiate from a resting quiescent state to either a 
ramified or an ameboid morphology, dependent on the surrounding microenvironment. The 
morphological change in the cell also coincides with upregulation of surface markers such as 
CD206 or CD86 (Heneka, Kummer and Latz, 2014). The classifications of polarized microglia 
are often compared to the classically activated M1-like macrophages and alternatively 
activated M2-like macrophages (Goldmann and Prinz, 2013; Zanier et al., 2015; Amici, Dong 
and Guerau-de-Arellano, 2017). However, given that these cells are quiescently ramified 
rather than resting, and in vivo studies have failed to demonstrate the presence of 
morphological regulators in isolation, there is some debate about the application of the 
M1/M2 dichotomy to microglial cells in general (Ransohoff, 2016).  
 124 
  
Assuming that microglial cells can be induced to demonstrate changed morphologies based 
on exposure to inflammatory stimuli, we attempted to quantify the presence of “M1-like” 
(activated, ameboid) and “M2-like” (activated, ramified) microglial cells following stimulation.  
 
Once again it was noticeable that cells did not fully shift towards a specific phenotype, 
supporting the evidence for a spectrum of inflammatory cells. In fact, it was observed that 
there was a 81.3±6.0% expression of iNOS in the M1-like population versus an 80.7±4.1% shift 
Figure 3.4.2: Exposure to inflammatory mediators induced significant changes in the phenotype of spinal cord derived microglial cells.  
B A 
Arginase-1 iNOS M1-Like cells 
M2-Like cells 
A) Triple-channel immunofluorescence using DAPI, iNOS (FITC) and Arg1 (TRITC) as markers for inflammation. All channels 
were exposed for 100mS to enable direct comparison. M1-like microglia demonstrated a more ameboid phenotype compared 
to a ramified phenotype in the M2-like populations of cells. 
 B) Converting detection of a marker to a % expression to quantify the effect of polarizing stimuli on the phenotype of cells. 
Results of a one-way ANOVA with selected pairs of comparisons. P<0.05 Significance threshold, F (3, 8)= 170.4. Post-hoc 
Sidaks test showed P<0.0001 and P<0.0001 respectively as shown. dF=8  
N=3 coverslips from 3 separate animal preparations. Error bars represent the SEM. Background fluorescence has been 













































towards Arg-1 in the M2-like cells (and 19.27±2.4% iNOS expression relatively.) Figures 3.4.2B 
represents an N=3 independent stainings (biological replicates,) with a minimum of 3 
representative areas (technical replicates) imaged per coverslip (mean± standard error of the 
mean%.) The threshold for each immunofluorescent image was set the same before the 
image was taken, so that the stainings were directly comparable.  
It was noticeable that unlike the M2-like macrophages, the M2-like microglia did not 
demonstrate a large shift towards the M2 phenotype given 24-hours exposure to IL-4 only. 
However, a quantifiable shift in morphology suggested that the cells had undergone 
translational regulation and were secreting different profiles of inflammatory cytokines (see 
appendix, figure 7.1.3 and table 7.1.4.1.) Therefore, exposure of the DRG terminals to the 
media extracted from these cells would theoretically either potentiate a state of hyperalgesia, 
or reduce excitability of the cell.  
 
 
3.4.2 Discussion and conclusions from the development of in vitro culture 
method of spinal cord derived microglial cells: 
 
Immunofluorescent staining successfully validated the extraction of embryonic spinal cord for 
the selective culture of microglia, although it did not help to determine the functional 
differences of the cell phenotypes. As resident immune cells of the CNS, in vivo microglial cells 
act as first-line defense cells against invading pathogens (Zhou et al., 2017). However, there 
may be a difference in the phenotype of microglia derived from the spinal cord versus the 
brain. It is understood that microglia localised to the brain are more involved in regulating 
cognitive function, whereas microglia found in the spinal cord are more relevant in the control 
of sensory-motor neuron mediated functions (Xuan et al., 2019) Usually in vitro models use 
immortalised cell lines such as cortical BV2 murine cells, where these cells are easily 
maintained in culture, and readily proliferate, reducing the need of fresh tissue (Timmerman, 
Burm and Bajramovic, 2018).  
It has also been suggested that in vitro culture of microglia leads to the development of a 
different phenotype than in vivo. Of particular interest was the length of time cells were kept 
in culture. Cells kept for over 14-days in vitro appeared to lose their ameboid shape and prefer 
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a more ramified, quiescent morphology. However, in vivo this shift towards M0-M2-like cells 
does not occur until the cells become “aged.”  
The physiology of microglial cells dynamically changes in response to secretions of pro- and 
anti-inflammatory cytokines into the surrounding  microenvironment (Helmut et al., 2011). 
Having ascertained it was possible to change the phenotype of the cells in response to a select 
stimulus, it was also important to investigate the capacity of the microglia to phagocytose 
foreign bodies (see figure 7.3, appendix 1). A number of functional assays were implemented 
in order to help further define polarisation states of the microglia in line with published 
literature. The results of a phagocytosis assay and a Feret’s diameter calculation are shown in 
appendix 1.   
The results of a phagocytosis assay supported the evidence that pro-inflammatory cells have 
a more active role in phagocytosis, whilst also demonstrating that the M2-like (anti-
inflammatory) phenotype displays some phagocytic behaviour. In order to improve the 
dynamic range of this experiment it would have been preferable to increase the number of 
biological repeats, or test other polarizing stimuli to induce the polarized microglial cell 
populations.  
A Feret’s analysis is often also used in statistical analysis of inflammatory cells. Feret’s 
(maximum) diameter is a measure of cell length and is useful where some cells change 
morphology dependent on their activity (Zanier et al., 2015). A good example of this is 
inflammatory cells like macrophages and microglial cells, which switch from an elongated 
morphology in quiescent or M2-like cells to a more rounded morphology in the M1-like cells 
as the phagocytic activity of the cell is increased (Caldeira et al., 2014). The results have then 
been combined as shown in table 7.1.4.1 to calculate an average diameter (µM). As expected, 
the analysis showed a larger value output for those cells deemed to be M2-like phenotype, 
where the cell area of cells in an M1-like phenotype was consistently lower as these cells were 
more amoeboid following exposure to LPS, and activation of phagocytosis.  
 
These results helped to support the evidence that we had successfully isolated microglia from 
the spinal cord of embryonic tissue, and used inflammatory stimuli to induce different 
populations of inflammatory cells based on morphology and phagocytic activity. The 
characterisation of changes in CNS microglia was useful for potential addition to the 
microfluidic model of hyperalgesic priming.  
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3.5 Chapter conclusions: 
The main objectives of this chapter were to develop protocols for the culture and 
characterisation of multiple cell types involved in nociceptive signalling. Due to the 
pseudounipolar nature of the DRG neurons, and the flexibility of microfluidic modelling, it 
would also be possible to model nociceptive signalling between the PNS and the CNS, by 
exposing the DRG axons to either macrophages or microglial cells.  
The characterisation of development of DRG neurons in the triple-channel microfluidic was 
previously carried out by Clara Patricio of the Dajas-Bailador lab. In the initial stages of this 
project, the microfluidic model in this project was simplified to a 2-cell model and the use of 
macrophages as peripheral cells changing the excitability of the axon of the DRG was further 
investigated.  
Reasonable efforts were made here to co-culture more than one cell type within a 
microfluidic with the DRG neurons. However, in order to optimise the environment required 
for in vitro culture of DRGs, it was decided to avoid changes in culture media that would be 
required for physical co-culture of primary cells. Although the cell types were easily cultured 
individually, each cell has its own timeline for development, ranging from 5-days in vitro for 
DRG neurons, to 7-days in vitro for macrophages, and longest of all 14-days minimum for a 
microglial rich culture (see chapter 2, section 2.2.3). It was also evident that each cell type 
required specific culture conditions, where macrophages were preferential to a bacterial 
grade plastic, but DRG neurons require tissue culture grade sterile plastic, coated with PLL (20 
μg/ml) and laminin (20 μg/ml.) 
 
The following conclusions can be drawn from the work shown in this chapter:  
1. DRG neurons can be isolated from E16.5 mice and cultured in microfluidic 
compartmentalised devices for the study of neuronal excitability in culture. 
2. It was possible to extract and maintain a healthy culture of bone marrow derived 
macrophages from an adult female mouse. Cells were polarised and used to 
investigate the effect on neuronal function.  
3. Using classical stimuli such as IFNy versus IL-4 it was possible to generate two 
populations of macrophages, with distinctive cytokine signatures of polarization.  
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4. It was also possible to isolate microglial cells on demand from the embryonic spinal 
cord tissue 
5. Similarly to macrophages, microglial cells could be polarised towards different 
phenotypes, changing the morphology and apparent phagocytic nature of the cell. 
(This metric would require further investigation to improve robustness of data.) 
 
The efforts of this project largely focus on the interaction between the periphery (where a 
stimulus would be applied in vivo) and the downstream effect on DRG excitability following 
infiltration of inflammatory cells. For this reason, more work was completed on characterising 
changes in bone marrow derived macrophages. Media from polarized cells was extracted at 
an optimised time-point, and frozen until required, meaning the model only required 
consistent culture of DRG neurons and improving the flexibility of experiments. The next step 
in development was to determine what, if any effect the inflammatory mediators released 
from macrophage cells would have on the excitability of DRG neurons at the peripheral 
terminals. Microfluidic modelling provides a useful tool for this setup, where media can be 
locally applied to the axonal compartment, and if an increase in free intracellular calcium is 


















4 Investigation of changes in DRG excitability 




As part of a model of changes in neuronal excitability as a proxy for pain, we were interested 
in utilising the microfluidic model to quantify changes in excitability of DRG neurons (see 
Chapter 1.5 and 1.6). Due to the compartmentalised nature of the microfluidic device, it was 
highly suitable for monitoring localised changes in calcium transients (Ca2+) at the soma, in 
response to axonal stimulation.  
 
The excitability of DRG neurons is dependent on stimulation of the neuronal terminals and 
membrane depolarization inducing the propagation of an action potential. When the action 
potential reaches the soma, the change in membrane potential elicits a response. This 
includes, but is not limited to the activation of voltage-gated Ca2+ sensitive channels and 
evoked release of Ca2+ transients from intracellular stores such as the endoplasmic reticulum 
(Berridge, Bootman and Roderick, 2003). Elevated concentrations of free, active Ca2+ is 
therefore dependent on propagation of the action potential along the axon, and can be 
assumed to be proportional to changes in excitability of the neuron.  
 
4.1.1 Using evoked Ca2+ transients as a reporter for changes in neuronal 
excitability: 
In excitable cells like neurons, changes in intracellular Ca2+ are essential for synaptic function 
(Stevens and Wesseling, 1998; Neher and Sakaba, 2008) as well as the activation of signalling 
pathways within the cell (Hagenston and Baing, 2011; Burgoyne and Haynes, 2015). In 
neurons, the cytosolic Ca2+  concentration is determined by an equilibrium between the influx 
and efflux of Ca2+ ions in the cell, where Ca2+ binding proteins (e.g. Parvalbumin in cortical 
interneurons) buffer the concentration of metabolically active free Ca2+ in the cytosol (Rink 
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and Merritt, 1990; Schwaller, 2010). Therefore, quantifying dynamic changes of intracellular 
Ca2+ within the cell was used here as a measure of cellular excitability.  
A rise in intracellular Ca2+ activates potassium channels to induce re-polarization of the 
membrane and trigger neurotransmitter release (Jow et al., 2004; Iosub et al., 2015). 
However, it has been demonstrated that the efficacy of Ca2+ as signalling molecule, is not only 
due to the concentration gradient maintained between extra and intracellular compartments 
of the cell, but also due to the physical distance of a Ca2+ sensor (e.g. VGCC) from a stimulus 
(Heine et al., 2019). To restrict Ca2+ fluctuations without physical stimulation, cells such as the 
neurons of the DRG regulate the level of free Ca2+ in the cytoplasm. Ca2+ is compartmentalized 
within the cell so that a small change in the intracellular concentration can potentiate 
downstream signalling, and modulate excitability of the neuron (Grienberger and Konnerth, 
2012a). It has been estimated that at rest most cells of the nervous system have an cytosolic 
Ca2+ concentration of between 50-100nM (Berridge, Lipp and Bootman, 2000). Depolarization 
of the membrane and propagation of an action potential stimulate the release of Ca2+ in the 
neuron (e.g. from the endoplasmic reticulum,).   
 
It is possible to quantify changes in cytosolic Ca2+ transients in vitro by loading cells using cell 
permeable, hydrophobic fluorescent indicator dyes. In this way, Ca2+ acts as a reporter for 
changes in neuronal excitability, where evoked Ca2+ transients at the soma can be quantified 
as a proxy for a change in cellular excitability. Following stimulation, when ‘free’ Ca2+ binds to 
the dye within the cell, a fluorescent signal is emitted (see Chapter 2.3.1). The change in 
fluorescence recorded can be assumed directly proportional to the fluctuations of Ca2+ within 
the cell. However, it is important to note that the indicator dye will only bind to Ca2+ that is 
freely diffusing through the cytosol following stimulation, whilst most intracellular Ca2+ 
remains sequestered to stores such as the endoplasmic reticulum.  
The efficiency of Ca2+ as a modulator of cell excitability is due to the capacity of a cell to 
maintain a concentration gradient of up to 20,000x fold difference between intracellular and 
extracellular stores of Ca2+ (Clapham, 2007). There is ongoing evidence for the use of evoked 
Ca2+ transients as a measure of cell excitability from in vivo models. Critically these in vivo 
setups monitor whole ganglia rather than Ca2+ transients in the soma corresponding with 
axonal stimulation. Recent advances have also led to the use of two-photon imaging of DRG 
neurons in awake animals. It was shown that hyperexcitability of DRG neurons induced by 
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plantar formalin injection correlated with ongoing pain behaviour in the animal across 5-
weeks of live recordings (Chen et al., 2019). 
This change in intracellular Ca2+  is also a validated method for monitoring neuronal function 
and changes in excitability in vitro (Grienberger and Konnerth, 2012b). Using neonatal rat 
cultures this technique has also been applied to neurons grown in microfluidic cultures, to 
quantify changes in neuronal excitability (Tsantoulas et al., 2013). In this setup, it was 
demonstrated that stimulation of the axonal compartment induced propagation of action 
potentials towards the somal compartment. It was hypothesised that these action potentials 
triggered the opening of voltage-gated Ca2+ channels upon reaching the soma (Tsantoulas et 
al., 2012, 2013).  
 
4.1.2 The effect of inflammation on neuron excitability and calcium transients 
in neurons: 
Inflammation is often associated with changes in excitability of the primary afferent fibres. 
The onset of inflammation often precedes changes in neuronal excitability including action 
potential conductance, propagation and neurotransmitter release (Ma, Greenquist and 
LaMotte, 2006; Wang et al., 2007). All of these factors contribute towards sensitization of the 
peripheral fibres (Hamilton and McMahon, 2000; Raddant and Russo, 2011). However, at a 
cellular level the onset of inflammation is critically associated with changes in the 
concentration of intracellular free Ca2+. Specifically an increased resting concentration of 
intracellular Ca2+ in the neuron, as well as an increase in the magnitude of evoked Ca2+  release 
upon stimulation (Lu and Gold, 2008). Several prominent findings from in vivo studies have 
helped develop an understanding of how inflammation affects Ca2+ transients of the DRGs 
through the use of fluorescence dyes (Chen et al., 2019). In these models the increase in 
fluorescence observed upon evoked release of Ca2+ transients at the soma is proportional to 
changes in the neuronal excitability. Electroporation of the L4/L5 ganglia in vivo also included 
direct stimulation of voltage-gated channels on the soma as well as membrane depolarization 
at the axonal terminals (Chen and Huang, 2017). Upon stimulation of the axons, the 
propagation of the action potential induces release of Ca2+ from intracellular stores and the 
opening of voltage-gated Ca2+ channels, both of which contribute to the fluctuation in Ca2+ 
transients recorded in the soma.  
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In a transient nerve injury model it was shown that there was a decrease in voltage-gated 
calcium channel density following the onset of nerve injury and inflammation (Baccei and 
Kocsis, 2000; Hogan et al., 2000). Axotomy of the DRG fibres also induced a reduction in 
intracellular Ca2+ in rats (Duncan et al., 2013) and reduced fluctuations of free Ca2+  recorded 
following stimulation of the axotomized fibres (Fuchs, Rigaud and Hogan, 2007). These 
findings were consistently observed in small and medium fibre subtypes of the DRG only, or 
those fibres involved in nociceptive signalling (Lu et al., 2010). I have discussed the 
implications of this in Chapter 5.  
 
4.1.3 Modelling in vitro responses to an acutely applied stimulus  
In a physiological environment, the peripheral terminals of the sensory neurons are exposed 
to an array of inflammatory cytokines and chemokines, especially upon invasion of a polarized 
macrophage. In chapter 3 the development of culture methods for both DRG neurons in 
microfluidic devices, as well as the culture and polarization of BMDMs was discussed. In the 
following chapter, a model was developed to investigate the effects of inflammatory 
mediators released from these polarized macrophages on neuronal excitability.  
Initial experiments involved acute stimulation with either a depolarising agent (KCl 25mM) or 
polarized macrophage media, whilst further development of the protocol included pre-
incubation of cells in polarized macrophage media to attempt to sensitize the axons before 
acute stimulation with KCl (25mM.) 
 
The method described in chapter 2.5.1 for a Ca2+ indicator assay gives an in-depth overview 
of how the assay was performed. In response to a stimulus (e.g. KCL) membrane 
depolarisation lead to a rapid and acute increased concentration of cytosolic Ca2+. Free Ca2+  
ions were bound by Fluo-5F in the cytosol (Thomas et al., 2000; Paredes et al., 2008) and the 
corresponding emission of fluorescence at a single wavelength of light was recorded.  
The increase Ca2+ transients were recorded as a change in fluorescence, and used as a proxy 
for neuronal excitability. It was hypothesised that stimulation of the neuronal culture would 
induce local depolarization of the membrane. If suprathreshold the action potential would 
propagate, whereby Ca2+ is released via opening of voltage gated sensitive channels, and 
intracellular mechanisms such as calcium induced calcium release involving secondary 
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messenger systems. The detectable increase in free intracellular Ca2+ was recorded as a 
transient change in fluorescence recorded.  
In order to quantify the increase in calcium fluorescence following stimulation of a population 
of cells the following formula was applied:  ΔCa2+ = ΔF/F = (F − Frest)/Frest 
 
4.1.4 Experimental aims and objectives of the chapter: 
Part A: 
• Demonstrate the advantages of compartmentalised microfluidic models in the 
investigation of neuronal excitability 
Part B: 
• Utilise compartmentalised microfluidic devices to model intrinsic and extrinsic cell 
processes in primary afferent nociception, by combining DRG neurons and bone 
marrow derived macrophages  
• Investigate the effect of inflammatory stimuli on neuronal excitability using 
compartmentalised microfluidic cultures 
• Compare the effect of acute versus prolonged inflammatory stimulation on neuronal 
excitability  
4.2 Part A: Axonal stimulation of embryonic DRG cultures in microfluidic 
devices evokes rapid Ca2+ transients and changes in cell excitability: 
 
Chapter 3.4 described the optimisation of culture of dissociated DRG neurons isolated from 
embryonic murine tissue in compartmentalised microfluidic devices. This model was used 
here to functionally test the stimulation of the axons for efficient transmission of an action 
potential. In order to quantify the result of stimulation, evoked Ca2+ transients in the soma 
were recorded as a change in fluorescence. This section describes the use of a Ca2+ signalling 
assay, to validate the use of embryonic microfluidic culture in the study of nociception in vitro. 
Following acute stimulation, a rapid and transient change in intracellular Ca2+ was recorded 
via change in fluorescence emitted. Initially a stimulus was added acutely to the axonal 




4.2.1 Stimulation of the axons with potassium chloride in a 
compartmentalised microfluidic device evoked Ca2+ transients in the 
soma: 
In the experiments discussed here, the fluctuation in Ca2+ transients at the soma were 
recorded as a proxy for the change in cell excitability induced by stimulation of the cell culture. 
Figure 4.2.1 below shows that microfluidic stimulation only records the somal response of 
those axons that have crossed to the lateral compartment of the device. Whereas, the 




Potassium chloride (KCL) is as a powerful depolarising agent of all subtypes of sensory 
neurons, and all neuronal cultures were only stimulated with KCL at a saturating 
concentration of 25mM. Figure 4.2.2 shows a comparison between the effects of acute 
application of KCL to a standard plate-based dissociated culture, versus the effects on 
localised axonal stimulation of a microfluidic culture.  
 
Stimulation of dissociated cultures with KCL evoked a higher amplitude and longer duration 
response with comparison to axonal stimulation of microfluidic devices (see figure 4.2.2A.) 
Dissociated culture Microfluidic culture 
Stimulation (e.g. KCL 25mM) 
Figure 4.2.1: Schematic representation of the differences between stimulating the axons in 
compartmentalised microfluidic culture versus the whole cell population in a standard dissociated plate 
culture. 
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This was likely reflection of the fact that this stimulation adds direct somal and axonal 
stimulation mechanisms. The response seen in neurons cultured in a microfluidic culture only 
reflected the Ca2+ transients evoked by stimulation of the axon and transmission of the action 
potential to soma of the DRG, following membrane depolarization. The direct comparison of 
peak excitability in figure 4.2.2B demonstrates that the method of culture did not significantly 
affect the response recorded.  
However, the AUC calculation in figure 4.2.2C demonstrated that the duration of the response 
was significantly increased in dissociated plate cultures, where Ca2+ mobilising processes 
being stimulated were present on the soma as well as the axon. This suggested the presence 
of longer duration excitation and ongoing cytosolic Ca2+ that outlasted the application of an 
acute stimulus. Where Fluo-5 binds free Ca2+ moving through the cell, the prolonged response 
suggests either Ca2+ stores are being replenished, or there is a background signal intensity 
that must be taken into account.  
 
Figure 4.2.2D shows that the Ca2+ signal recorded in microfluidic chambers stimulated with 
KCL recovered on average by 77.7% from the peak ∆F recorded in the 50-seconds following 
stimulation. Analysis of individual stimulations demonstrated that 5 out of 6 of the recordings 
in microfluidic culture showed 100% recovery to baseline fluorescence. In contrast, the 
average recovery of fluorescence in dissociated plate cultures was only 36.1% by the end of 
a 60-second recording. The increased recovery towards baseline fluorescence in microfluidic 
cultures served as further identification of rapid but transient Ca2+ responses recorded 
because of action potential propagation in compartmentalised and fluidically isolated 
cultures.  
 
This significant increase in cytosolic Ca2+ following axonal stimulation in a microfluidic culture 
was dependent on the following conditions:   
a) Crossing of the axons through the microgrooves whilst retaining microfluidic isolation 
in the device. 
b) Addition of a stimulus increasing the extracellular positive charge and inducing 
membrane depolarization via activation of voltage-gated ion channels either at the 
axonal terminal or on the axons  
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c) Subsequent propagation of the action potential to the cell body, where the change in 
excitability was recorded as a change in fluorescence evoked by the increase in 




































































































































Figure 4.2.2: By measuring change in fluorescence as a proxy for cell excitability, the effects of KCL stimulation on evoked Ca2+ 
transients was quantified in two different DRG neuron culture systems: 
 
A) Stimulation with KCL evoked rapid Ca2+ transients in normal and microfluidic culture. The increase in cell excitability in 
microfluidic cultures showed a lower amplitude and faster recovery due to local application of the stimulus to the axons.   




4.2.2 Capsaicin evokes increase in neuronal excitability by stimulation of C-
like fibres in vitro: 
 
Identifying an appropriate stimulus was dependent on what the model was trying to 
demonstrate. KCL was used as a general depolarising agent, where subtypes of potassium 
channels are found on all fibres of the DRG. However, the activation of fibres specifically 
involved in nociceptive signalling (Aδ and C fibres) required a more selective stimulus. Figure 
4.2.3 (shown below) demonstrates a significant increase in the excitability of embryonic 
cultures when stimulated with Capsaicin, a stimulus that is known to activate TRPV1, a 
sodium/calcium sensitive ion channel receptor expressed on small diameter nociceptors 
(Caterina et al., 1997; Yang and Zheng, 2017). Activation of the TRPV1 receptor has a key role 
in detecting thermal and chemical stimuli and is express on both the small-diameter 
unmyelinated C-fibres, as well as the myelinated Aδ-fibres in the adult (Morgan et al., 2019). 
However, in rodent behavioural studies investigating ablation of the TRPV1 receptor, it is 
often hard to distinguish between the behavioural responses mediated solely by fast-
conducting Aδ fibres. For that reason, behavioural studies often focus on thermal pain 
responses associated with TRPV1 activation in unmyelinated, slow conducting C-fibers 
(Mitchell et al., 2014). However, it is important to note that TRPV1 is expressed on both 
Figure 4.2.2 continued: By measuring change in fluorescence as a proxy for cell excitability, the effects of KCL stimulation on evoked 
Ca2+ transients was quantified in two different DRG neuron culture systems: 
B) Quantification of the peak Ca2+ transients showed a statistically significant increase from baseline fluorescence was 
recorded irrespective of the method of culture. Results of a one-way ANOVA showed P<0.0001 where F(3, 20)= 14.03. Post-
hoc Sidak’s test for multiple comparisons showed a significant increase in cellular excitability irrespective of the method of 
culture. As shown, P=0.0147 for stimulation with KCL in microfluidic culture and and P<0.0001 in dissociated plate cultures. 
The peak amplitudes recorded between cultures were not significantly different. P<0.05 significant threshold. N=6 
biological replicates.  
C) The AUC showed a significant difference in neuronal excitability following stimulation of cultures with KCL, where the AUC 
of dissociated cultures was increased due to the sustained duration of the Ca2+ transient response recorded at the soma. 
(P=0.0156) Unpaired t-test, ±SEM, P<0.05 significance threshold, 1 outlier removed via Grubbs’ analysis. 
D)  Recovery of cellular excitability following stimulation with KCL was represented as %-recovery in fluorescence. Cells 
cultured in microfluidic devices showed higher %-recovery in fluorescence in a 60-second recording (P=0.0038.) Unpaired t-
test, ±SEM, P<0.05. 
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myelinated and unmyelinated nociceptors. As discussed in Chapter 1.6 and 1.7 both the Aδ 
and the C-fibre subtypes have been demonstrated to be involved in nociception.  
 
In experimental models a stimulus such as KCL has the potential to depolarize any of the axons 
within the neuronal population. The time-courses plotted in figure 4.2.3A were used to 
visualise the change in fluorescence following stimulation of cultures with Capsaicin. In a 
similar manner to the depolarisation induced by exposure to the axonal terminals to KCL, the 
evoked increase in Ca2+ transients following stimulation by Capsaicin showed higher 
amplitude and longer duration in a plate-based culture. The smaller amplitude of the 
response to stimulation with Capsaicin suggested the involvement of TRPV1 receptors on the 
soma of the embryonic neurons as well as the axons.  
 
Previous evidence by Tsantoulas et al., (2013) has shown that there is a dose-dependent 
response of neonatal DRG neurons to capsaicin stimulation. For example, it was 
demonstrated that in neonatal experiments, the EC50 for capsaicin stimulation was 94µM 
from 3 independent axonal stimulations and 135µM from 3 independent somal stimulations. 
In these experiments, 72% of cells responded to a “low” concentration of capsaicin (100nM) 
whilst 92% of cells were shown to respond to stimulation with a “high” concentration of 
capsaicin (500nM) (Tsantoulas and McMahon, 2014). The concentration used in this setup 




Figure 4.2.3: Stimulation with Capsaicin evoked Ca2+ transients in subpopulations of DRG neurons in culture, recorded as 
an increase in fluorescence: 
A) Stimulation of microfluidic devices vs. dissociated plate cultures. The amplitude and duration of response 
observed in the dissociated plates was higher due to direct somal stimulation 
Legend continued overleaf… 













































































































As shown in figure 4.2.3B, there was a significant difference recorded between the peak 
excitability of the culture subtypes in response to stimulation with Capsaicin, where the peak 
excitability recorded from microfluidic cultures was significantly lower than that observed in 
dissociated plate-based cultures.  
 
The AUC for stimulation of microfluidic devices with Capsaicin was significantly smaller than 
the AUC for stimulation of dissociated plates (figure 4.2.3C.) Whereas, the recovery to 
baseline fluorescence was higher in microfluidic culture, where the duration and amplitude 
of the responses were lower. Following acute stimulation with capsaicin (200nM) in 
microfluidic devices, the average recovery was 100%, ranging from 87.9% to 100%. In contrast 
the average recovery of cells in dissociated cultures was only 23.66%, ranging from 19.3% to 
117%.  
 
It could be hypothesised that these results suggested that the TRPV1 receptors may not be 
uniformly expressed on the DRG neurons cultured from E16.5 tissue. The lower amplitude 
response from stimulation of microfluidics was dependent on propagation of the action 
potential. However, a larger amplitude response was observed following direct activation of 
TRPV1 on the soma in dissociated plates. 
Figure 4.2.3: Stimulation with Capsaicin evoked Ca2+ transients in subpopulations of DRG neurons in culture, recorded as an increase 
in fluorescence: 
B) Quantification of the peak Ca2+ transients showed a statistically significant increase from baseline fluorescence was 
recorded dependent on the method of culture.  Results of a one-way ANOVA with pre-selected pairs of comparisons 
showed P<0.0001 where F(3, 24)= 46.08. Post-hoc Sidak’s test for multiple comparisons showed a significant increase in 
cellular excitability irrespective of the method of culture. As shown, P=0.0036 for stimulation with capsaicin in microfluidic 
culture and and P<0.0001 in dissociated plate cultures. The peak amplitudes recorded between cultures were also 
significantly different at P<0.0001.. P<0.05 significant threshold. N=6-8 biological replicates.  
 
C) The AUC showed a significant difference in neuronal excitability following stimulation of cultures with Capsaicin, where the 
AUC of dissociated cultures was increased due to the sustained duration of the Ca2+ transient response recorded at the 
soma. Unpaired t-test, ±SEM, P<0.05 significance threshold, 1 outlier removed via Grubbs’ analysis.   
D) Recovery of cellular excitability following stimulation with Capsaicin was represented as %-recovery in fluorescence. Cells 
cultured in microfluidic devices showed higher %-recovery in fluorescence in a 60-second recording. Unpaired t-test, 
±SEM, P<0.05 significance threshold.  
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4.2.3 The peak excitability of a cell was affected by the cross-sectional cell 
area of the DRG neuron:  
 
Cell size is one of the earliest criteria used to differentiate the diverse populations of DRG 
neurons (Tandrup, 2004). Using electrophysiological recordings of whole cell DRGs, it has 
been demonstrated in vivo that the cross-sectional area of L4/L5 rat DRG neurons show 
normally-distributed populations of cells, with overlapping receptive fields (Lawson, Fang and 
Djouhri, 2019). As previously discussed in Chapter 1.6.2, the neurons of the DRG fibres have 
different roles in neuronal signalling, largely defined by the fibre size and threshold for 
activation. Larger diameter fibres, known as Aβ-fibres are involved in proprioception, whilst 
smaller diameter fibres (Aδ/C) with lower thresholds for mechanical and heat-sensitive 
stimulation are involved in nociception (Lawson, 2002). This functional dependence on cell 
size can be extrapolated to an in vitro model and used to determine what kind of stimulus 
might induce a response in the cells. However, one of the common problems with in vitro 
modelling is the limited capacity to recapitulate the myelination of whole nerve fibres 
observed in vivo (Thomson et al., 2008; Zuchero, 2014). In this experiment, we have used the 
observed cross-sectional area of the somata as an indication for the neuronal subtype. This 
measurement has previously been used in studies of the nociceptive function of selective DRG 
neurons via in situ hybridisation (Wang and Wessendorf, 2001; Xiuli et al., 2013) and whole 
DRG Ca2+ studies in L4/L5 ganglia of rats in vivo (Lawson, Fang and Djouhri, 2019).  
 
The results from figures 4.2.2 and 4.2.3 demonstrated that microfluidic culture was a useful 
and appropriate method of culture for in vitro investigation of neuronal excitability in an 
embryonic model of nociception. However, it was also important to ascertain what subset of 
DRG neurons was most likely prevalent in the embryonic culture, as well as eliminate the 
question of unintentional bias when selecting cells for analysis. Therefore, the results of 
axonal stimulations were used to statistically determine which subset of DRG fibres was most 
likely being stimulated in both embryonic and for comparison, in adult cultures of dissociated 
DRG neurons.  
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The cross-sectional area of 100 cells was compared to the peak excitability induced in each 
cell following axonal stimulation of the microfluidic device. Figure 4.2.4A (embryonic data 
only) shows the prevalence of each cell size dependent on the stimulus used.  This data 
represents the cross-sectional area at the nucleus in µM2 but the diameter of the cell body is 
estimated to be between 10-50 µM, as suggested by  (Lawson, Fang and Djouhri, 2019). No 
small cells were detected for either stimuli between 0-200µM2 or between 700-900µM2 if a 
culture was stimulated with KCL (25mM).  
The axonal stimulation of microfluidic devices with KCL was repeated with cells cultured from 
adult mice to compare the effects of tissue development on excitability. Figures 4.2.4B and 
4.2.4C show a comparison between embryonic and adult cell culture. When directly 
comparing embryonic to adult cultures, there was no statistical significance difference 
between amplitude of the peak excitability of each culture. The duration of the response was 
longer in embryonic cultures, where fluorescence did not return to baseline within 60-
seconds of recording, although neuronal excitability was stable at the end of the recording. 
The adult neurons also failed to return entirely to true baseline fluorescence, although there 
was a larger standard error of the data where embryonic cultures had not yet fully 
differentiated to express all subsets of receptors. In vitro studies have previously shown that 
electrical excitability of mouse DRG neurons evolves in waves. The emergence of mechano-
transductors emerged at E11.5 and nociceptive function emerging between E12.5 to E14.5 in 
gestation. However, the duration and amplitude of APs recorded did not resemble that of an 
adult population of neurons until P0-P1 (Stucky and Lewin, 1999; Lechner et al., 2009) 
 
Having determined that it was possible to perform the same Ca2+ experiment using 
dissociated adult DRGs in microfluidic devices, figure 4.2.4D shows the %-number of cells 
selected from each culture, dependent on the cross-sectional area of the cell. This figure 
showed that neither the adult nor the embryonic cultures showed the presence of small 
diameter DRGs with a cross-section of between 0-200μm2. Only the adult population 
appeared to have cells larger than 1000μm2, which have previously been suggested to be 
mechanosensitive or involved in proprioception in whole cell DRG Ca2+ imaging studies taken 
from adult rat tissue in vivo (Lawson, Fang and Djouhri, 2019). In fact, this figure 
demonstrated that 100% of the cells selected in the embryonic culture were less than 900μm2 
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in cross-section. It could be hypothesised that these most likely more closely resembled the 
in vivo development of Aδ or C-fibres involved in nociceptive signalling.  
 
There is significant evidence using this measurement as a proxy for fibre subtype from in situ 
hybridisation data in adult rodents (Holmes et al., 2000; Fang et al., 2006; Lawson, Fang and 
Djouhri, 2019). The evidence from in vitro culture is more limited. However, it has been 
demonstrated using dissociated E14.5 cultures of murine DRGs that the cross-sectional area 
of cells detected was normally distributed, with an average perikarayal area of 658 ± 7.9μM 
(Hall et al., 1997). The results here also showed a normal distribution in the cross sectional 
area of cells detected, although the average area was smaller, which could reflect the 
development of nociceptive neurons by E16.5 (Lechner et al., 2009). It is worth noting of 
course that dissociated cultures of DRG neurons in vitro may not directly replicate the 
morphology acquired in vivo.  
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Cross-Sectional cell area (µM2)
A) Cross-sectional area demonstrated development of multiple subtypes of sensory neurons in embryonic cultures. Embryonic cultures 
showed a higher proportion of neurons with a larger cross-sectional area.  
B) The peak amplitude of axonal stimulation was higher in embryonic culture (N=6) relative to adult DRG neurons (N=4.) The duration of the 
response in adult cells was shorter and returned rapidly to baseline, whereas stimulation of embryonic cultures only demonstrated partial 
recovery of excitability.  
C) The peak amplitude of evoked Ca2+ transients in embryonic cultures was not significantly different to the amplitude of adult culture 
(P=0.1.) Results of a one-way ANOVA with post-hoc Sidak’s test F(3, 16)=8.15. Significance threshold at (P<0.05). Error bars represent mean 
± SEM. Only the embryonic stimulation showed a significant increase in fluorescence following stimulation (P=0.001.) 
D) The culture of DRG neurons from adult mouse tissue demonstrated the development of larger diameter somata that were not present in 
the embryonic cultures.  
Figure 4.2.4: A comparison of cellular response to stimulation based on cell size and age of tissue: 
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4.3 Part B: Macrophage dependent changes in neuronal excitability and Ca2+ 
transients:  
Chapter 1.8 discussed the role of non-neuronal cells in the onset and development of 
neuronal hyperexcitability in pain. At the peripheral terminals of the nociceptors in vivo this 
includes, but is not limited to the influx of polarised macrophages in response to an 
inflammatory insult (Baral, Udit and Chiu, 2019). The release of cytokines and chemokines 
from polarised cells induces peripheral sensitisation via multiple mechanisms such as 
lowering the threshold for activation of receptors such as TRPV1 expressed on the terminals 
on the nociceptor (Pinho-Ribeiro, Verri and Chiu, 2016) (see Chapter 1.5-1.7.)  
The results shown in chapter 3 demonstrated the in vitro culture and polarisation of 
macrophages derived from bone marrow monocytes extracted from mice. The direct use of 
co-culture was complicated due to the extensive optimisation of culture conditions required 
for primary cells in vitro. Figure 7.1.2 showed that the extraction of media from polarised cells 
demonstrated quantifiable and unique signatures of inflammatory mediators released from 
different populations of inflammatory cells.  
A protocol was devised in order to be able to expose DRG axons to cytokines released from 
polarized macrophages, without the need for direct co-culture in the microfluidic devices. The 
schematic in figure 4.3 shows the timings of how macrophage cells and DRG cells were 
cultured in parallel. 
Figure 4.3: The optimised time-course of parallel culture for DRG neurons and macrophages in vitro. Once the DRGs reach 
DiV5, a stock of polarized macrophage media was extracted and used to stimulate the axons in Ca2+ imaging. 
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The effect of inflammatory cytokines on neuronal excitability was quantified following 
localised exposure of the axonal compartment to media extracted from polarized cells.  
 
4.3.1 Acute axonal addition of polarized macrophage media evoked changes 
in DRG neuronal excitability:  
 
A model was devised to investigate the effect of acute exposure to polarized macrophage 
media on DRG neuron excitability. Polarized media was generated using the protocol 
described in full in Chapter 2.2. All data shown here used phenol red free DMEM (NPR) to 
reduce cross-reaction fluorescence from excitation of Fluo-5 at 470nM.  
In the experiments described here “acute exposure” refers to neurons stimulated between 
DiV5-6, where the stimulus of interest was applied after a minimum of 10 second baseline 
recording, and images collected for a further 1-2 minutes. Tests are all comparable to the 
preliminary data recorded for “acute” exposure to KCL (25mM) and Capsaicin (200nM) 
described in part A (figures 4.2.2 and 4.2.3.)   
 
Acute stimulation with polarized macrophage media in the axonal compartment 
demonstrated significantly lower amplitude responses compared to a depolarising stimulus 
such as KCL. The time-course analyses in figure 4.3.2A below demonstrated that the addition 
of polarized media induced a negligible increase in fluorescence, with a 0.095∆F increase 
following M2-like media, and 0.077∆F max following M1-like media.   
(For reference, figure 4.3.2B includes the peak excitability following stimulation with KCL 









The increase in excitability from baseline was calculated for each stimulation. Figure 4.3.2B 
shows a comparison of the increase in fluorescence induced following stimulation with either 
M1-like or M2-like media. Using stimulation with KCL to compare the results for acute 
M1/M2-like stimulation, it was evident that the macrophage media induced little to no 
response at the axonal terminals of the DRGs in culture. Overall, and despite a very small 
transient increase, the acute addition of media extracted from polarized macrophages did not 
produce statistically significant changes in Ca2+ transients when applied to the axon.  
In vivo the cytokines released from inflammatory cells such as macrophages sensitize the 
axons of the DRG neurons over the course of hours, and therefore this model of ‘acute 
addition’ to the axons of the DRGs may not have induced results considered to be biologically 
meaningful in this setup. 














































A) Neuronal populations cultured in microfluidics were stimulated with polarized media.  The time-course analysis shows the change in 
excitability, recorded as change in fluorescence. Y-axis shown used the same scale as stimulation with KCL for direct comparison.  
B) The increase in excitability (as shown by dF max) was significantly reduced when cells were stimulated with M1-like media in particular 
(P=0.04). The data shown for M1/M2 like stimulation is plotted next to the results from figure 4.2.2 (stimulation with KCL) for direct 
comparison. One-way ANOVA with Dunnett’s multiple comparisons. ±SEM, P<0.05. F(3, 18)=1.319 
Figure 4.3.2: Addition of polarized macrophage media to the DRG axons demonstrated negligible changes in cell excitability 
relative to the stimulation with KCL  
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4.3.2 Acute stimulation with macrophage media induced changes in the 
amplitude of a subsequent stimulation with KCL :  
 
This model was also useful for determining if exposure to an inflammatory stimulus (such as 
media extracted from a polarized macrophage) would affect the amplitude of a subsequent 
response of the DRG neurons. In vivo, a phenomenon like this is referred to as “priming,” and 
is a key characteristic of peripheral sensitisation in nociceptive neurons (Fischer, Mak and 
McNaughton, 2014). A second acute stimulation of the axons with KCL was used here as a 
control for viable neuronal signalling.   
 
In this model, after 2 minutes exposure to macrophage media, the cells were re-stimulated 
with 25mM KCL to quantify what, if any, effect the cytokines secreted by polarized 
macrophages had on cell excitability and resting membrane potential. Only the first 50 
seconds following each stimulation have been shown, as by this point the fluorescence had 
returned to a baseline level of excitability.  
 
Figure 4.3.3A shows that the amplitudes of a primary stimulation to macrophage media and 
the secondary stimulation to KCL were not statistically significantly different. The primary 
stimulation of the cells with macrophage media reduced the concentration of unbound fluo-
5 in the cell, and therefore it was hypothesised that this might reduce the amplitude of a 
second stimulation such as KCL. However, given that the amplitude of the primary stimulation 
with macrophage media was so low, it was possible that the second stimulation with KCL 
would evoke a higher amplitude response (similar to that observed in figure 4.2.2.) Given that 
the amplitude of both the primary stimulation with macrophage media and the subsequent 
stimulation with KCL were negligible, it was possible that the macrophage media (or the 










Figure 4.3.3: The acute stimulation of the axons with inflammatory media induced no significant change  in cell excitability, but the 
subsequent axonal response to KCL was significantly reduced following a stimulation with inflammatory macrophage media: 
   A) There was no significant difference in cell excitability following  axonal stimulation with macrophage media and a 
downstream stimulation with KCL. One-way ANOVA showed no statistically significant difference between the dFmax 
following axonal stimulation with macrophage media versus subsequent axonal stimulation with KCL, F(3,18)=1.319, 
P=0.29. A post-hoc Sidak’s test for selected multiple comparisons also demonstrated no significance was observed 
comparing the peak excitability of M1-like and M2-like stimulations.  N=5 microfluidic chambers imaged for M1/KCL, N=6 
microfluidic chambers for M2/KCL. Error ± SEM, P<0.05 significance threshold.  
B) Stimulation of the axons with just imaging buffer showed a lower amplitude response than stimulation with inflammatory 
media.  A one-way ANOVA, with post-hoc Dunnett’s multiple comparison test (using buffer only exposure as the control 
comparison) determined that the amplitude of response to M1/M2 media (N=5/6) was not significantly greater than just 
buffer alone (N=3.) All data was deemed to be normally distributed.  M1-like data is plotted at N=5, where one biological 
replicate was removed by the Grubb’s outlier test. Bars represent mean ± SEM, where P<0.05 was deemed significant. F 






















The results of these experiments can be interpreted in multiple ways:  
1) Evoked Ca2+ transients in DRGs were lower in response to inflammatory media than 
by stimulation with KCL. The acute exposure to macrophage media potentially 
reduced the excitability of the cells. 
2) One potential limitation of only leaving 2-minutes between stimulations was that the 
Ca2+ stores in the cell may not have replenished by the second stimulation. Acute 
stimulation of axons with inflammatory macrophage media partially depleted the 
available stores of fluo-5 in the soma. Therefore, the reduced secondary response to 
KCL stimulation was likely partially because of reduced starting concentration of fluo-
5 in the cell.  
3) Given that the low amplitude of the response observed was similar over multiple cell 
preparations it was unlikely that the results observed were an artefact of low cell 
viability. Figure 4.3.3B also included a comparison with N=3 stimulations using just 
imaging buffer. The amplitude of these responses were lower than the responses to 
inflammatory media. Although not significant, this suggested that the response to 
acute stimulation with macrophage media was a ‘real’ response, and not the artefact 
of mechanical stimulation of the axons. 
4) The results in figures 4.3.2 and 4.3.3 showed a significant change in the amplitude of 
the response to KCL, if the axons were stimulated first with macrophage media. It 
could be hypothesised that the macrophage media (and cytokines within) had an 
inhibitory effect on the neuronal response to stimulation with KCL. Stimulation with 
KCL prior to the macrophage stimulation would help to confirm points 3 and 4.  
 
To confirm whether the contents of polarized media could affect neuronal excitability 
without reducing viability, the next step was to culture the axons in polarized media 






4.3.3 Prolonged exposure of the axon terminals to polarised macrophage 
media induced quantifiable changes in neuronal excitability  
 
As a model derived for the purpose of investigating the effects of inflammatory mediators on 
peripheral nociceptors, a timeline was devised to mimic “long-term” exposure of the DRG 
terminals to sensitising agents. A protocol was devised to quantify the effects of longer-term 
effects of axonal exposure to inflammatory cytokines on neuronal excitability. 
 
The diagram shown here represents a simplified version of the timeline used for these in vitro 
“priming” experiments.  
Once the axons covered the axonal compartment of the chamber (usually DiV5-6) the axons 
were exposed to polarized macrophage media for a period of 8 hours prior to stimulation 
with KCL (25mM) over a period of two minutes. It has previously been shown that 
intraganglionic injection with 8-bromo cAMP (transcription factor activator) induced 
hyperalgesic priming by a minimum of 6-12 hours. Although if injected to the hindpaw (i.e at 
the terminals) then 72-hours was required to observe a change in cell excitability (Araldi, 





Following an 8-hour incubation of the axonal compartment in polarized macrophage media, 
an increase in fluorescence was still observed when axons were stimulated with KCL (figure 
4.3.4A.) The change in fluorescence following stimulation was used again as an indirect 
DRG DiV5 






Figure 4.3.3.1: A schematic showing the setup for prolonged exposure of the axonal compartment to polarized macrophage 
media prior to stimulation of the axons with KCL.  
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measure of the change in cell excitability. The amplitude of the response for cells exposed to 
M1-like media was higher than if the axons were exposed to M2-like media for 8-hours. 
However, the amplitude of the responses in figure 4.3.4A were much lower than stimulation 
of naïve microfluidic cultures with KCL (as shown in figure 4.2.2, ΔF=0.65.)  
 
The comparison of the peak excitability induced by Ca2+ transients in the soma, did not show 
a significant difference between prolonged incubation of axons in M1-like media or M2-like 
media prior to stimulation with KCL (figure 4.3.4B.)  
 
In figure 4.3.4C the maximum change in fluorescence (as a proxy for cell excitability) for each 
condition has been directly compared to the result observed for cells cultured in DRG media 
and stimulated acutely with KCL. The amplitude of the response to stimulation with KCL was 
consistently lowered when axons were exposed to inflammatory media for 8-hours. Although 
incubation in both subtypes of inflammatory media demonstrated a reduction in cell 
excitability relative to stimulation of naïve microfluidic cultures with KCL, the viability of axons 
was not reduced. (i.e. Upon visual inspection, alongside the continual uptake of Fluo-5, it was 
determined that the prolonged exposure of the cells for 8-hours was not detrimental to cell 
viability.) It could be hypothesised that the terminals of the peripheral nociceptors had been 
‘desensitised’ by prolonged exposure to inflammatory media (and the cytokines within,) and 
were less excitable.  
 
In conclusion, it was determined that culture of the axonal compartment in macrophage 
media, prior to stimulation, was not detrimental to cell viability. The prolonged exposure for 
8-hours in culture appeared to reduce the evoked Ca2+ transients recorded following axonal 
stimulation with KCL. This data supported the results seen in figure 4.3.3 and suggested that 
exposure to macrophage media induced a reduction in axonal excitability. Figure 4.3.4D has 
been added to show a direct comparison of the results shown in figure 4.3.4C and figure 
4.3.3A. The stimulation of axons exposed to M1-like media for 8-hours with KCL was 
significantly different to those cells acutely stimulated with both M1-like media followed by 
KCL. However, there was no significant difference in the evoked Ca2+ transients recorded 
following prolonged exposure to M2-like media relative to acute stimulation with M2-like 
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media (and KCL.) These results indicated that there was potential for this model to be further 
developed, where the time-period for incubation with polarized media could be optimised.  
 155 
 
A) A time course analysis showing the effect of axonal stimulation with KCl (25mM) following 8-hours incubation of the axonal 
compartment in either M1-like or M2-like media. The amplitudes of responses was not significantly different between 
treatments.  
B). Exposure to inflammatory media exerted a reduction in excitability. However, the increase from baseline fluorescence in 
both conditions was deemed to be significant. Results of a one-way ANOVA withpost-hoc  Sidak’s multiple comparisons test, 
where P<0.05 was significant. Error ± SEM. F(5, 28)= 9.699 
Legend continued overleaf. 
 
Figure 4.3.4: Prolonged exposure of the axonal compartment to polarized macrophage media exerted a significant reduction in 
neuronal excitability compared to stimulation of naïve cultures with KCL.  




































































































4.4 Discussion and chapter conclusions: 
In recent years the use of compartmentalised microfluidic devices (such as those developed 
by Xona) has proved an invaluable tool in the study of primary cell cultures, including neuronal 
and glial cell populations ((Taylor et al., 2005; Park et al., 2006; Dajas-Bailador et al., 2012)). 
The fluidic isolation of the soma from the axons has led to in-depth study of 
compartmentalised changes in biochemistry of the cell (Taylor et al., 2005; Dinh et al., 2013; 
Neto et al., 2016; Garcez, Guillemot and Dajas-Bailador, 2017). Furthermore, microfluidics 
provide a flexible cell-culture platform to quantify changes in cellular excitability using live-
cell imaging formats, as well as downstream quantification of changes in biomarker 
expression arising from localised addition of a treatment.  
 
Unlike cortical neurons of the central nervous system the DRGs show limited spontaneous 
activity in normal physiological conditions.  (Esposito, et al., 2019 ). However, following nerve 
injury or exposure to an inflammatory stimuli (e.g. polarized macrophage media,) the DRGs 
may become hyperexcitable, since they are involved in maintaining chronic pain states (Weng 
et al., 2012). In line with the objectives for this chapter, I have shown here how the 
compartmentalised microfluidic nature of the 2-channel device has the potential to model 
changes in excitability of DRG neurons. In order to do this, live-cell imaging was used to 
quantify changes in cytosolic Ca2+ transients in the somal compartment of a device, following 
localised stimulation at the axonal compartment.  
 
C) The maximum fluorescence demonstrated no significant difference between M1-like and M2-like exposure prior to KCL 
stimulation. However, both treatments demonstrated a significant reduction in excitability relative to a negative control. One-
way ANOVA with Dunnett’s multiple comparison’s test, ±SEM, P<0.05 significance threshold. F(3, 21)=6.45 
D) Directly comparing the evoked Ca2+ transients recorded following acute stimulation with M-like media and KCL versus 
prolonged axonal incubation in macrophage media followed by stimulation with KCL. Only the prolonged incubation with M1-
like media induced a significant difference in cell excitability compared to relevant acute stimulations.  Results of a one-way 




This model demonstrated the rapid and dynamic response of the pseudo-unipolar DRGs when 
stimulated at the peripheral terminals. To ensure reproducibility of results, each chamber was 
only imaged once, and replicate data was taken from separate embryo dissections.   
One of the advantages of compartmentalised microfluidic modelling is the flexible nature and 
capacity for development of reproducible and adaptable protocols. Multiple stimuli (such as 
KCL and Capsaicin) were used to induce quantifiable changes in neuronal excitability, as well 
as the use of polarized macrophage media as a more biologically relevant stimulus for 
modelling changes in excitability. Not only was there a significant difference in evoked Ca2+ 
transients dependent on the stimuli used, but there was a reduced amplitude of response in 
cells stimulated selectively in the axonal compartment of a microfluidic device (compared to 
a standard dissociated culture.)  
In microfluidic devices, the evoked change in fluorescence quickly returned to a stable 
baseline, usually within 30 seconds of the stimulus being added. In these cultures, the action 
potential arriving at the soma had triggered the release of Ca2+ from intracellular stores such 
as the endoplasmic reticulum or via activation of voltage-gated Ca2+ channels. Consequently, 
the response was rapid, but short lived where the source of free calcium diffusing through 
the cell was sequestered rapidly. However, in dissociated plate culture the addition of a 
stimulus such as KCL or Capsaicin (a potent TRPV1 agonist) also opened voltage-gated ion 
channels on the soma, and induced further influx of Ca2+ ions into the cell. In these cultures, 
the fluorescence had not returned to true baseline by 60-seconds. Fluorescence was no 
longer increasing, but had not returned to the original baseline fluorescence observed prior 
to stimulation. The additional direct stimulation of the soma in dissociated plate cultures 
induced a larger amplitude and duration of response, where more cytosolic Ca2+ was available 
to interact with fluo-5 at the time of recording.   
 
Chapter 1.7.1.1 introduced the TRPV1 channel, for which Capsaicin is a potent agonist. The 
TRPV1 channel is Ca2+ permeable (Samways et al., 2016) and therefore evoked larger Ca2+ 
transients in the somal compartment, where propagation of the action potential was not 
always necessary. The somal compartment of the microfluidic device is also comprised of an 
axonal network connecting the soma, so it is likely that some of the response recorded was 
dependent on activation of TRPV1 receptors on the axons. However, the distance required 
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for the action potential to be propagated to the soma was clearly much less if the axons in 
the somal compartment were stimulated.  
Alternatively, activation of the TRPV1 channels located directly on the DRG soma induced a 
rapid influx of Ca2+, which was recorded by the increase in fluorescence following stimulation. 
TRPV1 receptors are only localised to selective fibres of the DRG, and although it has been 
demonstrated they are expressed throughout the sensory fibres (Andresen, 2019) the results 
shown here suggested  a more dense expression of TRPV1 receptors in the somal 
compartment (most likely on the soma,) from cells extracted at E16.5.  
 
The peak amplitude of response to capsaicin was also consistently lower than that of KCL in 
neuronal cultures from E16.5 tissue. This could be attributed to a higher prevalence of 
potassium sensitive ion channels expressed axonally and on the soma. Of particular relevance 
is the potential for selective protein expression at this early stage of development. These 
results suggested that stimulation of the axon by TRPV1 agonism was less effective at 
depolarising the membrane of the neuronal terminals (and subsequently generating an action 
potential) than the addition of a positive charge such as KCL to the extracellular space.  
  
It was concluded that not only are the microfluidic devices a useful tool for isolating the axonal 
and somal responses to a stimulus, but that the response of a cell in vitro is also dependent 
on age related functionality acquired in vivo (Lechner et al., 2009). The evidence for in vitro 
cultures of dissociated embryonic DRG cells is limited, but recent work has suggested that by 
E18.5 in development, a deficiency in Ret protein (tyrosine kinase) demonstrated a shift 
towards a cell distribution of smaller cells only, with limited development of 
mechanoreceptive DRG neurons (Honma et al., 2010). There is more supporting literature for 
a similar protocol performed from whole cell DRGs extracted from adult rodents. Chronic 
constriction models of injury conducted in adult mice identified three ‘ranges’ in somal cell 
area (Ruscheweyh et al., 2007). Small DRGs (<300 μm2) medium-sized cells (300–700 μm2) 
and large cells (defined as >700 μm2). However, what this study did not discern, was how the 
subtypes of A- and C-fibres can be subcategorised within these sizes.  
The results of the in vitro model shown here suggested a high percentage of small to medium 
size DRG neurons dissociated in culture, which would suggest the presence of cells with a 
similar function to C and Aδ nociceptive fibres. In vitro differences in cell body size did not 
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appear to be directly correlated with neuronal type. All dissociated neurons had the capacity 
to be depolarised by the addition of KCL at the neuronal terminals, but there was also a 
significant overlap in the responses of small diameter to cells to also be depolarised to 
selective stimuli such as Capsaicin.  
These results were particularly important in later experiments when identifying a protein 
target of interest downstream of a microRNA that was locally expressed in the axons or 
terminals of the DRG neurons.  
 
As well as utilising the microfluidic model to show differences in the evoked responses 
recorded between KCL and Capsaicin, we attempted to model peripheral sensitisation of the 
nociceptors. There is extensive research on the bi-directional signalling processes between 
inflammatory cells such as macrophages and sensory neuron fibres of the DRGs (R. R. Ji, 
Chamessian and Zhang, 2016). A common limitation of standard in vitro modelling is the 
limited capacity of most models to selectively record changes in excitability arising from direct 
axonal stimulation. This microfluidic model was also used to demonstrate how cytokines 
released by infiltrating polarized macrophages can induce rapid changes to DRG neuron 
excitability, with particular relevance to nociceptive function. Although it could be argued 
that further work would be required on development of the inflammatory stimuli used, the 
model shown was useful for inferring the link between addition of an inflammatory cytokine 
to the tissue and correlating downstream changes in excitability of the neurons.  
Whilst immune cells release cytokines and growth factors that act at the peripheral nerve 
terminals, the nociceptors in-turn release neuropeptides from the terminals to modulate this 
immune response (Baral, Udit and Chiu, 2019). However, it is not only polarized macrophages 
that release inflammatory mediators to modulate nociceptor activity. Where macrophages 
have been characterised in the release of cytokines such as TNFα,	IL-6 and	IL-1β, there are 
other inflammatory cell types involved in the regulation of nociceptive function. These include 
mast cells, neutrophil cells, TH-17 cells (Pinho-Ribeiro, Verri and Chiu, 2016) as well as cell 
shuttling from the satellite glial cells surrounding the nociceptor fibre.  Taken as a whole, it 
would therefore be very difficult to replicate the complexity of this bi-directional signalling in 
vitro using only two cell subtypes.  
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The resultant sensitisation of the peripheral nerve fibres that arises from release of cytokines 
from circulating inflammatory cells is implicated in several neuropathies and pain pathways 
(Coutaux et al., 2005; Burnstock et al., 2009; Reichling and Levine, 2009). In physiological 
conditions there are multiple mechanisms by which the nociceptors become sensitised, since 
many types of immune receptors are found on the terminals of the DRGs in close contact with 
inflammatory cells (Thacker et al., 2007). These include (but are not limited to) cytokine and 
chemokine receptors such as those found to be upregulated in the media of polarized 
macrophages. For example, following chronic constriction injury to the sciatic nerve, the 
concentration of both TNFα and IL-1β have been shown to increase 10-fold up to 1-hour after 
injury (Ueceyler, Tscharke and Sommer, 2007; Sacerdote et al., 2008). Both of these cytokines 
are pro-inflammatory and produced in high concentrations by M1-like macrophages (Lu et 
al., 2018). Furthermore, the release of these cytokines induces the cascade of further 
inflammatory cytokine production such as IL-6, and the increased activation of inflammatory 
signalling cascades.  
The mechanisms by which pro-inflammatory mediators modulate DRG neuronal excitability 
is also dependent on the nature of the inflammagen (Scholz and Woolf, 2007; Sandkühler, 
2009; von Hehn, Baron and Woolf, 2012). For example, TNFα is released from M1-like cells 
and has been shown to be important in the maintenance of neuropathic pain via sensitisation 
of the NaV channels (Jin and Gereau IV, 2006). Both TNF and the TNF-receptors have been 
shown to be upregulated post-injury in rodent models of pain (Schäfers et al., 2003). In vivo 
modelling has shown that following upregulation, TNF targets voltage-gated sodium 
channels, specifically the TTX-resistant NaV channels found on nociceptor terminals (Chen et 
al., 2011b; Leo et al., 2015). The direct application of TNFα to DRG neurons in culture has also 
been shown to transiently sensitize nociceptive firing in hairy skin isolated from the rat 
hindpaw (Bretag, 1969; Oprée and Kress, 2000) correlating with an induced upregulation in 
TRPV1 expression in dissociated ganglia from adult mice (Jin and Gereau IV, 2006). The 
increased activity of rat nociceptors to noxious heat was short lived, and none of the pro-
inflammatory cytokines tested (IL-6, IL-1B and TNFα) evoked a release of CGRP from larger 
diameter nociceptors at an innocuous temperature. In a similar mechanism to IL-1B, TNF 
phosphorylates NaV1.8 to facilitate channel opening (Jin and Gereau IV, 2006). This increase 
in activity of the sodium channels induces a neuropathic pain state by making nociceptors 
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hyperexcitable. However, there is also evidence that some cytokines target nociceptors 
indirectly, via glial cell shuttling.  
 
There is also evidence that pleiotropic anti-inflammatory cytokines have roles in 
neuroprotection and the resolution of neuro-inflammation (Amici, Dong and Guerau-de-
Arellano, 2017). One important example is the role of IL-4 (and M2-like macrophages) in 
ameliorating pain induced by increased circulation of pro-inflammatory cytokines. The 
application of IL-4 to nerve terminals in a mouse model of nerve injury, induced upregulation 
of anti-inflammatory macrophages (Brundu S, 2015). These M2-like cells synthesise opioid 
peptides (Met-enkephalin and β-endorphin) and induce reduction in nerve hypersensitivity 
downstream of the acute treatment with IL-4 (Celik et al., 2020). Other important examples 
include IL-10, a key cytokine involved in endogenous resolution of pain and released in high 
quantities from M2-like cells. It has been shown that intrathecal administration of cytokines 
like IL-10 can reduce neuropathic pain (Milligan et al., 2006) whilst injection of IL-10 
neutralising antibodies has been shown to prolong transient inflammatory pain in mice 
(Krukowski et al., 2016).  
Localised application of cytokine-rich macrophage media to axons of the DRG neurons was 
used to induce changes in excitability. Although circulating levels of cytokines in vivo are 
dynamic (Pettersen et al., 2011) it has also been demonstrated that endogenous M2-like 
macrophages will re-polarize to an MØ regulatory phenotype after around 6 days (Tarique et 
al., 2015). One of the advantages of polarized media was that the cytokines released by the 
cells would not deplete over time. In addition, the protocol used was optimised to ensure that 
the stimuli used to trigger the changes in the phenotypes of the cells were no longer 
circulating in the media, and wouldn’t produce a depolarization of the axon terminals. 
Neither acute stimulation nor prolonged exposure to polarized macrophage media increased 
the excitability of the DRG neurons in microfluidic culture. However, the use of the polarized 
media in the microfluidic device produced a significant reduction in neuronal excitability, 
compared with the evoked Ca2+ transients recorded following stimulation with KCL only. Of 
particular interest, the amplitude of the response to KCL following prolonged exposure to 
macrophage media was lower, and could potentially suggest that this subset of polarized 
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media desensitised the neuronal terminals to stimulation. These preliminary results with 
inflammatory media showed limited differences between the peak excitability induced 
following incubation of axons in proinflammatory media versus anti-inflammatory media. 
However, exposure to inflammatory media was not deemed to reduce viability of cells. There 
is evidence to suggest that there is temporal secretion of cytokines from macrophages, 
dependent on the state of polarization (Melton et al., 2015). It could be suggested that for 
the application of prolonged exposure to inflammatory media the set up would require either 
a) automated perfusion of media over extended periods of time, or b) live-cell imaging in a 
controlled atmosphere, regulating parameters such as CO2 and temperature.  In this way, 
images could be taken for hours without observing loss in neuronal viability. Since fluorescent 
dyes such as Fluo-5 cannot be followed for hours without photobleaching, development of 
this model in this way would require the use of transiently expressed Ca2+ sensitive molecules.  
 
The following conclusions were drawn from this Chapter: 
• Two-channel compartmentalised devices were very effective at modelling functional 
changes in neuronal excitability.  
• The peak amplitude of response to capsaicin was also consistently lower than that of 
KCL in neuronal cultures from E16.5 tissue 
• In order to model hyperalgesic priming the stimulus used would require further 
optimisation, however we were clearly able to show that exposure of the axons to a 
cytokine rich media acutely changed the excitability of the DRG neurons. 
• Significant differences in the evoked Ca2+ transients were also observed dependent on 
whether a stimulus was applied to the axon or directly to the soma. This unique 
feature of the compartmentalised devices helped to demonstrate that protein 
expression is not equally distributed throughout the terminals, axons and soma of the 




5 miR-138-5p regulates DRG excitability  
 
5.1 Introduction: 
MicroRNAs (miRNA) are small, non-coding sequences between 21-25 nucleotides that are 
involved in processed such as mRNA degradation, or more commonly in neurons repression 
of translation by targeting mRNA. Since their discovery in C.elegans in 1993 (Lee, Feinbaum 
and Ambros, 1993; Wightman, Ha and Ruvkun, 1993) over 2500 conserved miRNA sequences 
have been identified for humans (Kozomara and Griffiths-Jones, 2014). The role of microRNAs 
as regulators of translation in the nervous system has been discussed in Chapter 1.8.1. In this 
model we used the microfluidic nature of the devices to investigate the role of these small 
non-coding RNAs in local translation in the axon, and regulation of neuronal excitability in the 
context of those observed in nociceptive signalling.  
The role of neuronal plasticity in regulation of cell excitability has been more extensively 
studied in recent years. It has been demonstrated that local translation of mRNA in the axon 
is an important process for efficient regulation of neuronal plasticity. One such example of 
pathways known to be of importance, are the mTOR-dependent (mammalian target of 
Rapamycin) pathways, where mTOR-dependent local translation of mRNA has been shown to 
regulate excitability in a subpopulation of nociceptive neurons in vivo (Piper and Holt, 2004). 
Immunohistochemical staining showed that the mTOR machinery was present in subsets of 
primary afferent fibers, although most likely the A-fibres since phospho-mTOR labelling did 
not extend to the epidermal layer where the C-fibre terminals are located (Jiménez-Díaz et 
al., 2008).  Subcutaneous injection of rapamycin into the hindpaw of rats also significantly 
increased the threshold temperature for paw-withdrawal evoked by A-fibres. In contrast, 
rapamycin did not appear to affect the C-fibre dependent activity.  Furthermore, the injection 
of anisomycin (a global protein synthesis inhibitor) also reduced thermal sensitivity after fast-
heat ramps targeting A-fibre nociceptors (Jiménez-Díaz et al., 2008). Behavioural assessment 
using Von Frey filaments also showed that pre-treatment with Rapamycin significantly 
attenuated secondary mechanical hyperalgesia (Obara, Géranton and Hunt, 2012). These 
results showed that the local administration of rapamycin potentially affected the excitability 
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of subpopulations of sensory neurons, via inhibition of mTOR mediated local mRNA 
translation.  This mTOR dependent local translation is just one example of how and why local 
translation in the neuron is important and essential for regulating neuronal excitability.  
 
5.1.1 microRNA and pain: 
With roles in translational repression, microRNAs (miRs) have also been identified as useful 
biomarkers for disease pathologies such as chronic pain, and are an important area of interest 
in upcoming clinical trials. The pleiotropic nature of this class of non-coding RNAs makes them 
particularly useful for treatment of multifactorial origins. Therefore, as well as interest in 
understanding their physiological role, much of the research surrounding miRNA investigates 
their potential role as therapeutic targets (van Rooij and Kauppinen, 2014). The first evidence 
for the role of miRs in mechanisms of pain were shown by screening miR expression in 
different in vivo models of chronic pain (Andersen, Duroux and Gazerani, 2014). For example, 
CFA injection into the hindpaw of adult rats showed downregulation of 10-selective microRNA 
by RT-qPCR (Bai et al., 2007). This downregulation of mature microRNA correlated with the 
development of allodynia, and supported the evidence that miRs are involved in regulation 
of an appropriate response to an inflammatory stimulus. 
 
In work by Zhao et al., (2010) it was proven that reduced production of miRs in the sensory 
DRG neurons resulted in inflammatory pain attenuation (Zhao, M.-C. Lee, et al., 2010). This 
model used deletion of the Dicer gene in nociceptive neurons of the DRG that express NaV1.8 
to reduce production of miRs in these neurons. The NaV1.8+ neurons are small fibre, and 
known to have a role in detection of inflammatory pain-based signalling (Hameed, 2019). 
Whilst the behavioural response to painful stimuli was normal in Dicer knockout mice (apart 
from a deficit in cold-sensitivity) the response to inflammatory stimuli was dramatically 
different. The absence of Dicer correlated with lowered levels of expression of several 
proteins such as P2X3, NaV1.8 and NaV1.9, all of which have important roles in inflammatory 
pain signalling (Abrahamsen et al., 2008). Dicer-null mice did not show changes in threshold 
for activation in response to carrageenan or CFA, and at a cellular level no increased 
excitability was recorded in response to inflammatory stimuli such as bradykinin or PGE2 
(Zhao, M. C. Lee, et al., 2010). 
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The overwhelming evidence from models of chronic pain have undoubtedly highlighted the 
importance of miRs in regulation of pain responses. It is clear that knockout of mature 
microRNA leads to downregulation of proteins of interest, and subsequently the response of 
the DRGs to a painful stimulus is inappropriately modulated. In the transition from acute to 
chronic pain, it is evident that there is upregulation of proteins at the terminals of the 
nociceptors. Ferrari et al., (2013) tested the hypothesis that transient inhibition of translation 
in the peripheral terminals of the nociceptors could reverse hyperalgesic priming. The 
injection of translation inhibitors (e.g. cordycepin) to the peripheral terminals of the neurons 
in adult male rats showed reversal of hyperalgesic priming (Ferrari et al., 2013). The 
downregulation of mRNA translation corresponded with a reduced decrease in mechanical 
paw withdrawal threshold upon exposure to PGE2. Critically, the reversal of priming was 
shown to outlast the duration of the action of the translation inhibitors (Cordycepin and 
Rapamycin) used to prevent development of priming.  
At a cellular level it has been demonstrated that miRNAs modulate pain via post-
transcriptional regulation of proteins involved in nociception (Bartel, 2009). Therefore, 
combined with the evidence from Ferrari et al., (2013) that inhibition of local translation in 
the axon can reverse hyperalgesic priming, of particular interest to this project was the role 
of miRs in regulating local translation of proteins in the axon. 
 
 
5.1.2 miR-138-5p and pain: 
Figure 5.1.1: An overview of a hyperalgesic priming model in vivo, as used previously by members of the Dajas-
Bailador laboratory.  
 166 
Hyperalgesic priming experiments in the Hathway and Dajas-Bailador labs have previously 
demonstrated that out of 726 miRNA tested, only 4% (32 miRNA) showed an increase 
following hyperalgesic priming, including miR-138-5p. Data from the thesis of Clare Martin 
(submitted to the University of Nottingham for a doctorate of philosophy in 2018) showed 
the results of a preliminary microarray using tissue from the hyperalgesic priming model 
described above. L4, L5 and L6 DRGs (with nerve roots intact) were collected from primed 
and unprimed tissue 7-days post PGE2 treatment. Levels of microRNA were quantified by 
microRNA microarray using TORAY 3D gene (see figure 5.1.2.)  
All in vivo work was completed in Wistar rats using the paw withdrawal threshold as a 
measure of hyperalgesia. Of those microRNAs that were shown to be upregulated at day-14 
of the hyperalgesic priming model, miR-138-5p demonstrated a 2.4 log2fold change. As 
shown in Chapter 1.5.3 by day 14, the paw withdrawal threshold of primed animals remains 
low following removal of the inflammatory stimulus. In these animals the DRG neurons had 
become more excitable even in the absence of the inflammatory modulator. In line with 
published data demonstrating a role for miR-138-5p in neuropathic pain and peripheral nerve 
injury (Liu et al., 2013; Zhou et al., 2016), the results of this microarray pointed towards miR-
138-5p being a relevant candidate for further study of peripheral mechanisms regulating 




Figure 5.1.2: The results of a preliminary microarray showing upregulation of miR-138-5p in tissue extracted from adult rat 
primed tissue in the chronic phase of hyperalgesia (Clare Martin, 2016). Saline control N=1, Carrageenan primed tissue 
N=2.  
For example, miR-138 upregulation can be induced by exposure to proinflammatory 
cytokines, such as those which are released upon tissue damage to stimulate polarization of 
macrophages in the neuropathic pain response including LPS (Zhou et al., 2016).  
 
5.2 Materials: 
Cell culture consumables including media and culture dishes were obtained from 
ThermoFisher Ltd (UK) and Sigma, as listed in Chapter 2.  All microfluidic devices used in this 
study obtained from Xona Microfluidics were 2-channel chambers (SND150) with a 
microgroove length of 150µM. Full details of the methods used here have been described in 
Chapter 2.  
In order to investigate microRNAs functional mechanism, and specifically miR-138-5p with 
regards to regulation of neuronal excitability, I used commercially available miRNA mimics 
and inhibitors (miRCURY LNA miRNA Mimics and Inhibitors, Qiagen), a tool widely used in the 
field and in our laboratory (Dajas-Bailador et al., 2012; Lucci et al., 2020) 
 


























































































































































































































































































































































































Locked nucleic acid (LNA) technology incorporates high affinity RNA analogs where the ribose 
ring is “locked,” with an extra bridge connecting the 2’oxygen and 4’ carbon. This rigid binding 
forms the ideal conformation for Watson-Crick base pairing, and increases the thermal 
stability of the LNA oligonucleotide when hybridized to complimentary RNA or DNA (Stein et 
al., 2009). This increased melting temperature (Tm) is especially important when 
oligonucleotides are used to detect short sequences, or those with increased GC% such as 
microRNAs.  
 
5.2.1.1 MicroRNA mimics: 
miRNA mimics are designed to simulate the endogenous activity of a miRNA upon addition to 
a cell culture, by increasing the proportion of the RISC (RNA-induced silencing complex) 
containing the guide strand miRNA. The unique design of Qiagen LNA oligonucleotides are 
characterised by three RNA-LNA strands, rather than the traditional two. This includes an 
unmodified RNA strand with a complimentary sequence to miRNA of interest, and two LNA-
enhanced passenger strands. Since the passenger strand is divided into two, this helps to 
ensure that only the miRNA guide strand is loaded onto the RISC (Bramsen et al., 2007). This 
chapter describes the use of a dual-luciferase reporter assay, where a miR-138-5p mimic was 
transfected into HEK cells with a target of interest (see chapter 2.4.4.2.1.)  
 
5.2.1.2 MicroRNA ‘power’ inhibitors: 
miRNA silencing was induced using a miRNA power inhibitor for miR-138-5p. The miRNA 
inhibitor is an antisense oligonucleotide with a complimentary sequence to the mature 
sequence of miR-138-5p. Therefore, upon introduction into the cell the miRNA of interest is 
sequestered by the inhibitor, blocking normal translational repression by miR-138-5p. I have 
described the use of a cell-permeable miRNA inhibitors that 
carry phosphorothioate modifications on the LNA backbone. This improves stability in 
culture and enables transfection-free incorporation into the cell, which is useful for working 
with cells such as DRG neurons (Griffiths-Jones, 2004). Increased stability of the power 
inhibitor means it can be added directly to the culture media and up-taken by the cell via 
gymnosis (Soifer et al., 2012). The efficiency of inhibition is dependent here on several factors 
including cell density, length of incubation period and the concentration of inhibitor added.  
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Both the miRNA power inhibitor control and the miRCURY miR-138-5p LNA miRNA Power 
inhibitor were obtained from Qiagen. 
 
5.2.1.3 Small interfering RNA (siRNA):  
Also known as silencing RNA, siRNAs are short double-stranded RNA sequences that function 
as RNA interference molecules upon binding to complimentary target transcripts. In many 
ways, siRNA and miRNAs are similar. Both molecules decrease protein translation by binding 
to the RISC complex, however, the downstream mechanism of siRNA is different to that of 
miRNA. Unlike miRNA which can cause translation repression and degradation of multiple 
proteins via selective binding of the seed sequence, siRNA only targets a single sequence in 
mRNA. The RISC proteins unwind the double stranded siRNA molecule, whereupon the 
antisense siRNA strand binds to the select sequence on mRNA. Slicer protein subsequently 



















5.3 Part A: Investigation of miR-138-5p in modulating the excitability of small 
fibre DRG neurons 
 
This chapter investigates the functional role of miR-138-5p in the control and regulation of 
neuronal cell excitability. Using established techniques such as qPCR, the relative expression 
of miR-138 was quantified, with regards to the state of inflammation that the 
microenvironment of the axon was exposed to. However, regulatory control of microRNAs in 
the cell is dynamic, much like the processes surrounding inflammation in the cell. Whilst 
miRNA expression has been investigated in neuronal function, and implicated in processes 
such as pain, the involvement of miRNA in the development and resolution of inflammation 
has not yet been fully elucidated.   
Previous works from the Dajas-Bailador and Hathway labs showed upregulation of miR-138-
5p in a model of hyperalgesic priming. Based on these results it was hypothesised that 
expression of miR-138-5p would change following exposure to inflammatory mediators such 
as pro-inflammatory cytokines and chemokines. To investigate this, the axon terminals of DRG 
neurons were once again exposed to inflammatory media extracted from polarised 
macrophage media.  
 
5.3.1 Part A objectives: 
• Investigate localised changes in miR-138-5p in the modulation of DRG neurons 
cultured in microfluidic devices  
• Study the effect of inflammatory signals on miR-138-5p regulation of axonal 
propagation of action potentials DRG  
 
5.3.2 Exposure of axons to inflammatory media demonstrated upregulation 
of miR-138-5p in the soma: 
 
In this experiment DRG neurons were cultured on culture inserts (known as Twiss chambers, 
see figure 5.3.1) for up to 7 days in vitro. Unlike Xona microfluidic devices, these inserts do 
not provide complete fluidic isolation of the different compartments.  
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The diagram in figure 5.3.1 shows a schematic of how cells were cultured using these Twiss 
chambers. For experiments involving RNA extraction and qPCR, the Twiss inserts were utilised 
to increase the potential concentration of RNA isolated from each culture. If required for PCR 
between 20-30 DRGs were dissociated per chamber. Cells were dissociated and seeded into 
the upper compartment of the insert. On top of the mesh insert, a network of axons (and 
soma) develop, whilst axons would also pass through the pores in the insert and form an 
“axonal-rich” layer underneath the mesh. A much higher number of DRGs were dissociated 
per insert, especially when attempting to isolate RNA from the ‘axonal compartment.’ At 
DiV5-6 the DRG neurons showed >80% coverage of the mesh insert. From here, the insert 
was removed, and cells were extracted via gentle scraping and washing with TriZol (See 
Chapter 2.5 for complete methods.)  
 
The Twiss model was designed to replicate the layout of the Xona microfluidics used in the 
Calcium assay, and mirror what might be observed in vivo where the axonal terminals of DRG 
neurons become exposed to a cocktail of inflammatory mediators upon priming by a 
nociceptive stimulus.  
At DiV7, the media on the underneath of the insert (representative of the axonal 
compartment) was changed for 24 hours prior to RNA extraction. In order to quantify the 
effect of inflammation on miR-138-5p expression in the DRGs, the media in the axonal 
compartment was substituted for media extracted from polarized macrophages (see Chapter 









DRG Soma  
(+connective axons) 
DRG Axons  
Figure 5.3.1: Culturing cells in semi-permeable "Twiss" inserts for RNA extraction 
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The axonal RNA yield of the chamber was very low from the cells seeded. In un-pooled 
samples, the CT values were too high to be consistently detected for axons exposed to M1-
like media. The pooled samples in the supplementary data show how there was no significant 
fold change in the expression of miR-138 when cells were exposed to M1-like media. The 
upregulation of miR-138-5p was more easily detected when axons were exposed to anti-
inflammatory media.  
  
 
The effect of anti-inflammatory media on upregulating miR-138-5p was further investigated. 
Figure 5.3.2 refers to 5-independent RNA extractions, from 5 embryo preparations, where 
 A direct comparison between axonal and somal fragments at N=5 independent RNA extractions. One somal sample was 
undetected following axonal exposure to M2-like media, and therefore this bar represents N=4. Bars represent mean fold 
change ± SEM using the ddCT method. Housekeeper values for miR133b of CT=34.8 and 39.9  were removed from analysis 
prior to calculation of the fold change where the average CT was 24-29. Figure shows results of a one-way ANOVA from 
grouped data where F(3, 15)= 2.334.  
A post-hoc Holm-Sidak’s multiple comparisons test was also used to compare exposure to DRG media or M2-like media.. 
P<0.05 was deemed significant. Somal expression of miR-138-5p increased 6.3x on average, if the corresponding axons 
were exposed to M2-like media (P=0.03, DRG exposure N=5, M2-like exposure N=4.)  
Figure 5.3.2: Exposure of axons to inflammatory media significantly increased the expression of miR-138-5p in the soma  











































(N=5 for Axonal RNA)
(N=4* for Somal RNA) 
Axonal Exposure:




each Twiss insert utilised one dissociated embryo. In one biological repeat miR-138-5p was 
not detected in the somal compartment following axonal exposure to M2-like media (N=4.) 
 
Results showed that there was a quantifiable and significant increase in somal miR-138-5p if 
axons were exposed to M2-like media (figure 5.3.2, results of a one-way ANOVA with multiple 
comparisons.) This in vitro model of inflammation was used to demonstrate that the exposure 
of axons to anti-inflammatory mediators induced upregulation in somal miR-138-5p 
expression.  
 
5.3.3 Functional analysis of the dual effect of inflammatory mediators and 
miR-138-5p on neuronal excitability:  
 
Having shown that inflammatory mediators could change localised expression of miR-138-5p, 
we investigated the effect of the inhibition of miR-138-5p on neuronal excitability. In vivo 
modelling has shown that miRs are involved in the regulation of inflammatory pain-based 
signalling by the translational inhibition of protein on the neuronal terminals (Zhao, M.-C. Lee, 
et al., 2010). In vivo models of hyperalgesic priming have also shown that translational 
inhibition (e.g. treatment with either cordycepin or rapamycin) targeted at the peripheral 
terminals can reduce sensitisation of the nociceptors (Ferrari et al., 2013). In this study it was 
also shown that injection with anisomycin (protein translation inhibitor) prevented induction 
of hyperalgesic priming, suggesting that ongoing local peripheral translation is essential in 
both the development and maintenance of chronic pain. The capacity to investigate these 
localised changes in vitro has been limited until recently due to the nature of standard 
dissociated cultures. In this experiment, compartmentalised microfluidic cultures were 
exposed to inflammatory macrophage media at the same time as the miR-138-5p inhibitor. It 
was hypothesised that the incubation of peripheral terminals with inflammatory media in 
conjunction with axonal inhibition of miR-138-5p could promote an increase in excitability of 
the neurons.  
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The schematic in figure 5.3.3 shows how the miR-138 power inhibitor was applied to 
microfluidic devices in which the axonal compartment was also exposed to polarized 
macrophage media (and the cytokines within) for 24 hours prior to stimulation.  
 
If we refer back to Chapter 4 (figure 4.3.4) it was shown that prolonged incubated of the axons 
in polarized media reduced the overall excitability of neurons upon stimulation with KCL. The 
time-course in figure 5.3.3A shows that neuronal excitability was higher in cells incubated 
with the non-targeting probe (control) than the miR-138-5p inhibitor. The decrease in the 
amplitude of the response when the axons were incubated with the miR-138-5p inhibitor and 
M2-like media was not deemed to be statistically significant (figure 5.3.3C, P=0.3557 as shown 
by a one-way ANOVA with post-hoc Sidak’s multiple comparison’s test.)  
 
Figure 5.3.3B shows a time-course analysis for axons incubated with either the non-targeting 
probe (control) or a miR-138 inhibitor in the presence of M1-like media. In this setup, those 
cells incubated with the miR-138 inhibitor were more excitable than the control. This increase 
in excitability was also not deemed to be statistically significant (also shown in figure 5.3.3C, 























































































































24H (+miR inhibitor vs. 
inhibitor control) 
(+KCl 25mM) 
A) The effects of M2-like media and miR-138 inhibition in the axon on the modulation of DRG excitability as observed over a time-
course of 60-seconds. Stimulation of the axonal compartment with KCL is shown at 10-seconds.  
B) The effects of M1-like media and miR-138 inhibition in the axon on the modulation of DRG excitability as observed over a time-
course of 60-seconds. Stimulation of the axonal compartment with KCL is shown at 10-seconds. 
C) Results of a one-way ANOVA with post-hoc Sidak’s correction for multiple comparisons showed no statistically significant 
difference between peak excitability of cultures incubated with inflammatory macrophage media and a non-targeting control 
probe, or the miR-138 inhibitor. F(3, 22)= 2.573, N=5 (M1-like exposure) and N=8 (M2-like exposure) biological replicates. 
Figure 5.3.3: Incubation of the axons with either M1-like or M2-like 
media in the presence of the miR-138 inhibitor induced no significant 
change in the amplitude of Ca2+ transients and neuronal excitability 
compared to those observed following incubation of the axons with a 
non-targeting control. 
 176 
The peak excitability of neurons incubated with miR-138 inhibitor in the presence of 
macrophage media was also compared to the results previously observed when neurons were 
pre-cultured in macrophage media prior to stimulation with KCL (data extracted from figure 
4.3.4.) 
The average peak excitabilities have been compared in table 5.3.1 shown below: 
 
Table 5.3.1: Comparing average peak amplitude of evoked Ca2+ recorded dependent on axonal culture conditions. All axons 
were stimulated with KCL. Inhibitor control refers to a non-targeting control probe.  
If the DRG media in the axonal compartment was changed for media extracted from pro-
inflammatory cells (M1-like phenotype) then the peak excitability was unchanged between 
addition of the inhibitor control or the absolute control.  
However, the amplitude of evoked Ca2+ transients recorded following incubation with the 
miR-138 inhibitor was increased. Co-incubation of miR-138 inhibitor and M1-like media in the 
axonal compartment increased excitability of the neurons. 
 
In comparison, if the axonal compartment was exposed to M2-like media and the inhibitor 
control, the average peak excitability was increased relative to the absolute control. The 
amplitude of the response following incubation with the miR-138 inhibitor was also higher 
than the absolute control, but was lower than incubation with the inhibitor control. Co-
incubation of miR-138 inhibitor and M2-like media in the axonal compartment changed the 
excitability of the neurons. 
 
In line with the objectives for this chapter, the following conclusions can be drawn from 
this:  
 
1. The expression of miR-138-5p in the soma was increased when the axons were 
exposed to M2-like media as demonstrated by the qPCR in figure 5.3.2 
Axonal 
exposure  
miR Inhibitor (Peak 
Excitability (ΔF)) 
Inhibitor Control  
(Peak Excitability (ΔF)) 
Absolute Control 
(Peak Excitability (ΔF)) 
M1-like 
Media 0.33 0.16 0.17 
M2-like 
Media 0.22 0.33 0.085 
 177 
2. The excitability of DRG neurons was increased if the axonal compartment was cultured 
in M2-like media and either an miR-138-5p cell permeable inhibitor or the inhibitor 
control.  
3. The excitability of DRG neurons was only increased if the axonal compartment was 
cultured in M1-like media and the miR-138-5p cell permeable inhibitor.  
 
 
It could be hypothesised that the induced increase in miR-138-5p from exposure to M2-like 
media was counteracted by the addition of the miR-138 inhibitor. This could explain why the 
excitability of the cells cultured in M2-like media was reduced when incubated with the miR-
138-5p inhibitor compared to the non-targeting control probe. 
To continue this investigation into the effects of inflammatory mediators and sensitisation, it 
would have been interesting to determine the effects of miR-138 inhibition in the somal 
compartment of microfluidic devices where the axons are exposed to polarized macrophage 
media.  
 
This study showed that inflammatory mediators changed the expression or miR-138-5p in the 
soma. This increased expression of miR-138-5p was also shown to affect neuronal excitability. 
The next step was to investigate mechanisms by which changes in miR-138-5p expression 












5.4 Part B: Molecular and cellular analysis of the mechanisms underlying the 
effect of miR-138-5p on sensitization of peripheral neurons: 
 
In Chapter 4 it was demonstrated that axonal stimulation of untreated microfluidic cultures 
stimulated with KCL induced an increase in evoked Ca2+ transients recorded at the soma.  In 
Chapter 5, part A it was shown that inhibition of miR-138-5p affected neuronal excitability.  
The increase in fluorescence observed was representative of an increase in free cytosolic Ca2+. 
The delay following axonal stimulation of a microfluidic device likely reflected the time taken 
for action potentials to propagate from the nerve terminals and induce a Ca2+ response. 
 
In this study the role of miR-138-5p in local protein translation and modulation of neuronal 
cell excitability was further investigated. Microfluidic chambers were cultured until axons 
extended through the microgrooves and covered the axonal compartment >50%. Previous 
work from the Dajas-Bailador lab suggested that optimal time for use of microfluidic devices 
was between DiV5-8 dependent on the nature of the study (Lucci et al., 2020). In this model 
the media was removed and replaced with media supplemented with a cell permeable power 
inhibitor for miR-138, at a final assay concentration of 100nM. Due to the compartmentalised 
microfluidic nature of the devices the inhibitor was either applied localised to the axons, or 
the soma and the downstream effect on neuronal excitability was quantified.  
 
5.4.1 Part B objectives: 
• Use local application of a miR-138-5p inhibitor in a microfluidic model to investigate 
a) the effect of miR-138-5p expression on neuronal excitability and b) the 
mechanism of action by which miR-138-5p induces changes in neuronal signalling. 
• Identify and isolate potential downstream targets of interest for miR-138-5p 
• Validate targets based on seed sequence expression in the 3’UTR and interaction 
with miR-138-5p.  
• Investigate the effects of target protein expression on cell excitability using siRNA 
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5.4.2 Inhibition of miR-138-5p expression in the axonal compartment of 
compartmentalised microfluidic devices reduced evoked Ca2+ transients 
and changes in neuronal excitability:   
 
The schematic in figure 5.4.1 below shows an overview of the experimental setup where only 
the axons were stimulated with KCL. Figure 5.4.1A shows a visual representation of how the 
amplitude of neuronal response to stimulation was reduced where a miR-138-5p inhibitor 
was added to the axons (relative to the control chambers where a non-targeting miRNA probe 
control was added.)  
To quantify this reduction in excitability, an unpaired t-test was used to compare the KCL-
evoked peak excitability between cultures. Figure 5.4.1B shows that there was a significant 
decrease in peak excitability in neurons where the miR-138 inhibitor was added to the axonal 
compartment. (A comparison including the baseline has also been included in the 
supplementary data, using a one-way ANOVA to compare the baseline fluorescence to the 
peak fluorescence recorded.) 
Both treatments showed a rapid increase in fluorescence upon stimulation, but the duration 
of the responses returned to near baseline by the end of the 60-second recording. The 
decreased excitability in those axons incubated with the miR-138-5p inhibitor was reflected 
in the reduced AUC relative to the control (figure 5.4.1C.) 
 
Results also showed that unlike untreated populations of DRGs stimulated with KCL, both the 
treatments with the power inhibitor control or the miR-138 inhibitor reduced the overall 
amplitude of the Ca2+ response. This effect was observed across multiple cell preparations 
and was deemed to not be an artefact of specific tissue showing reduced excitability in the 
presence of KCL. These results demonstrated that the effect of miR-138 inhibition on reducing 
cellular excitability was not resultant from manual addition of a substrate to the cell, but 
reflected a “true” decrease in excitability when miR-138 activity was blocked in the axonal 
compartment. (Average peak amplitude (±SD) of an absolute control was 0.64± 0.45ΔF at N=6 
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biological repeats, see chapter 4 section 4.2.1. In comparison the peak amplitude following 
addition of miRNA non-targeting control probe was 0.35± 0.18ΔF at N=12.) 
























































































Figure 5.4.1: miR-138 inhibition in the axonal compartment induced a significant decrease in Ca2+ transients in the soma 




The same protocol was subsequently repeated using stimulation of the axonal compartment 
with Capsaicin (200nM) to selectively stimulate TRPV1+ve neurons. Although TRPV1 is 
expressed as early at E12.5, expression levels are not complete until around post-natal day 2. 
Our previous experiments had shown that there was a transient change in fluorescence when 
Capsaicin was applied to the axonal compartment of E16.5 DRG neurons.  In a similar way to 
the results observed following stimulation with KCL, axonal stimulation with capsaicin 
induced a rapid and transient increase in cytosolic Ca2+.  
 
The time course analysis in figure 5.4.2A (below) shows how fluorescence of the control 
population and the treated cells had returned to a stable baseline by the end of a 60-second 
recording period. Following stimulation with capsaicin, the amplitude of the responses of cells 
treated with the non-targeting miRNA control probe or miR-138 inhibitor overlapped (figure 
5.4.2A.)  
 
There was no statistically significant difference between the amplitude of the response of the 
control treatment population, and those cells in which miR-138 was inhibited in the axons 
(figure 5.4.2B.) Moreover, there was no significant reduction in amplitude of the response 
compared with the axonal stimulation of empty microfluidic cultures (Chapter 4, figure 4.2.3 
where average peak excitability was 0.23ΔF.)    
 
 
A)    Time-course analysis with stimulation by KCL shows that amplitude in response of cells incubated with a miR inhibitor was 
reduced relative to the control population. 
B) Increase in fluorescence (following stimulation) was statistically reduced following incubation with a miR-inhibitor. One-way 
ANOVA with multiple comparisons showed a statistically significant reduction in the excitability of those cultures incubated 
with a miR-138 inhibitor in the axonal compartment (P=0.0046). Significance threshold  P<0.05, showing representative data 
from N=12 independent biological repeats. F(3,44)=31.9 for comparison between treatments. Post-hoc Holm’s-Sidak test for 
multiple comparisons also demonstrated significant increase from baseline excitability irrespective of the axonal treatment. 
C) The AUC also showed a significant decrease in neuronal excitability following stimulation with KCL of cultures incubated with 
a cell permeable miR-138 inhibitor. Unpaired t-test with Welch’s correction showing P=0.05. Error showing mean ±SEM 








A) Time-course analysis with stimulation by Capsaicin shows that amplitude in response of cells incubated with a miR inhibitor 
was not significantly reduced relative to the control population. The change in fluorescence observed once again was used as a 
proxy for the change in excitability of the neurons.  
B) Excitable response following stimulation was not signficantly reduced following incubation with a miR-inhibitor and stimulation 
with Capsaicin. One-way ANOVA showed no statistically significant effect of miR-138 inhibition when stimulating the axonal 
compartment with capsaicin F(3, 42)= 15.20, where P=0.99 as shown by multiple comparisons. Post-hoc Sidak’s multiple 
comparison’s also showed that the increase in excitability from baseline was always statistically significant (P<0.001) irrespective 
of the axonal treatment. Representative of N=11 biological repeats, where bars represent mean ±SEM.  
DRG 
DiV5  24H 
(+miR inhibitor vs. 
inhibitor control) 
(+Capsaicin 200nM) 
























































Figure 5.4.2: miR-138 inhibition in the axonal compartment did not induce a significant decrease in Ca2+ transients recorded in the 
soma following axonal stimulation with Capsaicin (200nM): 
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The results of figures 5.4.1 and 5.4.2 suggested a selective role for miR-138-5p in regulating 
the excitability of small diameter DRG neurons. The stimulation with Capsaicin did not 
demonstrate any significant difference in the excitability of cells incubated with or without 
the miR-138 inhibitor. Therefore, it was hypothesised that the effect of miR-138 was localised 
to neurons more closely resembling A-fibres.
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It was also hypothesised that the effect of miR-138-5p was local to the axon. Therefore, it was 
predicted that inhibition of miR-138-5p in the soma would not induce a reduction in cell 
excitability following axonal stimulation of neurons. Microfluidic devices were cultured to 
DiV5, at which point the media was changed and the miR-138 inhibitor was added to the 
somal compartment for 24H. Following this, a stimulus was locally applied to the axonal 
compartment.  
 
Figure 5.4.3 shows the resultant change in fluorescence following somal inhibition of miR-138 
and subsequent axonal stimulation with KCL (25mM). The time-course in figure 5.4.3A shows 
that there was no difference in the KCL-evoked response when comparing the control group 
to those cells incubated with miR-138 inhibitor. Figure 5.4.3B shows that there was also no 
significant decrease in the KCL-evoked peak excitability of cells treated with a miR-138 
inhibitor versus the negative control. It was also shown that axonal stimulation with KCL still 
evoked a significant increase in Ca2+ transients recorded from baseline. Therefore, the somal 
incubation with miR-138 inhibitor did not decrease viability of the neurons. This result further 
supported the evidence that miR-138-5p was only affecting the excitability of the cell by 
acting locally in the axon terminal.  
 
The effect of Capsaicin-evoked neuronal excitability following somal incubation with the miR-
138 inhibitor was also studied. Figure 5.4.3C shows that there was no significant difference in 
the peak excitability of neuronal cultures incubated with either the miR-138 inhibitor or the 
non-targeting control in the somal compartment.  
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5.4.3 Inhibition of miR-138-5p in the somal compartment did not reduce KCl 
or Capsaicin-evoked increase in neuronal excitability:  
DRG 
DiV5  





A) Time course analysis comparing the amplitude of neuronal excitability 
axonal stimulation with KCl (25mM.) The miR-inhibitor (or a scramble 
control) was added to the soma for 24-hours prior to stimulation and did 
not evoke a significant reduction in neuronal excitability.  
B) Increase in fluorescence following axonal  stimulation with KCL was not 
significantly reduced following incubation of the soma with a miR-inhibitor. 
Results of a one-way ANOVA with post-hoc Sidak’s test showed no 
statistical significance between the peak excitability of treatments (NS) 
with P<0.05 significance threshold. N=7. Mean ± SEM. F(3, 24)=21.79. 
Sidak’s multiple comparisons showed a significant increase in fluorescence 






























































































Figure 5.4.3; Prolonged inhibition of miR-138 in the soma of DRG 
sensory neurons did not evoke significant changes in neuronal 
excitability: 
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(Legend continued overleaf) 
Figure 5.4.3 C) Increase in fluorescence following axonal  stimulation with Capsaicin was not significantly reduced following 
incubation of the soma with a miR-inhibitor. Results of a one-way ANOVA with post-hoc Sidak’s test showed no statistical 
significance between the peak excitability of treatments (NS) with P<0.05 significance threshold. N=7. Mean ± SEM. F(3, 
23)=7.858. Sidak’s multiple comparisons showed a significant increase in fluorescence from baseline at P=0.0031 for somal 
incubation with the miR-inhibitor, versus p=0.0173 following incubation with a non-targeting inhibitor control probe..  
 
In the final experimental setup, the somal compartment was incubated with miR-138 inhibitor 
for 24-hours prior to direct somal stimulation with either KCL at 25mM or Capsaicin at 200nM.  
 
The time-course in figure 5.4.4A shows how there was a rapid increase in cell excitability 
following direct stimulation of the soma with KCL. The amplitude of the response was higher 
than the amplitude of KCL-evoked Ca2+ transients recorded at the soma following axonal 
stimulation (figure 5.4.4.) The increase in excitability from baseline was deemed significant 
irrespective of what treatment the soma were incubated with.   
However, there was no significant difference between the peak excitabilities recorded 
following somal incubation with the miR-138 inhibitor or the non-targeting inhibitor control 
probe (figure 5.4.4B.) The direct stimulation of the soma with capsaicin following somal 
inhibition of miR-138-5p also did not induce a significant change in cell excitability relative to 
incubation with a non-targeting miRNA probe control (figure 5.4.4C.)  
 
Somal inhibition of miR-138-5p demonstrated higher amplitude in response if stimulated with 
Capsaicin than KCL. The following conclusions can be drawn from this data: 
 
miR-138-5p is involved in regulating excitability of the small fibres of the DRG. The effects of 
miR-138-5p most likely targets A-fibres since inhibition of miR-138 did not induce any 
significance changes in Capsaicin-evoked excitability (relative to treatment with a negative 
control). Based on this data it could be hypothesised that miR-138-5p has roles in regulating 
cellular excitability via local translation, most likely regulating neuronal conductance (e.g. 
potassium signalling) in small fibres of the DRG 
 
 187 
   
 
 
A) Time course analysis comparing the amplitude of neuronal 
excitability axonal stimulation with KCl (25mM.) The miR-inhibitor or a 
scramble control was added to the soma for 24-hours prior to somal 
stimulation. Treatment did not evoke a significant reduction in the 
amplitude of responses between treatments, but somal stimulation 
evoked a longer duration response.  
B) Quantification of the peak Ca2+ transients showed no significant 
difference in the fluorescence recorded at soma directly stimulated with 
KCL following incubation with a miR-138 inhibitor versus a non targeting 
control probe.  Results of a one-way ANOVA a post-hoc Sidak’s test for 
multiple comparisons showed a significant difference in cellular 
excitability irrespective of the somal treatment with miR-138 inhibitor. 
As shown, P=0.02 following incubation with the miR-138 inhibitor. F(3, 
24)= 23.40, with significance threshold at P<0.05. N=7 biological 
replicates showing mean ±SEM.  
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Figure 5.4.4: Prolonged inhibition of miR-138 in the soma of DRG 




Figure 5.4.4 C)  Quantification of the peak Ca2+ transients showed no significant difference in the fluorescence recorded at 
soma directly stimulated with Capsaicin following incubation with a miR-138 inhibitor versus a non targeting control probe.  
Results of a one-way ANOVA a post-hoc Sidak’s test for multiple comparisons showed a significant difference in cellular 
excitability irrespective of the method of culture. As shown, P=0.02 following incubation with the miR-138 inhibitor. F(3, 
23)= 4.314, with significance threshold at P<0.05. N=7 biological replicates showing mean ±SEM.  
 
5.4.4 Bioinformatic prediction for targets with roles in regulating neuronal 
excitability by interaction with miR-138-5p: 
 
Addition of the miR-138 inhibitor to compartmentalised microfluidic devices had 
demonstrated a clear role for miR-138-5p in regulating neuronal excitability. The inhibition of 
miR-138-5p only induced a significant decrease in neuronal excitability if the axonal 
compartment was incubated with the miR-138 inhibitor and the subsequent KCL stimulus was 
locally applied to the axons. As such it was hypothesised that miR-138-5p has roles in 
regulating neuronal excitability via local translation, most likely via regulation of membrane 
conductance. Since microRNAs are known to inhibit translation of mRNAs, a bioinformatic 
search was conducted to attempt to identify a protein target of interest that would help to 
explain the mechanism of miR-138-5p in regulating neuronal excitability. 
 
Initial attempts to identify a target for miR-138-5p included a conservative search and 
comparison of multiple bioinformatic prediction tools, each of which uses a different 
algorithmic model. Preliminary searches included MirGate, Diana Tools microT-CDS at 
inclusion threshold 0.7, (Paraskevopoulou et al., 2013a) Tarbase (26 targets,) (Karagkouni et 
al., 2018) TargetScan v7.2 (Agarwal et al., 2015) and miRTarBase (14 targets) (Hsu et al., 
2011). 
 
At a threshold of 0.7, DIANA tools identified 556 targets potentially associated with miR-138-
5p, where at 0.8 the predicted list was reduced to 267 targets. All targets that appeared in 
DIANA tools were converted from a transcript ID to a gene ID and cross-referenced with a list 
of results from a second bioinformatic database. When using TargetScan (v7.2) 630 
transcripts were initially identified, although some of these were later identified as “false 
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positives” where the seed sequence was predicted but not present in the 3’UTR. Between 
TargetScan and DIANA tools, 122 targets overlapped. From here a species conservation list 
was produced, where each target was cross-referenced for prediction with rat and human 
tissue. This yielded a list of 16 targets: 
 
 
Figure 5.4.5: Developing a pipeline for bioinformatic searches of predicted targets overlapping with miR-138-5p. 
From the 16 genes identified, the proteins identified were suggested to be involved in up to 
45 biological processes including 4 genes involved in cell signalling and 4 genes involved in 
‘response to stimulus.’ These included hits such as Calcipressin-2, involved in the signal 
transduction of calcium, and sodium channel beta subunits, which modulate channel 
conductance and action potential propagation. Furthermore, 7 protein classes were identified 
in this list, including intercellular signalling proteins, transmembrane signalling and transport 
proteins. Although the 16-targets identified appeared to have some roles in signal 
transduction, based on the results of the calcium assay previously described in this chapter, 
it was deemed that voltage-gated sensitive channels were potentially of high interest for this 
project, with particular regards to peripheral sensitisation. With the capacity to change the 
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search parameters of DIANA tools (Paraskevopoulou et al., 2013b) to include even those 
targets most lowly predicted targets, a second more biased search was conducted based on 
the results observed with the miR-138-5p inhibitor in Ca2+ signalling assays. A target was only 
deemed suitable if it was endogenously expressed by E16.5, where protein expression often 
begins in the embryo, but may not peak until post-natal development.  
 
This time the parameters on Diana tools microT-CDS were widened to include a prediction 
threshold of 0.1, in order to locate all potential voltage-gated targets containing the seed 
sequence of miR-138-5p. This search included calcium, potassium and sodium channels in line 
with the hypothesis that miR-138-5p has roles in signal transduction, and potentially regulates 
membrane conductance during states of hyperalgesia.  
A list of potential targets was created based upon reported expression of a) the seed 
sequence for miR-138-5p in the 3’UTR, and b) known expression of the relevant protein on 
fibres of the DRG. Only those channels with multiple predicted seed sequences in the 3’UTR 
were carried forward, and the 3’UTR was manually searched to confirm expression of the 
sequence.  It was noticeable that the DIANA prediction did not always accurately reflect the 
presence of the seed sequence in the 3’UTR. Those targets highlighted on figure 5.4.6 below 
were deemed the most appropriate for this study based on selective and localised expression 
throughout the DRG fibres.  
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5.4.4.1 Identifying which channels to investigate: 
 
The work by Tsantoulas and McMahon described in Chapter 1, figure 1.4 (Tsantoulas and 
McMahon, 2014) gives a comprehensive overview of the suggested expression patterns of 
multiple voltage-gated channels throughout the DRG fibre subtypes. In Chapter 1.7 I have also 
discussed the role for different subtypes of both Kv and NaV channels throughout the 
changing phases of the action potential. Understanding which channels are affected by a 
nociceptive stimulus may help to determine how miR-138-5p potentially regulates neuronal 
excitability of the DRGs.  
 
5.4.4.2 SCN family:  
There are 13 members of the genes encorporating voltage-gated sodium channel family (SCN 
genes) including the large α-subunit and a potential additional β-subunit. These voltage-gated 
sodium channels are essential in the initiation and propagation of action potentials, although 
they can be further sub-categorized dependent on the chromosomal expression (Yu and 
Figure 5.4.6: : Based on seed sequence expression in the 3’UTR, ion channels of interest were shortlisted and subsequently 
validated as predicted targets of miR-138-5p. 
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Catterall, 2003) and sensitivity to tetrodotoxin (TTX). In adult neurons the roles of NaV1.1, 
NaV1.6, NaV1.7, NaV1.8 and NaV1.9 have been established in regulating sensory neuron 
excitability in pain-based signalling. Furthermore, changes to the expression pattern or 
alterations to genetic variants of NaV1.7, NaV1.8 and NaV1.9 have all been linked to small 
fibre neuropathies. However, in those channels screened, the seed sequence for miR-138-5p 
was only identified in the 3’UTR of NaV1.6.  
 
5.4.4.3 KCN family: 
In a similar way, proteins of the voltage-gated potassium channel family were screened for 
known association with miR-138-5p. Of a total 40 channels screened, miR-138-5p was 
predicted to be associated with the regulation of 30 potassium channels. The 3’UTR for these 
candidates was manually searched to locate the seed sequence for miR-138-5p. Those 
channels showing multiple seed sequence expression for miR-138 were marked a good 
candidate for a luciferase assay.  
 
Also included in this screening process was potassium activated calcium channels, voltage 
gated calcium channels, potassium inward rectifier channels and two-pore potassium 
channels. 
 
A shortlist of candidate genes can be seen in table 5.4.1 below. Target genes were selected 
based on a) the TargetScan prediction with miR-138-5p, b) the expression of the seed 
sequence in the 3’UTR for miR-138-5p, c) the number of seed sequences expressed in the 
3’UTR and d) literature based on the role of the target in nociception or neuronal excitability. 
For example, where Kv1.2 (KCNA2) has been documented to be selectively expressed in the 
A-fibres, TREK-2 (KCNK10) has been localised to IB4 positive C-fibres only. The DIANA tools 
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microT-CDS prediction is also included here, although the prediction rate does not always 
correlate with the prevalence of the seed sequence in the 3’UTR.  
 
Those targets used for cloning into the pmiRGlo vector have been highlighted in the table 
above. Only the targets highlighted in green (KCNK10/ KCNA2) were successfully cloned into 
the reporter and used in the luciferase assay with a miR-138-5p mimic.  
 
 
5.4.4.4 Kv1.2:  
The shaker protein Kv1.2 belongs to the delayed rectifier family of voltage-gated channels, 
which rapidly induce repolarization of the cell membrane following conduction of the action 
potential. Furthermore, there is evidence to demonstrate that the Kv1.2 protein is widely 
conserved between species including rat, human and mouse. The distribution of the Kv1.2 
channel in murine neurons has been demonstrated to be uniform throughout the axons, 
terminals and cell body. However, as shown in Chapter 1 (Tsantoulas and McMahon, 2014) in 
mice these channels have been shown to be selectively expressed on the A-fibres of the DRG 
neurons.  
 
Table 5.4.1: Shortlisted target genes for interactions with mmu-miR-138-5p. 4 potassium channels of interest have been 
highlighted based on expression in the A/C fibres of the DRG and predicted number of seed sequences in the 3’UTR. 
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Figure 5.4.7 below shows high levels of Kv1.2 expression both at the axonal terminals, and 
throughout the axon of the DRG neurons, although in vivo Kv1.2 is known to only localise to 
A-fibre subtype DRGs.  
 
Figure 5.4.7: Dual staining immunofluorescence from a dissociated plate-based culture of DRG neurons at DiV5 showing high 
relative expression of Kv1.2 at the terminals (40X.) 
Following axonal injury, the juxtaparanodal region becomes exposed and there is a high 
expression of Kv1 channels in this area. This may lead to a reduction in conduction velocity of 
these damaged neurons, as well as a potential sensory loss of function. Reduced functionality 
of channels in the Kv1 family potentially induces peripheral hyperexcitability where the axon 
does not repolarize as efficiently.  
 
5.4.4.5 Two pore potassium channels: 
Since one of the targets investigated (TREK-2, KCNK10) belongs to the two-pore- potassium 
channel family, I have further discussed the role of these channels in maintaining resting 
membrane potential. Where voltage-gated potassium channels are elucidated in the 
movement of potassium out of a depolarised membrane, the two-pore channel domain is 
predominantly determined by the electrochemical gradient of K+ ions in the cell. Therefore, 
the K2P channels have a role in contributing to maintaining the background membrane 
potential (O’Connell, Morton and Hunter, 2002). Although there is relatively little homology 






acids forming the channel pores are highly conserved. These region makes the channel 
selective for K+ ion sensitivity, whilst allowing fast movement of ions across the cell 
membrane. Although not directly voltage-dependent, the K2P channel family are affected by 
a range of physiochemical variables. This is included but not limited to, changes in membrane 
potential, pH and surrounding temperature (Enyedi and Czirják, 2010). The first channel in 
the K2P family was identified in yeast in 1995 (Ketchum et al., 1995), although since the TOK1 
channel expresses eight transmembrane segments and is strongly outward rectifying, it is 
considered largely different from other members of the K2P channel family. In contrast, these 
channels, such as TREK-2, are acknowledged to possess 4-transmbrane domains and 2-
channel pore forming subunits. As a “background K+ current” channel, the probability of these 
channels opening is not altered in response to changes in the membrane potential. Although 
K2P channels are weakly voltage-dependent they are predominantly considered ‘leak’ 
channels.  
 
The first member of the TREK (TWIK-related K+ channel) family of proteins was discovered in 
1996, followed by two further proteins including TREK-2 (Fink et al., 1996)  although the group 
is functionally diverse due to the presence of several splice variants. In particular alternative 
translation initiation in TREK-2 induces a long segment of the intracellular termini missing on 
this channel, and as such can affect the biophysical properties of the channel activity (Y. Kim 
et al., 2001). Crucially, evidence has demonstrated that the TREK-2 channel is conserved 
between species, and is selectively expressed on the IB4-positive C-fibres of the DRGs (Acosta 
et al., 2014; Viatchenko-Karpinski, Ling and Gu, 2018) making this protein a good candidate 
for a small-fibre pain-based study. Evidence from siRNA knockdown of the TREK-2 channel in 
in vivo murine studies demonstrated a role for TREK-2 in the hyperpolarization of the 
membrane of IB4-positive C-fibres (Acosta et al., 2014). Moreover, in vitro studies 
demonstrated the expression of TREK2 as early as 2-days in vitro, suggesting the channel is 
not only expressed in mature DRG fibres.  
5.4.5 Luciferase reporter assay: 
 
Following the identification of predicted targets for miR-138-5p it was important to 
functionally validate these targets. The first step was cloning the 3’UTR region of interest into 
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the pmiRGlo vector containing the complementary seed sequence for miR-138-5p (as 
described in Chapter 2.4.4.1.) Following sequencing to confirm insertion of the primer into 
the pmiRGlo vector, a dual-luciferase reporter assay was carried out to confirm the 
interaction of miR-138-5p with the predicted target site in the 3’UTR. 
Of the primers shown in Chapter 2.4.4.1, seven predicted target sites were eventually 
investigated for the capacity to act as functional targets using the luciferase assay (see 
chapter 2.4.4.2.2.)  
 
Cells were transfected with DNA inserted into pmiRGlo and treated with either the miR-138 
mimic or a miR-control at 50nM for 48-hours prior to quantification of firefly luciferase signal. 
Preliminary tests included Kv1.2 site 3, Kv1.2 site 4, Kv1.2 site 5 and TREK-2 sites 1-4 as shown 
in figure 5.4.8. However, 3 target sites were identified as statistical outliers, demonstrating 
 
Figure 5.4.8: Preliminary results from a luciferase reporter assay at N=1: Results show %Change in fluorescence detected when 
cells were treated with 50nM miR-138 mimic for 48-hours. All 7-targets were previously validated using Sanger sequencing to 
locate the sequence of interest inserted into the pmiRGlo vector. Only the 4-targets marked with an asterix were carried 
forward to N=4, where they showed reduction in fLuc activity in the dual luciferase reporter assay. 
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very little (or a positive) change in fluorescence of the mimic relative to the control. Only 4 
targets were carried forwards to investigate statistical significance of target interaction with 
miR-138-5p, as shown later in figure 5.4.9.  
 
Of the 4 targets taken forward only two showed a statistically significant reduction in firefly 
luciferase activity, suggesting the miR-138 mimic was bound to the target site and protein 
translation was either repressed or degraded (see figure 5.4.9 A-D). The luciferase reporter 
assay was repeated to a minimum N=3 repeats to determine statistical significance of the 
reduction in firefly luciferase activity in each condition. Figure 5.4.9 below shows that only 
Kv1.2 site 4 and site 5 demonstrated a statistically significant decrease in fLuc activity. Since 
Kv1.2 is only expressed in A-fibres in vivo, this data further supported the hypothesis that 
miR-138-5p regulates excitability of the DRG neurons via local translation in A-fibres.  
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Following the preliminary validation of two target sites of interest via luciferase reporter, the 
primers for these target sites were mutated at the seed sequence to confirm the interaction 
with miR-138-5p. Via PCR the mutated primers were re-inserted into pmiR-Glo for use in a 
site directed mutagenesis recovery assay.   
In the mutagenesis recovery assay, nucleotides in the seed sequence of miRNA interaction 
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Significance was determined using unpaired t-tests, where P<0.05 was deemed statistically significant. Figures 
5.4.9B (N=4) and figure 5.4.9C (N=3, 1 outlier removed) demonstrated a significant reduction in fLuc activity, and 
validated these as targets for miR-138-5p. 
Figure 5.4.9: Transfection with miR-138 mimic and pmiRGlo with the target site inserted showed a reduction in firefly 
luciferase activity for four targets of interest. 
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parameters. If the miRNA was truly targeting the Kv1.2 sites of interest, it was hypothesised 
that by mutating nucleotides in the seed sequence, the luciferase activity would be recovered 
following transfection with a mutated DNA sample.  
 
 
Figure 5.4.10: A site-directed mutagenesis assay demonstrated a loss of function with mutation of the seed sequence for 
miR-138-5p in the 3’UTR. Transfection with the miR-138 mimic and the mutated DNA sequenced did not induce a reduction 
in firefly luciferase activity in the dual luciferase assay, (N=3.) No significant difference in fLuc acitivty was detected between 
the LNA control and the SDM miR-138-5p targets, therefore validating the presence of a binding site in the 3’UTR of Kv1.2 
for miR-138-5p. 
 
Figure 5.4.10 demonstrates that the mutation in the seed sequence led to a reduction in miR-
138-5p interaction with the target site on pmiRGlo, and confirmed the validity of the 
interaction of Kv1.2 with miR-138-5p. This was characterised by the increase in firefly 
luciferase activity to equal that of the results observed for the LNA control. This ‘rescue’ effect 
by mutation of the seed sequence of miR-138-5p, validated Kv1.2 as a target of interest. It 
was likely that in this context, the mutation in the seed sequence led to reduced interaction 
of the miR-138 mimic with the target mRNA, and consequentially reduced degradation the 









































































Site directed mutagenesis: Kv1.2 site 5A B
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5.4.6 Treatment of axons with small interfering RNA (siRNA) for Kv1.2 
demonstrated partial rescue of the decrease in excitability induced by 
miR-138-5p inhibition:  
 
At this point we had identified suitable target(s) of interest that could interact with miR-138-
5p in the 3’UTR, and used molecular biology to validate Kv1.2 at multiple binding sites. It was 
previously demonstrated that axonal addition of the miR-138 inhibitor alone led to a 
reduction in cellular excitability compared to addition of the non-targeting microRNA control 
probe (see figure 5.4.1.) Additional evidence from the literature had also suggested that in 
vivo Kv1.2 is primarily located in the A-fibres of the DRG neurons (Tsantoulas and McMahon, 
2014). Since microRNA is involved in translational repression or the degradation of target 
mRNA (Bartel, 2004; Jackson and Standart, 2007) it was deduced that miR-138-5p could 
regulate DRG excitability via repression of mRNA for ion channels regulating conductance of 
the action potential.  
 
In this experiment, small interfering RNA (siRNA, see Chapter 2.4.2) for Kv1.2 was added to 
the axons of neurons cultured in microfluidics. Unlike miR-138-5p, which most likely targets 
repression or degradation of multiple proteins in the axon, the siRNA for Kv1.2 only targets 
degradation of mRNA for Kv1.2.  
It was hypothesised that downregulation of the target of interest (Kv1.2) would lead to 
changes in the resting membrane potential, and increased excitability of the cell.  If Kv1.2 was 
a real target for miR-138-5p, then knockdown of Kv1.2 in the axon was hypothesised to mimic 
the effects of miR-138-5p on neuronal excitability. To investigate this hypothesis, siRNA for 




The time course analysis in figure 5.4.11A shows that there was a rapid increase in 
fluorescence observed upon stimulation with KCL. The treatment with the siRNA for Kv1.2 
(and subsequent knockdown of Kv1.2) did not reduce viability of the cells or render the 
neurons unresponsive to stimulation by KCL. The amplitude of the response following axonal 
stimulation with KCL was not significantly different if the axons had been exposed to the 
siRNA for Kv1.2 or the siRNA non-targeting probe (figure 5.4.11B.) 
For reference, the peak excitability of the neurons incubated with siRNA for Kv1.2 was 0.30ΔF, 
compared to 0.20ΔF following axonal incubation with a miR-138 power inhibitor (figure 5.4.1) 
and 0.64ΔF in untreated microfluidics (figure 4.2.2.) 
In these preliminary experiments knock-down of Kv1.2 in the axon did not appear to modulate 
excitability, so at the moment it does not appear to be the only target of miR-138-5p in this 
process. There was potential for this experiment to be development further focusing on 


















































A) Time course analysis comparing the amplitude of neuronal excitability following axonal stimulation with KCl (25mM.) siRNA 
for Kv1.2 or the non-targeting smartpool siRNA control was added to the axonal compartment for 24-hours prior to axonal 
stimulation. Treatment did not evoke a significant difference in the amplitude of responses between treatments.  
B) Increase in fluorescence following stimulation increased following axonal incubation with siRNA for Kv1.2 or the non-targeting 
siRNA control. Results of an unpaired t-test showed no significant difference between the evoked Ca2+ response between 
conditions. N=7, Bars show mean ± SEM. 
Figure 5.4.11: Prolonged incubation of the axonal compartment (24-hours) with 100nM siRNA for Kv1.2 evoked small changes in 
neuronal excitability relative to the non-targeting siRNA control sequence. Evoked change in excitability was not deemed 
statistically significant at N=7 biological replicates 
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different concentrations of siRNA, a longer incubation period with siRNA or the co-incubation 
with a second siRNA of interest (for example where Kv1.1 and 1.2 are often seen to form 
heterotetramers.) 
 
In line with the objectives for this chapter, the following conclusions can be drawn from 
these studies:  
1. miR-138-5p regulates excitability of DRG neurons via local translation in the axon. 
2. Two target sites for Kv1.2 were validated as targets for binding with miR-138-5p via 
bioinformatics, luciferase reporter and site directed mutagenesis 
 
Future works could have been to confirm the interaction between miR-138-5p and Kv1.2. It 
was hypothesised that the reduction in cell excitability observed by treatment with a miR-138 
inhibitor could be rescued by the dual addition of the miR-138 inhibitor and siRNA for Kv1.2.  
 
5.4.7 Discussion and Chapter Conclusions: 
The results of parts A and B of this chapter suggested that miR-138-5p is more likely involved 
in local translation and regulation of proteins such as potassium channels on the peripheral 
terminals of the small fibre DRG neurons, as opposed to the TRPV1 receptor. Some changes 
in excitability were detected when miR-138-5p was inhibited in the presence of inflammatory 
mediators. However, the somal upregulation of miR-138-5p in the cell associated with 
exposure to inflammatory mediators was not deemed to be significant. On the contrary, the 
localised inhibition of miR-138-5p in the axonal compartment induced a significant decrease 
in cellular excitability when axons were stimulated with KCL. Therefore, the role of miR-138-
5p in local translation of Kv channels was investigated.  
 
At a molecular level, pathologies such as pain are linked to changes in the way in which 
excitable cells signal. For example, in a state of hyperalgesia the exposure of the nerve 
terminals to an inflammatory stimulus has induced a state of increased excitability. Rapid 
evoked firing of the sensory nerves makes the terminals more sensitive to stimulation, and as 
such a noxious stimulus is often detected as more painful than it was before. At the centre of 
research on mechanisms of inflammatory pain have often been the VGSCs, specifically NaV1.7 
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and NaV1.8, where the exposure to inflammatory mediators induces phosphorylation of 
sodium channels and increased ectopic firing of DRG fibres (Cummins, Sheets and Waxman, 
2007; Hameed, 2019).  
In this work I have proposed a mechanism by which altered expression of voltage gated 
potassium channels, specifically Kv1.2 can be elucidated in the development of a state of 
increased excitability of DRG fibres. Voltage-gated potassium channels (Kv) have been shown 
to regulate both the amplitude and the duration of the action potential, as well as frequency 
of neuronal firing in response to membrane depolarization, and undoubtedly maintaining the 
resting membrane potential (Hille, 2001). The transmembrane Kv family are activated by 
depolarization of the membrane, and are responsible for the repolarization of the membrane 
potential to resting state (Kim and Nimigean, 2016). Therefore, it is understandable that the 
activation of these channels is dependent on the influx of sodium into the axon when the 
membrane is depolarized.  
 
The propagation of the action potential is dependent on sequential activation of K+ channels, 
as depicted in figure 1.4.3, chapter 1. In sensory neurons of the PNS, such as the DRG neurons, 
the Kv1 family of channels are largely expressed in medium to large diameter neurons 
(Rasband et al., 2001). The Kv1.2 channel is well documented to have roles in maintaining the 
resting membrane potential, as well as mediating repolarization of the neuron following firing 
of an action potential (Long, Campbell and MacKinnon, 2005). The heterotetrameric Kv1.2 
channels are slow to activate in order to rectify depolarization of the membrane (Manis, 
2014), and their role in modulation of the resting membrane potential is well documented 
(Trimmer, 2015). The inactivation of these delayed rectifier channels is not deemed to be 
dependent on a change in the driving force, and some evidence has also suggested that Kv1 
in the DRG neurons channels may cluster at the juxta-paranodal regions with other Kv (e.g. 
Kv1.1 and Kv1.4) subtypes to help modulate downstream action potential propagation 
(Rasband, 2010).   
Mutations in Kv1.2 have previously been observed in vivo with regards to both gain-of-
function and loss-of-function (Syrbe et al., 2015). At a single cell level it has become evident 
that loss of function of Kv1.2 can result in impaired membrane repolarisation and neuronal 
hyperexcitability (Kearney, 2015). There is even evidence to support the theory that different 
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variants of the Kv1.2 channel can be expressed, supporting a “gain-of-function” mutation and 
inducing hyperexcitability of neuronal networks in the CNS (Niday and Tzingounis, 2018).  
Evidence of Kv1.2 having a significant effect on peripheral nerve fibres is more limited. 
Although the Kv1.2 channel is well characterised in sensory neurons, especially the larger 
diameter A-fibres of the DRG  (Tsantoulas and McMahon, 2014) it is often hard to pin-point a 
pathological effect arising from changes in expression in one protein in vivo.  
 
It has been suggested, that the down-regulation of these channels is partly responsible for 
increased ectopic firing of DRG neurons in a neuropathic pain state (Fan et al., 2014). In a CCI 
model in rats, there was shown to be a concomitant link between knockdown of Kv1.2 and 
upregulation of a different microRNA of interest (Zhang et al., 2020). This work was 
completed in adult rats rather than embryonic mice, and studied changes in protein 
expression at the level of L4-L6 in the spinal cord following nerve injury. As anticipated, CCI 
at L4/L5 induced rapid reductions in the paw withdrawal threshold, and animals displayed 
signs of mechanical allodynia. This corresponded with a significant decrease in protein 
expression of Kv1.2 as determined by western blot (Zhang et al., 2020). However, given that 
Kv1.2 is implicated in neuropathic pain, and is known to be expressed on the select fibres of 
the DRG neurons it was considered a good target for miR-138 in this study.  
 
In a recent study it was shown that there was a link between long non coding RNA silencing 
of Kv1.2 in DRG neurons and the development of a neuropathic pain state by increased 
membrane depolarization (Zhao et al., 2013). On the contrary the role of short, non-coding 
RNA such as microRNAs have not been widely investigated with regards to the expression of 
Kv1.2.  
 
Based on the results of this work it could be hypothesised that miR-138-5p contributes to the 
regulation of neuronal excitability, potentially via translational repression of ion channels 
such as Kv1.2 on the terminals of sensory neurons. However, given that the addition of siRNA 
for Kv1.2 alone did not induce a significant increase in neuronal excitability, it is unlikely to be 
the only target for miR-138-5p involved in regulation of membrane excitability. 
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6 General Discussion and Conclusions 
 
6.1 Role of the DRG neurons in peripheral neuropathy:  
As described in Chapter 1.5.3 and 3.1.2 the development of chronic pain is concomitant with 
the peripheral nociceptor neurons of the DRG fibres becoming irreversibly sensitised. The 
molecular mechanisms underlying development of some pathologies including neuropathic 
pain are still being elucidated. Animal models have demonstrated that there is more than one 
peripheral and central component underlying the onset of painful neuropathies. At present 
there are several in vivo models that have been shown to successfully model behavioural 
characteristics of neuropathic pain. For example chronic constriction injury (CCI) models have 
shown the hyperexcitability of axotomized DRG neurons, and the eventual onset of central 
sensitisation (Chung and Chung, 2002). Other models include the use of spinal nerve ligations 
(SNL) to demonstrate onset of paw withdrawal resultant from reduction in thermal or 
mechanical threshold for stimulation (Wang and Wang, 2003; Jaggi, Jain and Singh, 2011). 
 
Until recently in vitro modelling has been less successful at studying the molecular 
mechanisms underlying the development of pain. Largely this was due to the limited capacity 
of standard culture techniques to replicate the polarized nature of neurons in vitro (see 
Chapter 1.2 and 3.1.3.). The results from Chapter 3 showed that the use of 
compartmentalised microfluidic chambers described in this thesis enabled the development 
of an in vitro model that can replicate some of the key aspects of neuronal excitability as seen 
in vivo. Although direct co-culture of macrophages and DRG neurons was not deemed 
possible in this format, the use of cytokine rich media led to the development of a flexible 
model for quantifying changes in neuronal excitability. Given that this work was carried out 
in vitro, it is important to re-iterate that this was not directly a model of pain, but modelled 
changes in excitability as a proxy for nociceptive neuron function. 
The results of live cell imaging in Chapters 4 and 5 have discussed that the amplitude and 
duration of a neuronal response was lower when only the axons were stimulated in 
microfluidic devices. These results highlighted how microfluidic chambers present advantages 
in terms of temporal responses, but also provide the capacity to modulate processes localised 
to the axon. Previous efforts by the Dajas-Bailador lab have used compartmentalised 
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microfluidic cultures to highlight the polarised nature of neurons and local protein expression 
in the axon (Lucci et al., 2020). The model described in this thesis brings a dynamic dimension 
where function of excitability was studied locally by quantifying evoked changes in Ca2+. Local 
translation is known to play a role in pain (Ferrari et al., 2013) but has largely been ignored so 
far due to the inaccessibility of local axons in vivo and inability of standard in vitro models to 
do it. In conclusion, compartmentalised microfluidic models such as ours provide a novel 
technique for studying local protein expression in the axon using in vitro models.  
 
6.2 Investigation of inflammation on the amplitude of evoked Ca2+ transients 
in the soma of sensory neurons: 
Following insult to the nerve, the onset of inflammation indirectly regulates excitability of the 
DRG neurons, most likely via the modulation of membrane conductance. In states of 
inflammation, the axons of the DRG neurons become “stressed” and depleted of 
mitochondrial stores (Jha et al., 2015; Misgeld and Schwarz, 2017). Neurons are highly 
metabolically active and the continual replenishment of ATP is essential for regulation of basic 
cellular functions. This includes resolving inflammation, regulating propagation of the action 
potential and regulation of membrane conductance. It has been shown that in the onset of 
peripheral sensitisation associated with inflammation, there is a rapid influx of M1-like 
macrophages to the damaged tissue (Godai et al., 2014). Furthermore, during the resolution 
of inflammatory pain (in mice) the M2-like macrophages infiltrate the nerve terminals of the 
DRG, concurrent with increased levels of oxidative phosphorylation in the neurons.  
 
In vivo, intraplanar injection of carrageenan into the hindpaw of mice shows rapid 
development of hyperalgesia (Winter, Risley and Nuss, 1962; Whiteley and Dalrymple, 2001) 
that can be measured using behavioural analysis such as ‘dynamic weight bearing.’ In a recent 
study it was shown that when macrophages were selectively depleted from mice, they still 
showed the rapid onset of pain in response to carrageenan, but critically this pain response 
did not resolve (Raoof et al., 2020).  
The work in this thesis has also investigated the role of inflammatory modulation on the 
terminals of sensory DRG neurons. The results in chapter 3 showed the development and 
characterisation of two populations of inflammatory macrophages. The results in Chapter 4 
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showed that the exposure of the neuronal terminals to the polarized media did not initiate a 
state of hyperalgesia, instead the cytokine-rich media reduced the overall excitability of the 
DRGs.  In Section 1.8.2 the dynamic nature of macrophage cells was discussed, and in vivo 
studies have demonstrated that it is the metabolic nature of the inflammatory cell that 
contributes to the development of pain states such as hyperalgesia. For example, in vivo, the 
M1-macrophages are known to be glycolytic cells, whilst the M2-like cells are dependent on 
oxidative phosphorylation (Rath et al., 2014b; Angajala et al., 2018; Hobson-Gutierrez and 
Carmona-Fontaine, 2018). In chronic pain it has been demonstrated that where oxidative 
phosphorylation is impaired (Duggett, Griffiths and Flatters, 2017) so is Ca2+  buffering in the 
cell, and consequently action potential propagation. It was hypothesised that in a similar way 
that cortical neurons uptake mitochondria from surrounding astrocytes following a stroke 
(Hayakawa et al., 2016), so do the DRGs uptake mitochondria from surrounding M2-like 
macrophages in the resolution phase of inflammatory pain (Raoof et al., 2020). 
Therefore, it could be hypothesised that the decrease in excitability of neurons exposed to 
cytokine-rich media in vitro was a response to the exposure of the cytokines present in the 
media, and not resultant from exposure to the macrophages themselves. Although the results 
of this model did not directly mirror what can be observed in vivo, this setup demonstrated 
the flexibility microfluidic modelling, with potential for the model described here to be 
developed further.  
 
6.3 The role of microRNA in regulation of sensory neuron excitability: 
In vivo the onset of pain and neuronal hypersensitivity is often associated with underlying 
changes in protein expression. For example, as described in Chapter 1.5.2, the sensitisation 
of peripheral nociceptors may be caused by translational regulation of receptors on the 
terminals of the DRG neurons. Given that microRNAs target translational repression (or 
degradation) of multiple mRNAs, it is hypothesised that microRNAs expressed in the sensory 
DRG nerves regulate local protein translation, and thus contribute towards regulation of 
neuronal excitability. Several studies have previously implicated the role of microRNAs in 
regulation of DRG excitability, often in the context of neuropathic pain (Aldrich et al., 2010, 
Zhao et al., 2010, Sakai et al., 2013.). 
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In an SNL model of neuropathic pain, it was observed that there was a significant down-
regulation of miR-183 in the ipsilateral L5 DRG, corresponding with the onset of mechanical 
hypersensitivity (Aldrich, et al., 2010). Furthermore, microarray analysis using total RNA 
isolated from L5 DRGs in rats implicated the downregulation of microRNAs such as miR-7a in 
the hyperexcitability of sensory neurons, arising from upregulation of voltage-gated channels 
(Sakai et al., 2013).  
In vivo loss of function studies have also previously elucidated the upregulation voltage-gated 
channels such as  NaV1.8 in hyperexcitability of the DRG neurons in neuropathic pain models 
(Thakor et al., 2009).  In a spared nerve injury model of neuropathic pain, the down-regulation 
of miR-182 correlated with the upregulation of the NaV1.7 channel on nociceptive DRG fibres, 
and the onset of neuropathic pain behaviours. The selective over-expression of miR-182 at 
L4-L6 was shown to reverse this change over-expression of NaV1.7 and reduce the 
hyperexcitability of the DRG neurons (Cai, et al., 2018).   
One advantage of the microfluidically isolated culture used in this thesis was the capacity to 
study changes in excitability at a molecular level. One mechanism of which has been explored 
in Chapter 5, investigating the effect of microRNA on excitability of small diameter DRG 
neurons. Of particular interest to this project was the role of miR-138-5p in regulating 
neuronal excitability in the context of pain. MiR-138-5p is a widely reported microRNA, with 
evidence for roles in suppression of axonal regeneration in the CNS (Liu, et al., 2013)  and has 
also been implicated in inflammation and tumour suppression (Bai, et al., 2018). Chapter 5.1.2 
describes the upregulation of miR-138-5p in a model of hyperalgesic priming. However, 
several other works have implicated miR-138-5p in pain. For example, in a recent CCI model 
for neuropathic pain in adult mice 125 microRNAs were differentially expressed in the sciatic 
nerve. This included a significant decrease in miR-138-5p corresponding with the onset of 
mechanical allodynia  (Wilkerson, et al., 2020).  
The microfluidic nature of the devices used in our model showed that localised inhibition of 
miR-138-5p in the axons of microfluidic culture of DRG neurons led to a decrease in neuronal 
excitability. As discussed in Chapter 5, bioinformatic targets searches combined with the 
results of the Ca2+ signalling assay suggested the role for miR-138-5p in specific inhibition of 
potassium channels.  
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6.4 Dysregulation of potassium channels in disease and neuropathy: 
Excitability is a key function of neurons, both with regards to homeostatic function and 
development of pathologies such as pain. This has been discussed at length in Section 4.1.1, 
and supported by the results shown in Chapters 4 and 5. Neuronal excitability is regulated by 
subcellular expression and localization of ion channels, with evidence showing that ion 
channels form ‘clusters’ at different sites throughout the axon (Rasband, 2010). The tight 
regulation of the conduction and propagation of an action potential along the axon is 
essential for normal neuronal function. Underlying this control of membrane excitability is 
the expression of multiple ion channels on the nerve terminals and along the axonal 
membrane. Perhaps one of the most well documented examples of this are the voltage-gated 
ion channels. The dual signalling between sodium and potassium is key in maintaining the 
resting potential of the neuron. But what happens when this signalling goes awry?  
 
It has been suggested, that down-regulation of the voltage-gated ion channels involved in  
regulating membrane conductance is partly responsible for increased ectopic firing of DRG 
neurons in a neuropathic pain state (Fan et al., 2014). In particular the down-regulation of 
Kv1.1 and Kv1.2, both of which are expressed on the juxta-paranodal regions of DRG neurons, 
has demonstrated hyperexcitability of cells in loss-of-function studies (Tsantoulas and 
McMahon, 2014). For example, in a CCI model in rats, there was shown to be a concomitant 
link between knockdown of Kv1.2 and upregulation of a different microRNA of interest (Zhang 
et al., 2020). This work was completed in adult rats rather than embryonic mice, and studied 
changes in protein expression at the level of L4-L6 in the spinal cord following nerve injury. 
As anticipated, CCI at L4/L5 induced rapid reductions in the paw withdrawal threshold, and 
animals displayed signs of mechanical allodynia. This corresponded with a significant 
decrease in protein expression of Kv1.2 as determined by western blot (Zhang et al., 2020). 
However, given that Kv1.2 is implicated in neuropathic pain, and is known to be expressed on 
the select fibres of the DRG neurons it was considered a good target for miR-138 in this study.  
 
6.5 Concluding remarks: 
The work in this thesis details the use of compartmentalised microfluidic cultures to model 
changes in excitability of sensory DRG neurons. It was possible to utilise the microfluidic 
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isolation of the device to expose the axons and the soma of the DRG to separate micro-
environments. Of particular interest to the study of nociception was the exposure of the 
axonal compartment to inflammatory stimuli. A unique set of in-house stimuli were 
developed from the culture and polarization of bone marrow derived macrophages. 
The model described was flexible and could be repeated with different sets of inflammatory 
mediators if desired. For example, protocols for culture and polarization of spinal cord derived 
microglial cells were also developed, which could be used to investigate changes in DRG 
excitability resulting from changes in signalling from the CNS.  
In our model, the use of live-cell imaging was particularly important to quantify changes in 
neuronal excitability, with the nature of microfluidic modelling providing the capacity to 
monitor changes in evoked Ca2+ transients at the soma as a result from axonal stimulation. 
This unique property of the microfluidic devices also permitted the investigation of local 
translation of protein. Neurons are highly polarised cells, and it was evident that localised 
stimulation of the axonal terminals with KCL induced a rapid and significant increase in 
neuronal excitability. Therefore, the effects of small non-coding RNA on translational 
repression in the axons were investigated. Kv1.2 was identified as a target for miR-138-5p, 
where inhibition of miR-138-5p in the axons induced a reduction of neuronal excitability in 
microfluidic cultures. It was hypothesised in Chapter 5 that Kv1.2 was a target for miR-138-
5p, with bioinformatic predictions showing 5 potential binding sites for miR-138-5p in the 
3’UTR (see Appendix, figure 7.7.1.) However, we were also able to validate some of these 
interactions between miR-138-5p and Kv1.2 using a dual luciferase reporter assay and site 
directed mutagenesis assays.   
In our final pilot studies, knock-down of Kv1.2 mRNA in the axon did not show a significant 
increase in neuronal excitability. Several other studies have investigated the role of Kv1.2 in 
hyperexcitability and development of pain-states such as neuropathic pain (Everill and Kocsis, 
2000; Xiuli et al., 2013; Laumet et al., 2015; Zhao et al., 2017). The majority of these pain-
based studies were conducted in vivo, due to the limited capacity of most in vitro models to 
replicate the complex morphology of the DRG neurons and surrounding non-neuronal cells. 
However, microfluidic model such as the one described in this work can overcome these 
hurdles. Of course, unlike siRNA, miRNAs target the translational repression of multiple 
mRNAs, and therefore it is unlikely that in vivo miR-138-5p only inhibits the expression of 
Kv1.2 at the axonal terminals of the DRG neurons. The results from the final experiment with 
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siRNA for Kv1.2 described in this thesis did not conclusively link upregulation of protein to 
miR-138-5p. The results of a bioinformatic target search also highlighted inward rectifiers and 
two-pore potassium channels such as TREK-2 as targets of interest. It could be hypothesised 
that miR-138-5p has roles in regulating the expression of multiple subtypes of potassium 
channels. The combined effect of miR-138-5p on multiple ion channels of interest could 
demonstrate a more significant effect on regulating membrane excitability (LaMotte & Ma, 
2007). 
 
6.6 Implications of this study on future work:  
In order to discover more effective medicine for pain, there is an ever-present need for 
biologically relevant in vitro models. Microfluidic models provide the necessary tool for 
reproducible culture in vitro that replicate the polarity of the cells observed in vivo. This could 
help to lead to the development of in vitro models for the study of pain, that are more 
predictable to the response observed in humans. 
The model described in this thesis provided the capacity to investigate the excitability of DRG 
neurons following localised exposure of the axons to a range of stimuli and molecular 
manipulations. Critically, the microfluidic nature of the devices meant that the DRG neurons 
retained their polarised morphology when cultured in vitro.  The work in this thesis has 
already led to advances in the optimisation of the method of culture used in the lab, as well 
as the development of high throughput templates for analysis of Ca2+ signalling.  As with the 
development of any model, there are still unanswered questions for future studies. The 
identification of future work would be dependent on the question being asked of the model. 
Here I have provided a few examples of how the model I have described could be further 
progressed in future works:  
 
6.6.1 Investigation of neuronal excitability on inflammation: 
Future works could involve the development of a model involving the use of triple channel 
devices (as show in schematic 3.1.2.) In the same way in which this project has modelled 
changes in excitability of the DRGs induced by changes in peripheral inflammatory cells, it 
could be interesting to investigate the downstream effect of this neuronal modulation on cells 
of the CNS such as microglia. This work also developed a protocol for the isolation and 
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characterization of populations of microglial cells in vitro. It could be hypothesized that for 
additional complexity, the next stage would be to investigate how the induced changes in 
neuronal excitability observed in this project could affect the morphology and phagocytic 
activity of spinal cord derived microglial cells.  
 
6.6.2  Investigation of the targets for miR-138-5p in regulating neuronal 
excitability: 
 
The preliminary study of siRNA for Kv1.2 on excitability of DRG neurons did not show a 
significant increase relative to the control at N=6. Expansion of the work shown in this project 
could include further development of the siRNA study, which time-permitting would have 
most likely been the next investigation of this Thesis. Using siRNA in co-incubation with a cell 
permeable miR-138-5p inhibitor, the decreased excitability induced by miR-138-5p inhibition 
could be potentially ‘rescued’.  
Other options could also include the development of the microfluidic model as a ‘screen’ for 


























7 Appendices  
7.1 Reduction in the concentration of GDNF did not prevent non-neuronal 
cell migration  
7.2 Composition of polarized macrophage media:  
Although 40 targets were tested relative to an endogenous positive control, a negative 
control and a blank control, the preliminary fold changes in select target of interest are 
displayed below. The positive control was provided by biotin-conjugated IgG printed directly 
onto the array membrane in the upper-left and lower-right corners. The negative control 
spots were printed with the same buffer used to dilute antibodies printed on the array. 
Therefore, the signal intensities of the negative controls represented the background plus 
non-specific binding to the printed spots and could be used for background correction of the 
signal.  
 
The fold change of each target was measured relative to the endogenous positive control 











Figure 7.1.1: Measuring non-neuronal cell migration in microfluidic cultures; A) DiV3 E18 rat DRGs (01/12). B) DiV4 P2 rat DRGs 
(04/12). C) DiV4 P2 Rat cells cultured with additional anti-mitotics.  
A) DiV3 E18 rat DRGs . B) DiV4 P2 rat DRGs. C) DiV4 P2 Rat cells cultured with additional anti-mitotics.  
  
Figure 6.6.1: Measuring non-neuronal cell migration in microfluidic cultures; 
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regulation, this assay was replicated once, using 2 samples for each polarized media, and 
where each repeat was extracted from a different batch of polarized cells.  
Luminescence was then used to detect the relative concentration of each antigen in the 
media. In this instance both conditions were exposed for 10 minutes for direct comparison, 
although it was noticeable that the M2-like media displayed lower raw integrated density, 
particularly with relevance to the positive control. For this reason, results are shown as the 
raw integrated density (in pixels) with the fold change of each cytokine relative to the 
endogenous positive control. On each membrane, the most highly expressed chemokine was 



















































































Figure 7.2.1: Results of a 40-target cytokine array using inverted densitometry for a semi-quantitative analysis of the fold 
change in the most highly expressed cytokines present in different media subtypes. N=2, error bars representing the 
standard deviation of the fold change. 
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Two batches of media were tested, from different dates of bone marrow extraction, and 
subsequent polarization. Although each batch of media show variation in the expression of 
specific markers there was some overlap between the most highly detected markers in both 
analysis formats. This is demonstrated by the prism analyses included above (figure 7.2.1). 
There was some initial concern by the low levels in expression of cytokines that have been 
heavily documented in inflammatory studies. However, it is important to note that different 
cytokines appear at different time points throughout the pro-inflammatory and resolution 
phase of injuries (Melton et al., 2015).  
 
It was unlikely that the protocol for polarizing macrophages generated two discrete 
populations of cells. The M1/M2 nomenclature is useful for defining the two populations of 
cells produced but fails to acknowledge the presence of intermediate polarization stages. 
Results of the cytokine array demonstrated that despite expected overlaps, the populations 
of polarized macrophages present clear shifts in cytokine profiles, and helps to define the 
inflammatory state (Orecchioni et al., 2019; Zajd et al., 2020). However, the M2 population in 
particular was unlikely to be purely an M2a phenotype. In order to better understand the 
results of the array, I have highlighted the importance of some of the most highly expressed 
cytokines.   
 
CCL2 (MCP-1): 
CCL2 (formerly MCP-1) is an inflammatory chemokine produced by monocytic cells, as well as 
fibroblasts and epithelial cells during the innate immune response (Deshmane et al., 2009). 
There is vast evidence for the role of CCL2 as a pro-inflammatory chemokine that is involved 
in the influx of macrophages and fibroblasts to a site of injury or inflammation. However, the 
role of CCL2 as an innate polarizing signal for macrophages remains somewhat unclear. A high 
level of CCL2 production can be indicative of a shift towards the M2-like phenotype, where 
blockade of CCL2 binding shows a decrease in anti-inflammatory cytokine production in in 
vivo modelling of inflammation (deSchoolmeester et al., 2003). However, CCL2 is also 
implicated in disease pathologies such as rheumatoid arthritis where macrophages are 
observed polarized towards an M1-like phenotype. For example, it has been demonstrated 
that stimulation by LPS induced polarization towards the M1-like phenotype, and correlated 
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with high levels of MCP-1 (CCL2.) Moreover, the level of CCL2 in the blood correlated with 
other markers of rheumatoid arthritis, and could therefore be considered a biomarker (Liou 
et al., 2013). Our results also showed that CCL2 was highly expressed in both M1-like and M2-
like cells relative to the positive control, although the release from M2-like cells appeared to 
be higher than that of the M1 population. Therefore, the role of CCL2 in driving cytokine-
specific immune responses is both complex and dynamic.  
 
RANTES (CCL5): 
CCL5 was detected at a 2.2x increase in the M2-like population of cells, despite widely being 
regarded as a pro-inflammatory cytokine. However, it has also been demonstrated that some 
M2-like cells produce high levels of CCL5 in order to recruit other inflammatory cells 
(neutrophils, monocytes etc.) in a regulatory inflammatory response (Atri, Guerfali and 
Laouini, 2018). There is evidence to support the release of CCL2 (and CCL5) from both M1-like 
and M2-like cells in bone marrow derived cultures (Zajd et al., 2020) although the relative 
concentrations of cytokines present will always be dependent on the microenvironment of 
the cell culture. This may have been affected by the time at which the media was removed 
from the cells for testing, or the length of initial exposure to a stimulus, or even the type of 
media cells were cultured in (Murray et al., 2014a).  
 
IL-6: 
Other important examples include the small increase in IL-6 (0.97X) observed in the M2-like 
culture. IL-6 is a pleiotropic cytokine, with roles in modulating both pro- and anti-
inflammatory pathways. However, it is acknowledged that the presence of IL-4 (the stimulus 
used to induce the M2-like phenotype) can cause downstream release of IL6 from M2-cells 











7.3 Microglial Phagocytosis assay:  
Having demonstrated that it was possible to detect changes in the phenotype of the spinal 
cord derived microglial culture, the next step was to investigate if this led to a functional 
change in the induction of phagocytosis, typical of polarized microglia cells (see figure 7.3.1 
below for images acquired at 63X magnification). By incubating pre-polarized cells with 
yellow-fluorescent latex beads (1µM diameter, Sigma L1030) the average number of beads 
ingested in a set time period was used as a measure of phagocytic activity. This assay is ideally 
completed using confocal microscopy to confirm the bead has been phagocytosed. Without 
access to this equipment, we used widefield imaging and z-stacks confirmation to determine 
overlap of the bead with the image of the cell suggests migration towards the cell body.  
 
Cells were exposed to the latex beads on separate occasions for either 24 or 48 hours, to 
quantify how quickly a microglial phenotype would begin to ingest a foreign body. In order to 
analyse these findings, the number of beads versus the number of cells in a single frame (20X 
magnification) was manually counted. From here, the number of beads overlapping with the 
cell body (stained with iba-1) was calculated and used to estimate the average number of 
beads phagocytosed per cell. After 24-hours exposure, results showed that the number of 
beads overlapping with the microglial cell body was highest in the M1-like population (20.2 ± 
15.8) compared to only 14.12 ± 14.1 in the M2-like cells, see figure 7.3.1C. Since this metric 
did not demonstrate a significant difference in the number of beads ingested between the 











7.4 Analysing changes in morphology dependent on cellular phenotype:  
Feret’s diameter is measured by the greatest distance between two points along the diameter 
of the cell. The equation for the transformation index is as follows: 













































A) M1-like cells. B) M2-like cells. Green= Latex fluorescent beads, Blue= DAPI nuclear stain, Red= Iba-1. C) Comparing average 
number of beads ‘ingested’ over 24-hours by M1-like cells vs. M2-like cells. P=0.1644 (NS), at N=3 coverslips, 5x ROI 
minimum. 
Figure 7.3.1: Looking at the overlay between Iba-1 and the green latex bead as a marker for how the phagocytic activity of 
microglial cells is dependent on phenotype. 
 219 
This equation can be used to calculated microglial ramification state, based on phenotype of 
the cell. A cell with long processes and a small soma, such as the standard “anti-inflammatory” 
phenotype, has a large index value, and via versa. It is also important to note that this index 
is only dependent on cell shape, not on cell size. Figure 7.3.1 (above) at 63X magnification 
clearly demonstrates distinct morphological changes of the microglial culture, dependent on 
the polarisation state and subsequent ramification.  
 
The images acquired from the phagocytosis assay were also used to calculated Feret’s 
diameter: 
 
M1-like  M2-like  
63X 30.35125 52.612 
20X 28.0848 27.60432 
Average area 
(µM) 29.218025 40.10816 
Table 7.1.: Morphological changes of microglial cultures as determined by a Feret’s diameter calculation 
In total 10 replicate images from the phagocytosis assay were used to calculate Feret’s 
diameter. (5x replicate images at 63X magnification and 5x images at 20X magnification.)  
 
 
7.5 The stimulation of axons by cytokines used to polarize macrophages did 
not evoke a significant increase Ca2+ transients: 
 
It was demonstrated that acute exposure of the axonal compartment to media extracted from 
polarized macrophages elicited a transient, but small increase in cellular excitability. Although 
the contents of the polarized media had been semi-quantified using the cytokine array in 
chapter 3 (supplementary figure 7.2.1) it had not yet been determined whether the stimuli 
used to polarize the macrophages would also induce a change in the excitability of the DRG 
neurons. When media was extracted from the polarized macrophages and used to stimulate 
the axonal compartment of a microfluidic device, it is likely that there was still a low level of 
cytokine in circulation, even following replacement of fresh media.  
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For this reason, cytokines such as IFNy and IL-4 were diluted directly into complete imaging 
buffer and used to stimulate the axonal compartment of microfluidic devices (N=3.)  
 
The exposure to the cytokines shown did not induce significant release of Ca2+ transients in 
the soma.  The average peak excitability recorded is shown in the table shown below for the 
relative stimuli used: 
 
Stimulus △F Max 
M1 (NPR 2H fresh) 0.053 
LPS 0.05 
IFNy 0.1 
    
M2 (NPR 2H fresh)  0.099 
IL-4 0.02 
Table 7. 2: Peak excitability induced following axonal exposure to stimuli shown 
The response to M1-like media was very close to that of LPS and less than that of IFNY. On 
the contrary, if cells were stimulated solely with IL-4, the average peak excitability was lower 
than if the cells were stimulated with the media containing the cytokines released from anti-
inflammatory like macrophages. The increases in excitability were negligible with respect to 











7.6 QPCRs from Pooled samples:  
 
Figure 7.4.1 shows an N=1, where 3 biological replicates of RNA extractions were pooled prior 
to qPCR reactions.  
Result of two-way ANOVAs, where the mean fold-change has been compared with the other 
averages for the same compartment of the insert. In this way an ‘adjusted’ P-value was 
calculated allowing for inter-sample variation.  Results showed that there was no statistical 
significant increase in miR-138-5p expression in either the somal compartments in either the 
M1-media exposed cells or the M2-media exposed culture. It was hypothesised that by 
pooling the samples the significance was lost by reducing the N-number to 1. The data in 
supplementary figure 7.4.1 demonstrated a 0.9X change in miR-138-5p in axons exposed to 
M1-like media, relative to a 1.91X increase in miR-138-5p if cells were exposed to M2-like 
media. Evidence also showed that there was an increase in miR-138-5p in the soma relative 

















































Figure 7.5.1: Quantification of localised effects of inflammatory mediators on expression of miR-138-5p in pooled 
samples of RNA 
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like media (3.92X increase) or M2-like media (5.68X increase.) However, only if the neurons 
were exposed to M2-like media was an increase in miR-138-5p observed both in the somal 
RNA and the axonal RNA extracted from the cells. 
 
7.7 pmiRGlo Plasmid Map (Promega): 
 
Figure 7.7.1: Plasmid map for pmiRGlo (Promega) 
 
7.8 miR-138-5p binding sites in the 3’UTR of Kv1.2: 
Figure 7.7.2; mmu-miR-138-5p binding sites in Kv1.2 as predicted by Ensembl. 
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